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Abstract		Wilms’	tumour	is	the	most	common	paediatric	renal	tumour.	In	Europe	treatment	involves	pre-operative	chemotherapy	followed	by	surgery.	Many	patients	receive	MRI	scans	which	include	diffusion	weighted	imaging	(DWI)	throughout	their	diagnosis	and	treatment.		This	thesis	retrospectively	acquired	Wilms’	tumour	MRI	data	and	prospectively	acquired	renal	DWI	data	in	healthy	volunteers.	Four	models	of	diffusion	were	used	throughout	this	thesis;	mono-exponential,	IVIM	(intravoxel	incoherent	motion),	stretched	exponential,	and	kurtosis.		In	healthy	volunteers,	models	were	compared	based	on	the	reproducibility	of	the	parameters,	when	calculated	based	on	different	b	values	and	magnetic	fields	strengths.	It	was	shown	that	ADC,	D	(IVIM),	f	(IVIM),	Dk	(kurtosis),	and	α	(stretched	exponential)	had	high	levels	of	reproducibility	whereas	reproducibility	was	poorer	in	D*	(IVIM),	K	(kurtosis)	and	DDC	(stretched	exponential).		Model	fits	were	compared	in	Wilms’	tumour	and	contralateral	normal	kidney	data	using	the	Akaike	Information	Criterion.	It	was	shown	that	all	raw	DWI	data	favoured	non-Gaussian	models	as	opposed	to	a	mono-exponential	model.	DWI	data	acquired	in	Wilms’	tumour	favoured	the	stretched	exponential	model,	and	DWI	data	acquired	in	normal	kidneys	favoured	the	IVIM	model.	The	volume	of	necrotic	tissue	post-chemotherapy	is	an	important	marker	of	treatment	response.	However,	currently	identification	of	necrosis	relies	on	gadolinium	contrast	enhancement.	It	was	shown	that	a	combination	of	T1weighted	imaging	and	ADC	could	provide	an	alternative	method	to	visualising	and	quantifying	necrosis,	allowing	future	studies	to	estimate	the	volume	fraction	of	necrosis	in	Wilms’	tumour	without	gadolinium.		Finally,	it	was	shown	that	certain	Wilms’	tumour	subtypes	could	be	distinguished	
in	vivo	using	DWI,	whereas	currently	this	relies	on	histological	tissue	analysis	post-surgery.	The	parameters	D*	(IVIM)	and	K	(kurtosis)	provided	the	best	stratification	between	subtypes,	however,	the	earlier	study	demonstrated	that	the	reproducibility	of	these	parameters	was	poor,	which	may	limit	their	clinical	utility.		 	
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Impact	Statement		 	This	thesis	investigated	the	use	of	diffusion	weighted	imaging	in	Wilms’	tumours.	A	range	of	advanced	non-Gaussian	models	of	diffusion	were	compared.	Each	model	provides	various	biomarkers	of	diffusion	and	have	the	potential	to	provide	clinically	useful	information.		 This	thesis	demonstrated	that	in	Wilms’	tumour	tissue	and	normal	renal	tissue,	diffusion	does	not	exhibit	mono-exponential	behaviour,	but	is	better	described	by	non-Gaussian	models.	In	Wilms’	tumour	the	stretched	exponential	model	provided	the	best	description	of	the	data	and	in	normal	renal	tissue	the	IVIM	model	(intravoxel	incoherent	motion)	provided	the	best	description.	This	finding	could	be	beneficial	in	many	areas	of	research	as	many	studies	utilise	ADC	(a	diffusion	parameter	derived	from	a	mono-exponential	model)	and	thus	assume	the	tissue	has	a	mono-exponential	signal	decay	as	the	diffusion	weighting	is	increased.	Being	aware	that	tissue	may	be	better	described	by	other	models	may	lead	to	more	accurate	representations	of	the	underlying	tissue	structure.			 Another	finding	was	that	many	parameters	produced	from	diffusion	models	are	reproducible,	including	ADC,	D	(IVIM),	f	(IVIM),	Dk	(kurtosis),	and	α	(stretched	exponential),	when	generated	based	on	acquisitions	using	different	b	values	and	at	different	magnetic	field	strengths.	This	finding	will	help	with	generalising	the	results	from	this	thesis	and	interpreting	research	from	different	centres	who	do	not	have	identical	imaging	protocols.	Furthermore,	some	parameters	were	less	reproducible	[D*	(IVIM),	K	(kurtosis)	and	DDC	(stretched	exponential)],	thus	aiding	the	interpretation	of	future	research	using	these	parameters,	as	some	findings	may	not	be	able	to	be	replicated	across	different	centres.			 A	key	result	from	this	thesis	was	the	ability	to	identify	necrotic	tissue	within	Wilms’	tumour	using	a	non-invasive	method.	It	was	shown	that	necrotic	tissue	could	be	visualised	and	quantified	using	a	combination	of	ADC	and	T1weighted	imaging,	whereas	currently	an	injection	of	gadolinium	contrast	is	required.	This	finding	has	the	potential	to	be	clinically	useful	as	the	volume	of	necrotic	tissue	post-chemotherapy	is	informative	of	treatment	response,	and	gadolinium	is	not	always	appropriate	in	some	patients.		 Furthermore,	this	thesis	highlighted	that	subtypes	of	Wilms’	tumour	may	be	able	to	be	identified	in	vivo	using	diffusion	measurements,	whereas	currently	this	can	only	be	determined	via	histological	analysis	after	surgery.	This	thesis	suggested	that	non-Gaussian	
7 
 
diffusion	parameters	may	be	superior	to	ADC	in	distinguishing	different	Wilms’	tumour	subtypes.		Therefore,	overall	this	thesis	has	suggested	that	non-Gaussian	models	of	diffusion	should	be	investigated	in	future	research	in	Wilms’	tumour,	and	potentially	other	forms	of	abdominal	cancer.	These	models	provided	an	improved	fit	to	the	raw	DWI	signal	and	provided	novel	biomarkers	to	describe	the	microstructure	and	physiology	of	the	tumour	tissue.					 	
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Chapter	1:	Wilms’	Tumour		This	chapter	discusses	Wilms’	tumour,	highlighting	the	aetiology	and	histological	presentation	of	the	disease.	Additionally,	this	chapter	explains	the	differences	in	treatment	approaches	used	across	the	world	and	recent	updates	in	protocols.	Throughout	this	thesis	patients	with	Wilms’	tumour	are	referred	to	as	Wilms’	tumour	patients.			
1.1:	Wilms’	Tumour	in	Context	Wilms’	tumour,	otherwise	known	as	nephroblastoma,	accounts	for	approximately	5%	of	all	cancers	in	children	under	15	years	of	age1.	Wilms’	tumour	is	the	most	common	paediatric	renal	tumour	equating	to	approximately	80-90%	of	all	kidney	tumours1.	The	majority	of	these	tumours	are	unilateral;	affecting	only	one	of	the	kidneys,	but	around	7%	of	all	cases	are	bilateral1.	The	majority	of	diagnoses	are	in	those	between	3	and	4	years	old,	with	a	decline	in	frequency	being	seen	in	children	over	5	years;	however	Wilms’	can	present	in	older	children	and	even	in	adults	in	very	rare	cases1.		
	
1.2:	Wilms’	Tumour	Aetiology		The	kidneys	are	formed	through	the	development	of	nephrons	from	foetal	metanephric	blastema	which	surrounds	the	ureteric	bud2.	In	healthy	development	the	foetal	renal	tissue	will	mature	during	gestation,	however	in	some	cases	foetal	tissue	can	remain	into	infancy	in	the	form	of	nephrogenic	rests2;	these	rests	represent	clusters	of	abnormally	persistent	immature	embryonal	cells3.	Nephrogenic	rests	can	be	sub	classified	as	either	perilobar	nephrogenic	rests	or	intralobar	nephrogenic	rests;	the	former	being	limited	to	the	renal	cortex,	and	the	latter	occurring	throughout	the	renal	lobe3.	Nephrogenic	rests	are	thought	to	be	precursors	to	Wilms’	tumour4;	in	that	these	rests	can	undergo	transformation	into	malignant	renal	tumour2,	although	only	approximately	1%	of	children	with	nephrogenic	rests	go	on	to	develop	Wilms’	tumours5,	other	rests	will	become	hyperplastic,	dormant	or	spontaneously	involute6.	Nephrogenic	rests	can	often	be	confused	with	Wilms’	tumour,	particularly	in	the	cases	of	bilateral	tumours;	as	nephrogenic	rests	have	been	found	in	94-99%	of	those	with	bilateral	Wilms’	tumour3.	In	a	small	number	of	Wilms’	tumour	patients	all	or	part	of	the	WT-1	gene	is	deleted,	and	it	was	suggested	that	metanephric	stem	cells	cannot	differentiate	to	normal	
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kidney	components	when	WT-1	is	inactivated7.	However,	the	majority	of	Wilms’	tumour	patients	do	not	have	this	gene	mutation	and	the	genetic	components	of	Wilms’	tumour	is	much	more	complex8.	Around	1-2%	of	cases	are	familial9,	but	in	most	cases	the	causes	of	Wilms’	tumour	are	unknown.		
	
1.3:	Clinical	and	Histological	Presentation	Wilms’	tumour	presents	clinically	as	a	large	painless	abdominal	mass,	with	only	around	a	third	of	patients	exhibiting	abdominal	pain,	vomiting,	and	tiredness6.	Studies	have	shown	that	around	25%	of	patients	have	hypertension,	and	other	abnormalities	and	syndromes	such	as	genitourinary	malformations,	aniridia,	Beckwith-Wiedemann	syndrome,	and	Denys-Drash	syndrome,	are	also	present	in	around	13-28%	of	patients6.		Histologically,	Wilms’	tumours	are	comprised	of	blastemal,	stromal	and	epithelial	cells;	the	microscopic	appearance	will	differ	depending	on	the	amount	of	each	of	these	components.	In	addition	to	these	components	Wilms’	tumours	can	be	characterised	as	having	‘favourable’	or	‘unfavourable’	histology;	this	is	related	to	the	absence	or	presence	of	anaplasia	(cells	with	poor	differentiation,	orientation,	and	abnormal	morphological	characteristics	compared	to	mature	cells).	Anaplastic	Wilms’,	or	unfavourable	Wilms’,	accounts	for	around	5%	of	cases,	and	5	year	event-free	survival	rates	are	much	lower	than	those	with	a	favourable	histology,	with	rates	of	around	40-50%10,11,	compared	to	approximately	90%	in	those	with	favourable	Wilms’12.	However,	the	amount	of	anaplasia	is	correlated	with	patient	outcome,	and	those	with	minimal	localised	(focal)	anaplasia	have	similar	outcomes	to	favourable	Wilms’	patients,	whereas	as	those	with	diffuse	anaplasia	have	far	worse	outcomes2.	Anaplastic	Wilms’	are	more	resistant	to	chemotherapy,	however	these	tumours	are	not	aggressive	in	terms	of	tumour	growth10.	Additionally,	it	is	the	older	patients	who	are	more	likely	to	have	anaplasia	and	thus	if	older	children	with	nephrogenic	rests	develop	a	mass,	it	has	been	suggested	that	immediate	surgical	resection	should	be	performed2.				
1.4:	Approaches	to	Treatment		There	are	two	approaches	used	to	characterise	and	investigate	Wilms’	tumour,	these	are	the	Children’s	Oncology	Group	(COG)	-	formally	known	as	the	National	Wilms’	Tumor	Study	Group	(NWTSG),	and	the	Société	Internationale	d׳Oncologie	Pédiatrique	
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(SIOP)	–	the	International	Society	for	Paediatric	Oncology.	It	is	the	combined	efforts	of	these	approaches’	which	have	led	to	survival	rates	of	approximately	90%12.	The	COG	approach	favours	nephrectomy,	where	possible,	followed	by	post-operative	chemotherapy.	This	approach	provides	access	for	immediate	histological	confirmation	and	analysis	of	tumour	tissue;	providing	information	on	the	presence	and	proportion	of	cell	composition.	The	SIOP	approach,	however,	advocates	pre-operative	chemotherapy,	aiming	to	reduce	the	size	of	the	tumour;	resulting	in	easier	removal	with	fewer	tumour	ruptures	during	surgery.	The	SIOP	approach	is	used	throughout	Europe,	and	the	following	details	on	staging	and	classification	are	based	on	this	approach.				
1.5:	Wilms’	Tumour	Stages	and	Subtypes	Wilms’	tumours	can	be	categorised	by	their	stage	which	is	dependent	on	their	extension	and	surgical	outcomes;	details	of	these	stages	as	described	by	SIOP13	are	given	Table	1.1.			
	
Table	1.1.	Wilms’	tumour	stages	as	described	by	the	SIOP-2001	protocol	
Stage	 Staging	as	Described	by	SIOP-2001	Stage	I	 The	tumour	affects	one	kidney,	it	has	not	spread	and	was	completely	removed	during	surgery	Stage	II	 The	tumour	has	spread	beyond	the	kidney,	but	no	cancerous	cells	are	found	in	more	distant	organs	such	as	the	lungs.	The	tumour	was	completely	removed	in	surgery	Stage	III	 The	tumour	was	not	completely	removed	in	surgery,	and/or	it	has	spread	to	lymph	nodes	in	the	abdomen,	and/or	it	ruptured	prior	to	or	during	surgery	Stage	IV	 The	tumour	has	spread	to	distant	organs	beyond	the	abdomen,	commonly	this	is	the	lungs,	however	it	can	also	include	the	liver,	bone	or	brain	Stage	V	 The	tumour	is	bilateral	and	affects	both	kidneys	
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In	addition	to	staging,	the	revised	SIOP-2001	protocol	also	classified	Wilms’	tumours	as	low	risk,	intermediate	risk	and	high	risk13,	based	on	their	histological	appearance.	Table	1.2	provides	details	of	this	classification	system.				
		Treatment	is	based	on	stages	and	risk	groups;	for	those	with	stage	I	the	treatment	is	4	weeks	of	chemotherapy	followed	by	surgery	to	remove	the	kidney,	if	the	tumour	is	low	risk	then	this	is	the	end	of	treatment,	however,	if	the	tumour	is	intermediate	or	high	risk	then	more	chemotherapy	may	be	necessary	following	surgery.	For	stage	II	low	and	intermediate	risk	tumours,	chemotherapy	is	usually	given	for	4	weeks	followed	by	surgery	after	which	the	patient	may	undergo	further	chemotherapy	for	4	or	27	weeks	depending	on	the	risk	category	of	the	tumour.	If	the	tumour	is	stage	II	with	a	high-risk	type,	the	treatment	is	the	same,	except	post-operative	chemotherapy	is	more	intense;	for	34	weeks.	Stage	III	patients	will	have	a	similar	treatment	plan	to	stage	II	patients,	however,	the	post-operative	chemotherapy	will	be	dependent	on	the	risk	type	and	the	patient	may	also	receive	post-operative	radiotherapy.	Stage	IV	patients	will	undergo	6	weeks	of	pre-operative	chemotherapy,	and	the	treatment	following	surgery	will	be	dependent	on	the	risk	type	and	how	well	the	patient	is	responding	to	the	previous	treatment.	The	treatment	plan	for	stage	V	is	pre-operative	chemotherapy,	followed	by	surgery	to	remove	as	much	of	
Table	1.2.	Wilms’	tumour	risk	type	classification	as	described	by	SIOP-2001		
Risk	Group	 Description	
Low	Risk	 Cystic	partially	differentiated	nephroblastoma	Completely	necrotic	
Intermediate	Risk	
Epithelial	Subtype	Stromal	Subtype	Mixed	Subtype	Regressive	Subtype	Focal	Anaplasia	
High	Risk	 Blastemal	Subtype	Diffuse	Anaplasia	
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the	tumour	as	possible	from	each	kidney.	Post-operative	chemotherapy	and	radiotherapy	will	then	be	dependent	on	surgical	outcome,	risk	category	and	treatment	response.		In	the	UK	a	percutaneous	biopsy	is	performed	prior	to	chemotherapy	to	confirm	the	Wilms’	diagnosis	(this	does	not	occur	in	other	SIOP	countries)14.	After	chemotherapy	and	surgery,	a	more	accurate	diagnosis	is	given,	and	the	tumour	will	be	assigned	to	a	histological	subtype	and	risk	group,	as	well	as	a	stage.		A	subtype	is	given	to	a	Wilms’	tumour	based	on	histological	features.	Firstly,	the	percent	of	necrosis	and	regressive	change	as	a	result	of	chemotherapy	is	determined,	and	if	only	necrotic	tissue	is	present,	and	no	viable	tumour	remains,	then	the	tumour	is	labelled	as	completely	necrotic.	If	more	than	two	thirds	of	the	tumour	has	undergone	regressive	change	then	it	will	be	labelled	as	regressive.	If	less	than	two	thirds	of	the	entire	mass	has	undergone	regressive	change	then	the	subtype	is	classified	based	on	the	predominant	viable	cell	type;	either	stromal,	epithelial	or	blastemal.	If	a	tumour	has	a	range	of	cells,	none	of	which	having	a	66%	majority	then	it	is	classed	as	mixed.			
	
Table	1.3.	Wilms’	tumour	subtypes	as	described	by	SIOP-2001	
Tumour	
Subtype	
Histological	Features	of	Tumour	
	 Chemotherapy	Induced	Changes	 Epithelial	Tissue	 Stromal	Tissue	 Blastemal	Tissue	Completely	Necrotic	 100%	 0%	 0%	 0%	Regressive	 >66%	 0-33%	 0-33%	 0-33%	Mixed	 <66%	 0-65%	 0-65%	 0-65%	Epithelial	 <66%	 66-100%	 0-33%	 0-10%	Stromal	 <66%	 0-33%	 66-100%	 0-10%	Blastemal	 <66%	 0-33%	 0-33%	 66-100%	
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It	is	important	to	be	aware	of	the	distinction	between	a	stromal	or	epithelial	subtype,	as	based	on	the	SIOP-2001	classification,	and	a	stromal	or	epithelial	predominant	tumour,	as	based	on	the	COG	classification.	For	example,	the	SIOP	approach	classifies	a	tumour	as	stromal	if	stromal	cells	make	up	more	than	66%	of	the	viable	tumour	but	the	remaining	viable	tumour	must	have	less	than	10%	blastema,	otherwise	it	is	classed	as	a	mixed	type.	In	the	COG	approach,	the	remaining	viable	tumour	can	have	up	to	33%	blastemal	and	still	be	regarded	as	a	stromal	predominant	tumour.	Table	1.3	provides	further	details	of	how	the	SIOP-2001	categorises	Wilms’	tumour	subtypes13.	There	are	some	issues	with	the	classification	system	which	were	highlighted	by	Vujanić	and	Sandstedt15.	For	example,	defining	necrotic	tissue	is	difficult	as	there	are	no	clear	criteria	for	defining	tissue	as	having	no	viability.	The	authors	highlighted	that	it	can	be	easy	to	recognise	‘dead’	cells,	but	it	is	much	more	difficult	to	define	the	cells	which	are	‘dying’.	Necrotic	tissue	can	be	visualised	using	MRI	(magnetic	resonance	imaging)	and	a	gadolinium-based	contrast	agent;	where	areas	of	reduced	signal	represent	necrotic	tissue.	However,	gadolinium	has	many	associated	side	effects	such	as	vomiting,	headaches	and	irritation.	It	also	requires	venous	access;	thus,	it	may	not	always	be	appropriate.	Additionally,	gadolinium	can	accumulate	in	neuronal	tissue,	however	the	resulting	pathology	of	this	is	unknown16.	Further	details	of	studies	which	have	used	gadolinium	contrast-enhanced	MRI	in	Wilms’	tumour	can	be	found	in	Chapter	4	and	an	investigation	into	an	alternative	approach	for	identifying	necrosis	in	Wilms’	tumour	can	be	seen	in	Chapter	8.	Furthermore,	the	most	difficult	problem	associated	with	the	SIOP-2001	classification	system	is	determining	whether	a	tumour	has	over	66%	of	a	certain	cell	type.	This	can	have	implications	for	treatment,	for	example,	a	mixed	type	Wilms’	tumour	with	lots	of	blastemal	tissue	is	part	of	the	intermediate	risk	category,	however	a	blastemal	type	is	a	high-risk	tumour,	and	the	treatment	for	these	two	types	differs.	Currently	classification	is	semi-quantitative,	based	on	looking	at	a	few	tumour	slides	and	generating	estimates.	However,	Wilms’	tumours	can	be	highly	heterogeneous	and	cellular	composition	can	differ	per	slice,	thus	based	on	the	current	methods	it	is	possible	that	errors	could	be	made	when	classifying	the	tumour	subtype.	It	would	thus	be	very	beneficial	to	able	to	non-invasively	determine	the	volume	of	necrotic	tissue	and	assess	the	histological	subtype	over	the	entire	the	tumour.	When	considering	the	subtypes	of	Wilms’	tumour	is	it	important	to	keep	in	mind	that	the	different	approaches	(either	pre-operative	chemotherapy	or	immediate	surgery)	may	also	alter	the	presence	of	certain	subtypes	in	patient	populations.	For	example,	in	
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early	SIOP	trials	in	which	immediate	surgery	was	performed	the	most	common	subtypes	were	mixed	followed	by	blastemal	and	epithelial	predominant	types.	However,	when	pre-operative	chemotherapy	was	used	the	most	common	type	was	regressive,	then	mixed,	stromal,	blastemal	and	epithelial	predominant,	and	also	a	small	proportion	of	completely	necrotic	tumours.	It	has	been	suggested	that	that	the	chemotherapy	destroys	the	blastemal	and	epithelial	components,	and	induces	maturation	of	the	existing	stromal	tissue,	thus	more	stromal	subtypes	are	likely	to	be	seen	in	pre-operative	chemotherapy	patient	groups15.		The	blastemal	subtype	has	been	a	point	of	discussion	over	the	years,	with	reports	suggesting	that	it	is	one	of	the	most	responsive	subtypes	to	chemotherapy17,	as	this	subtype	has	shown	to	have	a	greater	decrease	in	volume	following	treatment	compared	to	other	subtypes18.	However,	the	presence	of	blastema	after	chemotherapy	indicates	a	poorer	outcome19.	It	has	been	suggested	that	rather	than	calculating	the	percent	of	blastemal	cells	which	remain	after	treatment,	instead	the	absolute	volume	of	blastemal	tissue	should	be	considered,	with	a	threshold	of	20–50	ml	of	remaining	blastemal	tissue	being	classed	as	high-risk20.			
1.6:	Survival	Rates	Survival	rates	in	patients	with	stromal,	epithelial,	mixed	and	regressive	subtypes	are	generally	high,	with	approximately	89%	of	patients	having	relapse-free	survival	at	4	year	follow-ups19.	However,	as	stated	earlier,	the	blastemal	subtype	has	a	worse	outcome;	with	patients	experiencing	approximately	62%	relapse-free	survival	at	5	year	follow-ups21.	As	the	blastemal	subtype	is	higher	risk	than	epithelial,	stromal,	mixed,	and	regressive,	it	was	suggested	that	treatment	should	be	intensified	for	blastemal	subtypes	and	perhaps	a	milder	treatment	plan	used	for	the	intermediate	subtypes19.	To	investigate	this,	survival	rates	of	unilateral	blastemal	subtypes	from	SIOP-2001,	where	an	intensified	post-operative	chemotherapy	was	used,	were	compared	to	the	survival	rates	from	unilateral	blastemal	subtypes	from	previous	SIOP	protocols	(1993-2001)18.	It	was	shown	that	5-year	event	free	survival	rates	increased	from	67%	to	80%	when	the	more	intense	therapy	was	used.	However,	overall	survival	rates	did	not	significantly	differ,	increasing	only	from	84%	to	88%	across	all	blastemal	subtypes.	Although,	when	analysis	was	constrained	to	stage	I	blastemal	subtypes	overall	survival	did	increase	from	71%	to	100%,	therefore	survival	is	heavily	dependent	on	both	staging	and	histological	subtype.		
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While	overall	survival	rates	and	event	free	survival	rates	in	Wilms’	tumour	are	relatively	high,	it	is	important	to	note	the	longer-term	effects	of	treatment.	It	was	reported	that	65.4%	of	Wilms’	tumour	patients	developed	later	chronic	health	problems	following	chemotherapy	when	assessed	at	a	25	year	follow-up,	with	24.2%	reporting	severe	health	conditions22.	Thus,	adapting	treatment	based	on	subtypes,	risk	and	staging,	and	potentially	reducing	treatment	in	lower	risk	groups	may	alleviate	future	health	problems.			
1.7:	Recent	Updates:	The	UMBRELLA	protocol		The	UMBRELLA-2016	protocol	was	recently	introduced	to	replace	the	SIOP-2001	protocol.	It	aims	to	incorporate	data	from	histology	and	imaging	to	implement	a	more	standardised	treatment,	and	also	focus	on	genetic	factors23.	In	addition	to	Wilms’	tumours,	non-Wilms’	renal	tumours	are	also	addressed.	However,	diagnosis	and	treatment	of	Wilms’	tumour	subtypes	have	not	significantly	changed	since	SIOP-2001.	Although,	currently	still	under	review,	it	is	likely	that	the	blastemal	subtype	will	be	characterised	using	absolute	volume	of	blastema	rather	than	percentage	as	was	previously	suggested20.	Additionally,	this	higher-risk	subtype	will	continue	to	receive	more	intensive	post-operative	chemotherapy,	based	on	the	results	from	SIOP-200118.		The	UMBRELLA	protocol	is	also	similar	to	SIOP-2001	in	its	recommendations	for	children	under	6	months;	suggesting	that	they	have	immediate	surgery	instead	of	pre-operative	chemotherapy,	and	that	histological	assessment	prior	to	treatment	is	not	advised	as	it	delays	treatment23.		Stage	IV	Wilms’	tumours,	in	which	the	tumour	has	spread	to	other	locations,	was	found	in	approximately	17%	of	patients23,	and	the	UMBRELLA	protocol	recommends	6	weeks	of	pre-operative	treatment,	similar	to	the	SIOP-2001	approach,	as	it	was	found	that	61-67%	of	patients	had	a	complete	metastatic	response24,25.	Additionally,	the	UMBRELLA	protocol	suggests	that	individual	centres	discuss	the	best	treatment	path	for	those	with	stage	IV	Wilms’.		For	bilateral	Wilms’,	stage	V,	the	UMBRELLA	protocol	suggests	avoiding	total	nephrectomy	as	it	has	been	shown	that	bilateral	nephron	sparing	surgery	provided	better	functional	renal	outcomes	compared	to	other	surgeries26,	this	once	again	is	similar	to	the	SIOP-2001	approach.	However,	unlike	the	SIOP-2001	approach,	the	UMBRELLA	protocol	suggests	that	pre-operative	chemotherapy	in	bilateral	Wilms’	is	limited	to	a	maximum	of	12	weeks,	with	evaluation	of	treatment	at	6	weeks23.	Evaluation	is	likely	to	be	based	on	
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imaging	techniques	such	as	MRI;	which	is	a	non-invasive	tool	that	has	the	potential	to	assess	tissue	status.		The	UMBRELLA	protocol	also	details	guidelines	for	diagnoses	of	Wilms’	tumour	in	adults23.	As	adult	Wilms’	tumour	is	incredibly	rare,	and	diagnosis	is	frequently	made	unexpectedly	after	nephrectomy,	there	are	often	substantial	delays	in	treatment.	If	histological	diagnosis	can	be	made	prior	to	surgery	then	pre-operative	chemotherapy	is	also	recommended,	however	these	cases	are	exceptionally	rare.			
Summary	of	Wilms’	Tumour	Wilms’	tumour	is	the	most	common	form	of	renal	tumour	in	childhood,	and	in	general,	survival	rates	are	relatively	high,	but	this	is	dependent	on	histology,	staging,	and	risk	group.	Subtypes	of	Wilms’	can	be	classified	as	low,	intermediate	or	high	risk	based	on	their	histological	features.	Treatment	in	Europe	involves	pre-operative	chemotherapy	to	reduce	tumour	size,	followed	by	surgery.	The	protocol	is	known	as	SIOP,	however	very	recently	the	name	has	been	changed	along	with	a	few	differences	in	treatment	to	UMBRELLA.		The	current	challenges	seem	to	be	the	identification	of	necrotic	tissue	and	subtypes.	MRI	may	be	able	to	aid	in	these	investigations	as	it	is	a	non-invasive	tool	which	allows	one	to	visualise	the	entire	tumour	and	inspect	it	on	a	slice-by-slice	basis.	Additionally,	MRI	can	provide	quantitative	information	potentially	indicating	the	cellular	density	of	tissues.	By	analysing	tumour	tissue	using	MRI,	necrosis	and	individual	subtypes	may	be	able	to	be	identified	which	in	turn	will	impact	treatment	decisions	and	prognosis	as	described	in	Sections	1.5	and	1.6.	Furthermore,	the	findings	may	be	able	to	be	applied	to	other	abdominal	tumours	such	as	neuroblastoma.		This	thesis	focused	on	the	use	of	MRI	in	Wilms’	tumours,	and	data	was	collected	from	Great	Ormond	Street	Hospital,	London.	It	is	one	of	the	UK’s	most	prominent	Wilms’	tumour	referral	centres	and	sees	around	25%	of	all	Wilms’	tumour	patients,	making	it	an	excellent	centre	for	these	investigations.	The	following	chapters	describe	MRI	and	various	models	of	diffusion	weighted	imaging	(DWI)	and	look	into	how	these	techniques	have	been	previously	used	in	Wilms’	tumour.	The	later	chapters	include	original	research	which	investigate	these	models	in	healthy	kidney	tissue	and	in	Wilms’	tumours.			 	
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Chapter	2:	Fundamentals	of	MRI	
	Magnetic	Resonance	Imaging	(MRI)	is	a	safe,	non-invasive	tool	which	allows	us	to	study	the	inner	workings	of	the	human	body.	This	chapter	focuses	on	explaining	the	fundamentals	and	basic	principles	of	MRI.	Information	in	this	chapter	is	based	on	several	textbooks	and	articles,	which	are	given	in	references	1	–	7.			
	
2.1:	Proton	Spins	and	Magnetisation		The	human	body	is	primarily	made	up	of	water	(over	60%),	with	the	main	component	of	water	being	hydrogen.	It	is	this	abundance	of	hydrogen	in	the	human	body	which	forms	the	basis	of	MRI.	A	hydrogen	nucleus,	or	a	single	positively	charged	proton,	rotates	around	its	axis.	As	this	is	a	moving	charge,	it	has	its	own	very	small	magnetic	field,	which	is	known	as	a	magnetic	moment.	When	a	proton	is	placed	in	an	external	magnetic	field	(known	as	B0)	it	attempts	to	align	itself	to	the	direction	of	this	magnetic	field.	Due	to	the	laws	of	quantum	mechanics	it	cannot	perfectly	align	and	so	continues	to	spin,	or	precess,	around	the	direction	of	the	field.	The	precessional	frequency	is	proportional	to	the	external	magnetic	field,	the	higher	the	external	field	the	higher	the	frequency,	and	this	can	be	given	by	the	Larmor	equation	(Equation	2.1):			 $ = 	&'(				[2.1]	$	=	Precession/Larmor	Frequency		&	=	the	gyromagnetic	ratio	(a	constant	=	42.57Mhz	T-1	for	hydrogen	nuclei)	B0	=	the	external	magnetic	field		Protons	can	be	orientated	in	any	direction,	creating	a	near-spherical	distribution	although	there	is	tendency	to	point	along	the	external	magnetic	field.	The	application	of	this	magnetic	field	also	makes	the	proton	distribution	precess	around	this	fixed	axis.	An	example	is	shown	in	Figure	2.1.			
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	Due	to	the	vast	number	of	protons	in	the	human	body,	we	can	represent	the	spins	as	a	vector	of	the	average	magnetic	moments	rather	than	look	at	each	proton	individually.	The	sum	of	all	the	spins	is	known	as	the	net	magnetization,	M0,	and	is	aligned	with	the	main	magnetic	field	(B0).	For	convention,	it	is	shown	in	the	z-direction.	This	magnetisation	is	very	small	compared	to	the	main	external	magnetic	field.	When	M0	is	parallel	to	B0	it	cannot	be	measured,	and	thus	it	is	flipped	90°	into	the	x-y	plane,	also	known	as	the	transverse	plane,	as	shown	in	Figure	2.2.	To	flip	M0,	a	radio	frequency	pulse	(RF	pulse)	is	used,	which	is	applied	at	the	Larmor	frequency.												 	
Figure	2.1.	The	distribution	of	spins	is	almost	spherical,	with	tendency	to	point	in	the	direction	of	the	external	field,	shown	here	by	more	arrows	pointing	towards	the	larger	arrow	(the	applied	field).	The	field	also	makes	this	distribution	precess	about	the	direction	of	this	field,	shown	with	the	red	arrow.			
Figure	2.2.	(A)	The	net	magnetisation	(red	arrow)	precessing	around	the	z-axis,	B0.	(B)	The	net	magnetisation	after	the	application	of	the	radio	frequency	pulse	so	that	it	is	in	the	transverse	plane.	
A	 B	
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This	M0	magnetisation	is	now	precessing	in	the	transverse	plane	and	can	thus	be	measured.	This	precession	induces	a	voltage	which	is	detected	by	receiver	coils	(loops	of	wire)	via	electromagnetic	induction.	The	coil	detects	the	magnetic	field	which	oscillates	at	the	Larmor	frequency.	The	induced	signal	decays	exponentially	as	the	protons	start	to	dephase	with	respect	to	one	another,	which	is	termed	the	free	induction	decay	(FID).	However,	the	FID	is	not	measured	directly	but	rather	echoes	are	created.			
2.2:	Echoes	There	are	two	common	types	of	echoes:	gradient	echo	(GE)	and	spin	echo	(SE).	For	a	SE	sequence	a	90°	RF	excitation	pulse	is	applied,	the	spins	thus	flip	into	the	transverse	plane	and	begin	to	dephase.	After	a	certain	time,	a	180°	pulse	is	applied	which	then	reverses	the	dephasing	of	the	spins	(albeit	not	completely),	forming	the	spin	echo,	as	shown	in	Figure	2.3.	(The	‘TE’	in	this	diagram	is	the	echo	time,	which	is	explained	in	section	2.6).								
		In	a	GE	sequence	immediately	after	the	RF	excitation	pulse,	a	magnetic	field	gradient	is	applied,	which	causes	the	spins	to	rapidly	dephase.	Subsequently,	a	second	gradient	with	opposite	polarity	is	applied,	which	reverses	the	dephasing	caused	by	the	first	applied	gradient,	causing	the	spins	to	come	back	into	phase	and	create	a	gradient	echo.	Importantly,	only	the	additional	dephasing	which	was	caused	by	the	first	magnetic	field	gradient	is	rephased.	This	can	be	seen	in	Figure	2.4.	
Figure	2.3.	A	spin	echo	sequence	showing	the	initial	90°	pulse	followed	by	the	180°	pulse.	TE	=	echo	time.			
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2.3:	Relaxation	After	the	excitation	pulses	are	turned	off	the	spins	gradually	return	to	equilibrium.	This	process	is	known	as	relaxation	and	has	two	key	features;	the	dephasing	of	the	spins	in	the	transverse	plane	and	realignment	of	the	net	magnetization	along	the	z-axis.	The	dephasing	of	the	spins	occurs	not	only	due	to	inhomogeneity	of	the	main	magnetic	field,	but	also	because	of	the	interactions	between	the	spins.	This	interaction	is	known	as	spin-spin	relaxation.	This	can	be	characterized	by	the	spin-spin	relaxation	time,	also	known	as	the	transverse	relaxation	time	or	T2.	The	T2	of	a	tissue	is	given	by	the	time	for	the	transverse	magnetization	to	decease	to	37%	of	its	initial	value.		Dephasing	in	the	transverse	plane	does	not	result	in	a	net	loss	of	energy.	However,	as	protons	interact	with	the	lattice	(the	surrounding	tissue)	energy	is	lost,	and	this	is	known	as	spin-lattice	relaxation.	It	is	characterised	by	the	spin-lattice	relaxation	time,	also	known	as	the	longitudinal	relaxation	time	or	T1.	The	T1	of	a	tissue	is	given	by	the	time	for	the	longitudinal	magnetisation	to	recover	to	63%	of	its	equilibrium	value.	T1	depends	on	field	strength	and	will	generally	increase	as	field	strength	increases,	while	T2	will	decrease	with	higher	field	strength,	however	the	T2	effects	are	much	smaller.	T2	and	T1	are	independent	processes,	and	the	dephasing	of	T2	is	a	quicker	process	than	T1	relaxation.					
Figure	2.4.	A	gradient	echo	sequence	showing	the	initial	RF	excitation	pulse	followed	by	the	negative	and	positive	magnetic	field	gradients.	TE	=	echo	time.		
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2.4:	Contrast	Agents	Contrast	agents	can	be	used	to	modify	the	T1	and	T2	times	of	tissues,	and	thereby	enhancing	contrast	in	the	resulting	MR	images.	Gadolinium	is	a	paramagnetic	contrast	agent	and	therefore	has	unpaired	electrons,	causing	it	to	become	temporarily	magnetised	when	placed	in	a	magnetic	field.	A	gadolinium	contrast	agent	can	be	injected	into	the	bloodstream	to	highlight	pathology	and	tissue	status.	In	the	healthy	brain	it	cannot	cross	the	blood	brain	barrier	(BBB)	and	thus	it	is	useful	for	highlighting	lesions	where	the	BBB	is	compromised.	In	the	body	it	is	distributed	to	the	extracellular	fluid	spaces	and	is	eventually	excreted	via	the	kidneys,	and	so	those	with	kidney	failure	should	not	be	administered	gadolinium.	The	strong	paramagnetic	effects	of	gadolinium	cause	a	decrease	in	local	T1	relaxation	times,	this	results	in	increased	signal	intensity	on	T1-weighted	images.			
2.5:	Spatial	Encoding			 When	someone	is	placed	in	an	MR	scanner,	all	the	protons	within	their	body	are	experiencing	approximately	the	same	magnetic	field	and	are	thus	excited	by	the	same	frequency	RF	pulse,	applied	at	the	Larmor	frequency.	The	‘raw’	signal	received	is	not	dependent	on	location	and	therefore	the	signal	needs	to	be	localised.	This	localisation	is	done	by	applying	magnetic	field	gradients,	which	can	be	applied	in	3	orthogonal	directions	(along	the	x-axis,	y-axis	and	z-axis).		 Gradients	are	additional	magnetic	fields	with	linear	variations	which	modify	the	strength	of	the	main	external	magnetic	field,	B0.	During	the	application	of	these	gradients,	the	protons	are	exposed	to	different	magnetic	field	strengths,	meaning	they	have	different	precessional	frequencies	(based	on	Equation	2.1).	The	slice	selecting	gradient	(Gss)	(for	example	applied	in	the	z-direction)	and	RF	pulse	are	applied	simultaneously,	and	the	application	of	the	slice-select	gradient	ensures	that	only	spins	within	a	selected	region	are	precessing	at	frequencies	which	are	on-resonance	with	the	applied	RF	pulse.	The	slice	thickness	is	determined	by	the	bandwidth	of	the	RF	pulse,	and	the	gradient	strength.		 To	locate	the	point	from	which	the	signal	originates	within	the	selected	slice,	two	further	gradients	are	applied	in	the	remaining	two	orthogonal	directions;	the	frequency	encoding	gradient	and	phase	encoding	gradient.			 The	frequency	encoding	gradient	(GFE)	is	applied	after	the	Gss	in	another	orthogonal	direction	(for	example	the	y-axis).	This	causes	a	small,	spatially-dependent	
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variation	in	the	precessional	frequencies	along	this	axis,	and	as	such	the	location	along	this	axis	is	encoded	by	frequency.	The	phase	encoding	gradient	(GPE)	is	applied	along	the	remaining	axis,	in	this	case,	the	x-axis.		The	GPE	is	turned	on	only	for	a	short	time	after	the	RF	pulse,	and	during	this	time	the	protons	will	precess	with	varying	frequencies	along	the	x-axis.	This	gradient	is	then	turned	off,	and	all	the	protons	return	to	their	original	precessional	frequency.	However,	the	protons	will	now	be	out	of	phase	with	each	other,	and	this	phase	change	can	be	detected	and	encoded	along	this	axis.	By	combining	the	GFE	and	GPE	following	the	GSS,	the	relationship	between	the	MR	signal	and	the	spatial	location	of	the	spins	contributing	to	this	signal	can	be	determined	within	the	selected	slice.			
2.6:	Combining	Gradients	and	Pulse	Sequence	Diagrams			 As	explained	previously	(Section	2.5),	the	Gss	selects	the	appropriate	slice	to	be	imaged,	and	through	the	subsequent	addition	of	the	GPE	and	GFE	the	signal	can	be	localised.	To	obtain	an	image	in	MRI,	the	process	of	exciting	protons,	and	applying	RF	pulses	and	gradients	is	repeated	many	times.	This	a	controlled	process,	with	specific	timings,	and	can	be	represented	in	a	pulse	sequence	diagram.	Two	key	timings	are	often	referred	to,	these	are	the	TE	(echo	time)	and	TR	(repetition	time).	TE	refers	to	the	time	between	the	application	of	the	RF	pulse	and	the	peak	of	the	induced	echo.	TR	refers	to	the	time	between	the	application	of	an	RF	excitation	pulse	and	the	next	RF	pulse.	An	example	of	a	gradient	echo	pulse	sequence	diagram	is	shown	in	Figure	2.5.		Alterations	to	TE	and	TR	can	affect	the	contrast	of	resulting	MR	images.	For	example,	a	short	TR	and	TE	will	produce	a	T1-weighted	image	where	CSF	(cerebral	spinal	fluid)	appears	dark,	however	a	long	TR	and	TE	will	produce	a	T2-weighted	image	where	CSF	appears	bright.							
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Summary	of	Fundamentals	of	MRI	This	chapter	provided	a	brief	overview	of	the	fundamental	processes	involved	in	MRI	which	are	required	to	obtain	an	image.	There	are	numerous	sequences	in	MRI	which	can	provide	different	contrasts	and	information	regarding	the	tissue	under	investigation.	The	following	chapter	(Chapter	3)	explores	one	of	these	techniques.			 	
Figure	2.5.	A	gradient	echo	sequence	showing	the	RF	pulse,	GSS	(slice	selecting	gradient),	GPE	(phase	encoding	gradient),	GFE	(frequency	encoding	gradient),	with	time	running	horizontally.	The	diagram	also	shows	the	TE	(echo	time)	and	TR	(repetition	time).		
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Chapter	3:	Diffusion	Weighted	Imaging	and	Models	of	Diffusion	
	This	chapter	focuses	on	explaining	the	underlying	processes	of	diffusion	weighted	imaging	(DWI).	It	also	explores	four	models	used	to	describe	the	diffusion	signal;	mono-exponential,	IVIM	(intravoxel	incoherent	motion),	stretched	exponential	and	kurtosis.	The	chapter	provides	an	overview	of	each	model	and	gives	examples	of	the	clinical	utility	of	the	models	in	the	body.	Specific	details	about	the	use	of	diffusion	imaging	in	Wilms’	tumour	are	provided	in	Chapter	4.				
3.1.1:	Background	of	Diffusion	Weighted	Imaging	and	the	Apparent	Diffusion	
Coefficient		Diffusion	weighted	imaging	(DWI)	is	a	semi-quantitative	MRI	technique,	based	on	the	random	Brownian	motion	of	water	molecules1.	The	displacement	of	water	molecules	over	a	given	time	(*)	can	be	described	though	Einstein’s	equation	(Equation	3.1):		<r2>	=	6D*				[3.1]	<r2>	=	mean	square	displacement	D	=	diffusion	coefficient		When	there	is	no	internal	structure	to	inhibit	the	motion	of	these	molecules	it	is	known	as	free	diffusion.	However,	within	the	body	there	are	different	structures	(such	as	cell	membranes)	which	can	hinder	the	motion	of	water	molecules.	For	this	reason,	DWI	can	be	greatly	informative	about	tissue	structure	and	cellular	environments	within	the	body.		 A	common	method	for	achieving	a	diffusion	weighted	image	is	to	use	a	pulsed	gradient	spin	echo	(PGSE)	sequence2.		A	diagram	for	this	can	be	seen	in	Figure	3.1	PGSE	consists	of	a	90°	RF	pulse	followed	by	a	diffusion	gradient	applied	along	a	given	axis,	which	dephases	the	spins.	Following	this	a	180°	RF	pulse	is	applied	and	then	another	diffusion	gradient.	The	gradient	moments	of	both	the	diffusion	gradients	are	equal	in	magnitude.			
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	The	strength	of	the	gradient	(G),	the	duration	(#)	and	time	between	the	gradients	(∆)	control	the	diffusion	weighting,	otherwise	known	as	the	b	value,	which	is	measured	in	units	of	s/mm2.	In	a	PGSE	sequence	b	can	be	calculated	by:		 b	=	&,-,#, .∆ − 012				[3.2]	The	parameter	.∆ − 012	is	also	known	as	the	diffusion	time	(*),	mentioned	above.				 	The	degree	of	signal	attenuation	is	proportional	to	the	amount	of	diffusion	in	the	direction	of	the	applied	diffusion	gradients.	The	application	of	the	first	gradient	will	cause	the	spins	to	become	out	of	phase	and	the	second	gradient	will	rephase	only	the	static	spins.	For	example,	if	there	is	no	movement	between	these	two	gradients;	if	diffusion	is	restricted,	then	the	spins	will	be	become	back	in	phase	producing	a	high	signal.	Therefore,	on	a	diffusion	weighted	image	in	areas	where	tissue	has	a	higher	cellularity,	and	diffusion	is	more	restricted,	the	signal	will	appear	bright.	However,	if	the	spins	have	moved	between	the	gradients	the	second	gradient	will	not	cause	the	spins	to	become	back	in	
Figure	3.1.	A	pulsed	gradient	spin	echo	sequence	showing	the	two	RF	pulses	(90°	and	180°)	and	the	two	diffusion	gradients	with	magnitude	G,	spacing	∆	and	duration	#.	TE	=	echo	time.		
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phase	and	thus	these	areas	will	have	a	reduced	signal	intensity	on	a	diffusion	weighted	image.	The	strength	of	the	signal	can	be	given	by:		 4(5) = 4(6789				[3.3]		Where	S(b)	is	the	signal	intensity	as	a	function	of	b	value	(b).	S0	is	the	signal	intensity	obtained	without	diffusion	weighting	(b=0).	The	parameter	D	is	the	diffusion	coefficient,	however,	as	this	is	influenced	by	a	number	of	factors,	such	as	the	presence	of	cell	membranes,	we	refer	to	this	as	the	ADC;	the	Apparent	Diffusion	Coefficient.	ADC	maps	can	be	calculated	by	acquiring	data	using	two	or	more	b	values.	Tissue	with	high	ADC	values	will	be	represented	as	bright	on	an	ADC	map.			
3.1.2:	Clinical	Utility	of	ADC	in	the	Kidneys		ADC	has	been	used	in	a	variety	of	organs	and	pathologies;	however,	the	following	section	focuses	on	research	applications	in	the	kidneys.	Previous	work	has	highlighted	that	ADC	in	normal	renal	parenchyma	is	significantly	higher	than	ADC	in	a	large	range	of	solid	renal	tumours3.	This	is	most	likely	because	a	highly	dense	cellular	environment,	such	as	a	malignant	solid	tumour,	would	have	reduced	diffusion	and	thus	a	lower	ADC.	Moreover,	it	has	also	been	shown	that	benign	lesions	had	significantly	greater	ADC	values	compared	to	malignant	lesions4.	This	retrospective	study	also	showed	that	benign	cysts	had	significantly	higher	ADC	values		than	renal	cystic	cancers,	a	finding	which	has	also	previously	been	reported5.	The	lower	ADC	values	in	malignant	cystic	tumours	may	be	due	to	the	increased	blood	and	protein	products	in	complex	cysts	and	also	larger	molecules	and	cellular	debris	which	could	hinder	diffusion4.	The	authors	also	suggested	that	ADC	may	be	useful	in	identifying	cysts	and	malignancies	when	gadolinium	is	not	an	option,	due	to	patients’	impaired	renal	function4.	Furthermore,	in	a	prospective	study	it	was	shown	that	those	with	renal	failure	had	significantly	lower	ADC	values	than	healthy	volunteers6.	The	implication	was	that	water	was	restricted	in	the	extravascular	extracellular	spaces	resulting	in	the	reduction	of	ADC.	Thus,	ADC	has	the	potential	to	provide	clinically	useful	information	regarding	renal	function.		
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A	retrospective	study	of	chronic	kidney	disease	also	highlighted	the	efficacy	of	ADC7.	It	was	shown	that	median	ADC	was	significantly	greater	in	healthy	tissue	than	those	with	stage	3,	4,	or	5	chronic	kidney	disease.	Furthermore,	ADC	could	significantly	differentiate	between	controls,	stage	1,	and	stage	2	groups	compared	with	stage	3,	4	and	5	groups	with	reasonably	high	sensitivity	and	specificity	(75%	and	69%,	respectively).	The	authors	did	note	that	determining	an	ADC	cut-off	value	to	separate	these	stages	is	challenging,	as	ADC	could	be	affected	by	b	value	ranges	and	field	strength,	thus	a	much	larger	study	with	a	range	of	patients	and	protocols	would	be	needed	to	provide	a	cut-off	which	could	be	applied	clinically.			Other	research	has	highlighted	that	ADC	could	be	correlated	with	renal	function.	For	example,	it	was	shown	that	ADC	was	positively	correlated	with	residual	renal	function	in	continuous	ambulatory	peritoneal	dialysis	patients8.	Furthermore,	it	has	also	been	shown	that	ADC	correlated	with	estimated	glomerular	filtration	rates	(eGFR)	in	patients	with	diabetic	nephropathy	and	in	those	with	chronic	kidney	disease	without	diabetes9.	Biopsies	from	the	chronic	kidney	disease	group	also	showed	that	ADC	correlated	with	renal	pathology.		There	is	therefore	potential	for	ADC	to	assess	renal	function	as	many	renal	processes	are	associated	with	diffusion	of	water,	such	as	tubular	reabsorption,	secretion,	and	glomerular	filtration7.			Overall	it	can	be	seen	that	ADC	has	great	potential	to	be	used	clinically	to	assess	normal	renal	function	and	a	range	of	renal	impairments.			
3.2.1:	The	IVIM	Model	(Intravoxel	Incoherent	Motion)	IVIM	is	a	bi-exponential	model	of	diffusion	introduced	by	LeBihan	(1988)10.	The	mono-exponential	model	which	provides	a	measure	of	apparent	diffusion	of	water	molecules	was	thought	to	be	too	simplistic,	thus	IVIM	was	proposed.	IVIM	aims	to	describe	the	relationship	of	increasing	b	values	and	signal	attenuation	by	not	only	describing	the	movement	of	the	water	within	the	extra-vascular	/	extra-cellular	space,	but	also	within	the	micro	capillary	network.	IVIM	produces	the	fitted	parameters;	D,	D*	and	f	and	is	given	by	Equation	3.410:				
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4(5) = 4([(1 − <)6(78.9) + <6[78.(9?9∗)]]				[3.4]	S(b)	=	signal	at	a	given	b	value	S0	=	signal	with	no	diffusion	weighting	
D	=	‘Slow’	Diffusion	Coefficient	
D*	=	‘Fast’	Diffusion	Coefficient	
	f	=	Perfusion	Fraction			The	S0	parameter	represent	the	signal	from	b	=	0	and	the	remaining	parameters	represent	different	contributions	from	the	diffusion	signal	and	micro	capillary	perfusion11.	
D	represents	the	molecular	diffusion	of	water	through	static	tissue	and	can	represent	hindered	diffusion	due	to	cellular	structures,	which	is	free	from	the	influence	of	fast	flowing	water	in	the	capillary	network.	D	is	therefore	often	referred	to	as	‘slow’	diffusion.	
D*	can	be	thought	of	as	the	‘fast’	diffusion	coefficient,	which	is	due	to	the	motion	of	water	molecules	in	the	blood	as	it	flows	in	the	randomly	orientated	capillary	network.	As	water	is	flowing	in	many	directions	across	this	network,	D*	is	sometimes	referred	to	as	‘pseudo-diffusion’,	as	the	combination	of	randomly	orientated	flow	in	this	network	can	appear	like	diffusion.	At	higher	b	values	the	contribution	of	‘fast’	diffusion	diminishes,	however	at	lower	b	values	(0	–	200	s/mm2)	the	influence	can	be	significant.	The	f	parameter	is	also	known	as	the	‘perfusion	fraction’	which	represents	the	intra-voxel	volume	fraction	associated	with	the	fast	diffusion	component	and	can	act	as	a	surrogate	biomarker	for	the	local	microvascular	volume	fraction.			An	example	of	an	IVIM	fit	to	raw	DWI	data	can	be	seen	in	Figure	3.2;	where	a	bi-exponential	fit	provides	a	good	description	of	the	raw	DWI	data.	It	can	be	seen	in	Figure	3.2	that	there	is	initially	a	fast	decay	in	signal,	followed	by	more	gradual	signal	attenuation	(b	values	>	200	s/mm2).								
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	It	has	been	noted	that	while	D*	may	represent	the	fast	diffusion	component	and	be	sensitive	to	micro-capillary	perfusion,	it	may	also	be	influenced	by	other	factors	such	as	tubular	flow	or	glandular	secretion11.	It	was	therefore	suggested	that	it	may	be	difficult	to	isolate	perfusion	effects	and	caution	should	be	taken	when	interpreting	this	parameter11.			The	choice	of	b	values	is	important	in	the	IVIM	model;	crucially,	low	b	values	(<	200	s/mm2)	are	needed	to	capture	the	perfusion	effects.	However,	there	is	no	universally	agreed	consensus	on	the	optimal	range	of	b	values	to	use11.	Using	many	b	values	over	a	large	range	may	produce	high	quality	data,	however	due	to	the	increase	in	scan	time	this	is	not	always	clinically	feasible.			
3.2.2:	Fitting	Methods	for	the	IVIM	model	There	are	various	methods	for	performing	an	IVIM	fit,	for	example	parameters	can	be	fit	in	a	piece-wise	manner	or	fit	simultaneously12.	There	are	different	forms	of	piece-wise	fitting;	for	example,	fitted	values	could	be	constrained	by	using	a	mono-exponential	
Figure	3.2.	An	example	of	the	IVIM	effect	within	a	healthy	adult	kidney.	The	plot	shows	the	natural	logarithm	of	the	signal	intensities	against	the	b	values	from	normal	kidney	tissue	(red	circles).	The	IVIM	fit	(blue	solid	line)	is	shown	against	the	raw	data,	along	with	a	mono-exponential	fit	(dashed	green	line).	Data	is	based	on	the	kidney	of	a	healthy	adult	male	(age	28.26	years)	from	a	3T	scanner,	with	b	values	=	0,	50,	100,	150,	200,	250,	500,	1000	s/mm2	
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fit	at	high	b	values	(for	example:	≥	200	s/mm2)	to	determine	D,	and	then	subsequently	fitting	for	D*	and	f.	This	is	to	ensure	that	D	is	not	influenced	by	D*	and	f	and	is	possible	because	the	influence	of	D*	is	negligible	at	these	higher	b	values.	Another	version	of	piece-wise	fitting	builds	on	the	previously	mentioned	model	by	determining	D	at	high	b	values	and	then	calculating	f	by	extrapolating	a	linear	fit	of	the	natural	logarithm	of	signal	intensity	back	to	b=0	and	taking	the	intercept.	With	D	and	f	now	fixed,	D*	can	then	be	fit	to	the	raw	data.	Alternatively,	an	un-constrained	approach	could	be	used,	in	which	all	parameters	are	fit	simultaneously.		Studies	have	compared	these	fitting	methods	and	have	shown	that	the	most	constrained	method	(constraining	D	and	f	prior	to	fitting	for	D*)	outperform	the	simultaneous12,13	and	partially	constrained	methods12;	providing	more	reproducible	and	accurate	(based	on	simulated	data)	diffusion	parameters.	However,	the	simultaneous	and	less	constrained	methods	have	been	shown	to	provide	better	fits	to	the	raw	data	(according	to	the	Akaike	Information	Criterion	[AIC])	compared	to	the	more	constrained	method14.	Although,	it	should	be	noted	that	the	more	constrained	method	did	provide	more	robust	and	reproducible	values	of	D*	and	f	compared	to	the	other	two	methods14.	Thus,	it	can	be	challenging	to	determine	which	is	the	most	appropriate	method,	with	unconstrained	fitting	methods	providing	the	best	fit	to	the	raw	data,	but	at	the	expense	of	poorer	reproducibility	in	the	values	of	the	fitted	parameters.		Other	fitting	methods	have	also	been	investigated;	such	as	Bayesian	fitting	methods,	which	have	also	been	compared	to	the	previously	mentioned	most	constrained	technique15.	It	was	shown	that	all	methods	were	highly	similar	in	terms	of	reproducibility	and	accuracy.	Thus,	the	authors	suggested	that	the	constrained	method	should	be	favoured	as	it	is	less	numerically	complex	and	computationally	demanding.			
3.2.3:	Clinical	Utility	of	the	IVIM	Model	in	the	Body		The	IVIM	model	has	been	applied	in	a	wide	range	of	tissues	across	the	body;	for	example,	in	the	prostate16,17,	pancreas18,	and	liver19,20.	In	a	study	of	healthy	volunteers	and	patients	with	prostate	cancer	it	was	shown	that	D	and	D*	values	were	significantly	lower	in	cancerous	tissue	compared	to	healthy	tissue16.	Additionally,	this	was	also	seen	in	f,	but	only	in	the	peripheral	zone	of	the	prostate.	This	is	in	line	with	previous	work,	where	it	was	shown	that	ADC	of	cancerous	tissue	was	lower	than	that	of	benign	prostate	tissue21,22.	This	is	likely	to	be	due	to	the	increased	cellularity	in	cancerous	tissue,	leading	to	a	decrease	in	apparent	diffusion.	Therefore,	it	is	unsurprising	these	effects	are	also	present	when	using	
51 
 
the	IVIM	model.	However,	the	IVIM	model	did	provide	a	superior	fit	to	the	raw	data,	compared	to	a	mono-exponential	model,	when	compared	using	AIC16.	This	has	also	been	shown	in	prostate	cancer17.		Research	into	the	pancreas	has	highlighted	the	utility	of	the	f	parameter18.	When	those	with	pancreatic	carcinoma	were	compared	to	the	healthy	volunteers	it	was	shown	that	f	was	superior	to	ADC	in	terms	of	visual	depiction	of	pancreatic	carcinoma.	Furthermore,	it	was	also	shown	that	f	had	a	significantly	larger	AUC	(area	under	the	curve)	compared	to	D	and	D*	(p	<	0.05)	when	distinguishing	between	cancerous	and	healthy	tissue	according	on	ROC	curves	(receiver	operator	curves).	Although	it	should	be	noted	that	this	study	used	many	b	values,	with	several	smaller	b	values	(5	b	values	<	100	s/mm2),	and	employed	breath	hold	techniques	to	minimise	registration	errors.	Thus,	other	studies	may	struggle	to	replicate	these	results.		In	the	liver	it	has	been	shown	that	D*	was	able	to	highlight	decreased	perfusion	in	liver	cirrhosis	compared	to	healthy	liver	tissue19.	Furthermore,	both	D	and	D*	showed	significantly	lower	values	in	malignant	hepatic	lesions	compared	to	benign20.		As	previously	mentioned	the	fast	diffusion	coefficient,	D*,	may	also	be	related	to	laminar	flow,	and	thus	it	is	very	difficult	to	isolate	the	microcapillary	perfusion	effects,	and	differentiate	these	from	‘through-flowing’	water	in	larger	vessels11.	Due	to	this,	it	was	previously	suggested	that	IVIM	may	not	be	able	to	measure	vascular	perfusion	in	the	kidneys23.	It	was	argued	that	high	values	of	fast-diffusion	in	the	kidneys	are	likely	to	be	more	related	to	renal	tubular	flow	as	opposed	to	vascular	perfusion.	It	was	claimed	that	even	if	vascular	perfusion	was	contributing	to	the	signal	it	would	not	be	possible	to	isolate	this	effect	using	the	IVIM	model.	However,	while	the	exact	physiological	basis	of	the	fitted	parameters	remains	unclear,	it	does	not	prevent	this	model	from	being	clinically	useful	in	renal	studies.		The	IVIM	model	showed	promise	in	detecting	early	changes	in	diabetic	kidneys;	with	f	being	significantly	higher	in	diabetic	kidneys	compared	to	controls	and	D	being	significantly	lower.	D*,	however,	did	not	show	significant	differences24.	Furthermore,	IVIM	parameters	have	been	shown	to	be	useful	in	highlighting	kidney	function	in	those	with	chronic	kidney	disease,	with	both	D	and	f	being	related	to	estimated	glomerular	filtration	rate	(eGFR),	again	D*	was	not	shown	to	be	a	useful	parameter25.		Previous	work	has	also	shown	that	D	was	significantly	related	to	eGFR,	and	additionally	this	work	also	showed	that	D,	D*	and	f	were	significantly	lower	in	those	with	severe	renal	injury	compared	to	those	without26.	However,	other	work	has	opposed	this,	showing	that	none	of	the	IVIM	
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parameters	were	related	to	eGFR27.	Furthermore,	although	the	IVIM	parameters	were	related	to	renal	injury,	the	model	did	not	add	significantly	to	the	assessment	of	renal	dysfunction	when	compared	to	ADC26.	It	can	be	seen	that	it	is	possible	to	use	the	IVIM	model	in	the	kidneys,	and	that	there	is	potential	for	this	model	to	be	clinically	useful.	However,	clearly	more	work	is	needed	to	understand	the	benefits	of	this	model	and	whether	all	the	IVIM	parameters	are	useful	in	renal	investigations.			
3.3.1:	The	Stretched	Exponential	Model	The	stretched	exponential	model	of	diffusion	was	introduced	to	describe	the	heterogeneity	in	diffusion	within	a	single	voxel28.	Initially	proposed	to	describe	the	heterogeneity	of	diffusion	measurements	in	the	cerebral	cortex28;	the	stretched	exponential	model	provides	a	measure	of	the	deviation	from	a	mono-exponential	signal	decay.	The	model	includes	the	fitted	parameters	DDC	and	a,	and	the	parameter	S0	is	the	signal	at	b=0	and	is	described	by	Equation	3.528.		 4(5) = 4(6(7(8.99B)C)				[3.5]	S(b)	=	signal	at	a	given	b	value	S0	=	signal	with	no	diffusion	weighting	
DDC	=	the	Distributed	Diffusion	Coefficient	
α	=the	stretching	parameter	describing	the	deviation	from	a	mono-exponential	decay		 The	stretching	parameter	(α)	ranges	between	0	and	1;	the	nearer	to	1	the	closer	the	signal	decay	is	to	a	mono-exponential	function.	A	lower	value	of	α	indicates	greater	inhomogeneity,	suggested	to	be	due	to	multiple	discrete	proton	pools	within	the	same	voxel28.		If	b*DDC	>	1	then	signal	attenuation	occurs	with	a	decrease	in	α	as	a	function	of	b.	Conversely,	when	b*DDC	<	1,	a	decrease	in	α	produces	a	faster	decay	in	signal28.	An	example	of	this	change	in	signal	attenuation	is	given	in	Figure	3.3.	At	b*DDC	=	1	the	lines	cross,	this	can	represent	the	separation	between	‘high’	and	‘low’	ranges	of	decay	rates28.	At	higher	values	of	b*DDC	the	signal	attenuation	is	more	reliant	on	the	slow	decaying	terms,	as	the	faster	decay	terms	have	already	disappeared.	
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	The	‘stretching’	aspect	of	the	model	is	observed	at	higher	b	values	where	lower	values	of	α	prevent	the	model	from	decaying	too	rapidly,	however	maximum	b	value	selection	will	depend	on	the	structure	being	imaged.	Studies	of	the	kidney29	and	bladder30	have	used	a	maximum	b	value	of	1,700	s/mm2,	while	in	the	liver31	a	value	of	1,000	s/mm2	was	deemed	appropriate.	Furthermore,	in	the	prostate	it	has	been	suggested	that	b	values	up	to	2,000	s/mm2	provide	greater	diagnostic	performance	in	DDC,	compared	to	a	maximum	b	value	of	1,000	s/mm2	32.	This	is	also	in	agreement	with	previous	work	in	prostate	cancer33.	Additionally,	it	was	suggested	that	b	values	>	2,000	s/mm2	do	not	improve	the	diagnostic	ability	of	this	parameter	in	the	prostate32.	However,	it	should	be	noted	that	a	maximum	b	value	for	stretched	exponential	modelling	has	not	been	conclusively	determined	in	the	prostate32,	or	in	other	body	organs.				
Figure	3.3.	The	differences	in	signal	decay	given	by	the	stretched	exponential	function	according	to	varying	values	of	α.	Signal	is	displayed	as	S(b)/S0	where	S(b)	is	the	signal	at	a	given	b	value	and	S0	is	the	signal	with	no	diffusion	weighting.	This	signal	is	plotted	against	b*DDC	where	b	is	the	b	value	and	DDC	is	the	distributed	diffusion	coefficient.	Data	is	based	on	DDC	=	2.2	*10-3	mm/s2,	and	b	values	=	0	50	100	250	500	750	1,000	s/mm2.	
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3.3.2:	Clinical	Utility	of	the	Stretched	Exponential	Model	in	the	Body		As	the	stretched	exponential	model	was	originally	proposed	for	use	in	the	cerebral	cortex	research	has	mostly	focused	on	its	utility	in	the	brain.	For	example,	in	gliomas	the	α	parameter	managed	to	significantly	separate	tumour	from	normal	tissue34	additionally	α	provided	greater	diagnostic	power	in	differentiating	higher	and	lower	grade	gliomas	compared	to	ADC35.		However,	there	is	also	some	literature	on	the	clinical	utility	of	this	model	in	the	body.	Here,	the	stretched	exponential	model	has	demonstrated	that	both	DDC	and	α	were	significantly	lower	in	prostate	cancer	when	compared	to	normal	prostate	tissue36.	This	study	also	compared	the	stretched	exponential	model	to	a	mono-exponential	model.	There	was	a	strong	relationship	between	ADC	and	DDC,	particularly	when	measured	in	urine,	where	values	were	near	equal.	This	relationship	can	be	explained	as	urine	is	similar	to	pure	water,	thus	would	not	deviate	from	a	mono-exponential	pattern,	and	therefore	α	would	be	very	close	to	1.	Within	areas	of	normal	prostate	tissue	there	was	also	high	similarity	between	ADC	and	DDC,	this	was	explained	due	to	the	many	fluid	filled	structures	and	large	areas	of	free	water,	thus	also	giving	α	values	close	to	1.	Within	the	cancer	tissue	there	was	greater	discrepancy	between	ADC	and	DDC,	due	to	the	more	heterogeneous	nature	of	the	tissue,	thus	giving	a	lower	value	of	α.	The	authors	concluded	that	the	stretched	exponential	model,	and	the	inclusion	of	the	extra	parameter	α,	may	add	further	diagnostic	information	when	distinguishing	between	benign	and	malignant	prostate	tissue.		The	utility	of	the	stretched	exponential	model	in	body	imaging	has	been	further	examined	by	comparing	it	to	a	mono-exponential	and	a	bi-exponential	model	in	the	kidneys29.	This	study	sought	to	determine	which	parameters	from	a	variety	of	models	were	best	suited	for	distinguishing	between	minimal	fat	angiomyolipoma	and	renal	cell	carcinoma.	Compared	to	the	other	models,	DDC	was	the	weakest	parameter,	failing	to	reach	significance	to	discriminate	between	the	two	tissue	types.	However,	α	reached	significance	(p	<.001),	and	produced	far	higher	levels	of	sensitivity	(90.5%)	and	specificity	(84.2%)	compared	to	ADC,	and	D*	and	f	from	the	IVIM	model.		Research	in	both	brain	and	body	imaging	has	suggested	that	α	may	be	an	important	diagnostic	parameter29,34–36,	however	DDC	may	not	provide	as	pertinent	information	given	that	it	has	been	shown	to	be	very	similar	to	ADC36	and	also	failed	to	reach	significance	in	the	previously	mentioned	study29.			
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3.4.1:	The	Kurtosis	Model	In	the	case	of	completely	free	diffusion,	a	mono-exponential	decay	of	signal	with	increasing	b	value	would	be	expected37.	However,	in	reality	water	molecules	do	not	always	obey	free	diffusion	due	to	restrictions	of	diffusion	caused	by	cellular	structures,	therefore	the	kurtosis	model	is	used	to	describe	this	deviation	from	a	Gaussian	distribution38.	The	model	aims	to	describe	the	non-Gaussian	behaviour	of	diffusion	which	may	reflect	tissue	heterogeneity,	and	provide	important	information	about	tissue	microstructure39.	The	kurtosis	model	produces	the	fitted	parameters	Dk	and	K,	and	the	S0	parameter	is	the	signal	at	b=0,	the	model	is	described	by	Equation	3.638.		 4(5) = 4(678.9D?8E9DEF/H				[3.6]	S(b)	=	signal	at	a	given	b	value		S0	=	signal	with	no	diffusion	weighting	
Dk	=	the	diffusion	coefficient	corrected	for	the	non-Gaussian	displacement	of	water	molecules		
K	=	the	Kurtosis			From	a	mathematical	perspective,	the	kurtosis	value	describes	the	peaks	of	a	curve	compared	to	a	Gaussian	bell	curve40.	A	kurtosis	(K)	of	zero	indicates	a	perfectly	Gaussian	distribution	and	a	distribution	where	K	>	0	would	have	higher	peaks	and	sharper	tails,	this	can	be	seen	in	Figure	3.4.	K	<	0	is	possible	from	a	mathematical	perspective,	however	in	the	context	of	diffusion	it	is	not	possible;	diffusion	would	have	to	be	completely	restricted	which	is	not	the	case	in	tissue.												
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		 In	the	case	of	diffusion	imaging,	a	higher	value	of	K	would	suggest	a	more	complex	tissue	environment40.	Additionally,	it	has	been	suggested	that	K	may	reflect	the	interaction	of	water	molecules	with	intracellular	compounds	and	cell	memebranes38,41,	however	the	exact	underlying	biophysical	nature	of	K	is	not	well	defined.		The	selection	of	b	values	used	for	the	kurtosis	model	is	very	important.	In	a	mono-exponential	fit	it	may	be	reasonable	to	use	b	values	up	to	1,000	s/mm2	in	body	imaging,	however	the	signal	deviates	from	a	mono-exponential	decay	at	higher	b	values	(b	>	1,500	s/mm2),	demonstrating	the	non-Gaussian	nature	of	water	diffusion38.	It	is	thus	important	to	use	higher	b	values	to	capture	the	kurtosis	effects.	The	kurtosis	model	becomes	more	sensitive	to	heterogeneous	structures	and	shorter	molecular	distances	at	b	values	>	1,500	s/mm2	as	the	signal	deviates	away	from	a	mono-exponential	decay40.	Ultra-high	b	values	(>	3,000	s/mm2)	should	also	be	avoided	when	using	a	kurtosis	fitting;	rather	than	maintaining	a	decay	in	signal,	this	will	cause	an	increase	which	is	not	physiologically	accurate42.	When	selecting	the	upper	bound	of	b	values,	it	should	be	selected	based	on	the	rule	given	in	Equation	3.742:			
Figure	3.4.	An	example	of	a	Gaussian	distribution:	K	=	0	(blue	line),	and	a	non-Gaussian	distribution,	given	by	K	>	0	(red	line).			
K	=	0 
K	>	0 
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	 5	 ≤ 	 19D∗F				[3.7]	
Dk	=	the	diffusion	coefficient	corrected	for	the	non-Gaussian	displacement	of	water	molecules	
K	=	the	Kurtosis		
b	=	the	maximum	b	value		 Given	typical	values	of	Dk	(~1	x	10-3	mm/s2)	and	K	(~	1)	in	healthy	brain	tissue	(grey	matter),	it	has	been	suggested	that	b	should	not	exceed	2,000	–	3,000	s/mm2	in	the	brain42.	In	body	imaging,	however,	a	lower	b	value	may	be	used	for	the	upper	limit	as	values	of	Dk	and	K	vary	throughout	the	body.	For	example,	a	maximum	b	value	of	800	s/mm2	has	been	used	in	the	prostate43,44	and	in	whole	body	imaging45.	A	study	into	the	impact	of	b	value	selection	on	the	kurtosis	model,	however,	did	highlight	that	higher	b	values	(b	maximum	=	2,300	s/mm2)	provided	the	best	distinction	between	healthy	and	cancerous	tissue	in	the	prostate46.		Within	the	kidneys,	kurtosis	modelling	was	achieved	as	part	of	two	feasibility	studies	with	maximum	b	values	of	60047	and	1,00048	s/mm2.	The	upper	bound	of	1,000	s/mm2	was	justified	by	the	authors	as	diffusion	coefficients	of	healthy	kidney	tissue	are	around	twice	as	high	as	the	brain	(for	both	cortex	and	medulla)6,49,	and	thus	based	on	the	relationship	described	above	(Equation	3.7),	the	authors	hypothesised	that	a	maximum	b	value	of	1,000	s/mm2	was	reasonable	to	use.	However,	it	has	since	been	suggested	that	the	deviation	from	a	mono-exponential	decay	is	more	apparent	at	higher	values	and	testing	at	600	and	1,000	s/mm2	was	not	an	appropriate	test	of	feasibility50.			
3.4.2:	Clinical	Utility	of	the	Kurtosis	Model	in	the	Body	Clinical	applications	of	the	kurtosis	model	in	body	imaging	have	been	mainly	demonstrated	in	prostate	cancer46,50–52.	In	a	study	comparing	cancerous	prostate	tissue	and	normal	contralateral	peripheral	zone	it	was	shown	that	Dk	was	significantly	reduced	in	cancer	tissue,	and	K	was	significantly	higher51.	This	may	be	because	diffusion	would	be	less	restricted	in	benign	tissue,	resulting	in	a	higher	Dk	and	that	cancerous	tissue	may	have	a	more	complex/heterogenous	tissue	environment	thus	producing	a	higher	value	of	K.	
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	This	study	also	used	ROC	analysis	(Receiver	Operator	Characteristics)	to	further	investigate	whether	kurtosis	parameters	could	separate	the	two	tissue	types51.	Furthermore,	it	also	investigated	whether	the	kurtosis	model	improved	this	separation	compared	to	ADC.	It	was	shown	that	Dk	had	a	significantly	smaller	AUC	(Area	under	Curve)	compared	to	ADC.	K	had	a	larger	AUC	than	ADC,	but	this	difference	was	not	significant,	K	also	had	the	highest	sensitivity	compared	to	the	other	two	parameters.	Therefore,	although	Dk	may	not	add	to	the	separation	of	benign	peripheral	zone	and	prostate	cancer,	
K	may	provide	added	value.			Similar	results	were	also	highlighted	in	another	study	which	aimed	to	separate	healthy		peripheral	zone	and	prostate	cancer	using	a	range	of	diffusion	models46.	K	had	the	highest	AUC	compared	to	ADC,	Dk,	D	(IVIM)	D*	(IVIM),	and	f	(IVIM).	However,	this	was	only	true	when	higher	b	values	were	used	(ranges	from	0-2,300	s/mm2,	and	0-1,800	s/mm2),	when	a	maximum	b	value	of	800	s/mm2	was	used	the	AUC	of	K	and	ADC	were	comparable.	This	again	highlights	the	need	for	higher	b	values	in	the	kurtosis	model.		Further	research	into	the	kurtosis	model	and	prostate	cancer	has	again	shown	that	
K	could	significantly	distinguish	between	benign	peripheral	zone	and	prostate	cancer	and	also	that	K	was	correlated	with	Gleason	score52.	Additionally,	K	has	also	been	able	to	differentiate	between	high	and	low	grade	prostate	cancers	with	greater	sensitivity	than	ADC	and	Dk50.	However,	other	research	has	not	found	this	to	be	the	case53,54;	a	mono-exponential	model	was	found	to	be	adequate	for	discriminating	between	tissue	types	and	tumour	characterisation	in	prostate	cancer	in	studies	using	b	values	of	up	to	80053	and	2,00054	s/mm2;	it	was	shown	in	both	instances	the	kurtosis	model	did	not	add	to	this	estimation.		The	clinical	utility	of	the	kurtosis	model	has	also	been	shown	in	body	imaging	outside	of	the	prostate55,56.	In	breast	cancer	it	was	shown	that	K	was	significantly	higher	in	malignant	tissue	compared	to	benign	and	Dk	was	significantly	reduced	in	malignant	tissue55.	Furthermore,	both	K	and	Dk	were	superior	in	terms	of	sensitivity	and	specificity	at	distinguishing	between	these	tissue	types	compared	to	ADC.	Additionally,	K	and	Dk	were	both	significantly	correlated	with	the	histological	tumour	grade.		A	study	has	also	investigated	the	use	of	kurtosis	in	determining	viability	of	hypervascular	hepatocellular	carcinoma56.	It	was	shown	that	K	was	significantly	higher	in	viable	tissue	compared	to	necrotic,	potentially	because	higher	values	of	K	may	represent	more	complex	tissue	environments40.	It	was	also	shown	that	K	was	superior	in	this	viable/necrotic	distinction	in	terms	of	sensitivity,	specificity,	and	AUC	compared	to	ADC.	
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The	kurtosis	model	has	clearly	been	shown	to	be	clinically	useful	in	body	imaging,	and	while	it’s	use	in	kidney	research	is	sparse	it	has	been	suggested	that	that	this	model	may	be	useful	in	kidney	fibrosis57.	However,	further	research	is	needed	to	determine	its	clinical	utility	in	this	organ.		
Summary	of	Diffusion	Weighted	Imaging	and	Models	of	Diffusion		 Chapter	3	detailed	Gaussian	and	non-Gaussian	models	of	diffusion	and	reviewed	research	into	their	clinical	utility	in	the	body.	The	mono-exponential	model,	which	provides	ADC,	has	been	widely	applied	to	many	organs.	It	does	not	need	a	large	range	of	b	values	and	thus	is	relatively	easy	to	acquire	in	clinical	environments.			 There	has	been	less	research	into	non-Gaussian	models	of	diffusion	in	the	body.	However,	from	reviewing	the	literature	a	few	key	points	can	be	identified.	The	IVIM	model	can	provide	additional	information	regarding	microcapillary	perfusion	as	well	as	diffusion	information	and	can	be	clinically	useful	in	describing	renal	function.	It	also	seems	that	constrained	step-wise	fitting	methods	of	IVIM	are	preferable	to	simultaneous	fittings.		The	stretched	exponential	model	describes	the	deviation	from	a	mono-exponential	decay,	with	increased	deviation	representing	increased	tissue	inhomogeneity.	Based	on	the	described	research	DDC	does	not	seem	to	be	as	clinically	useful	as	α.		The	kurtosis	model	describes	the	non-Gaussian	nature	of	diffusion	and	provides	two	fitted	parameters:	Dk	and	K.	Both	Dk	and	K	have	been	shown	to	be	clinically	useful,	particularly	in	the	prostate,	and	it	has	been	demonstrated	that	this	model	may	be	superior	to	mono-exponential	fitting	when	discriminating	between	benign	and	malignant	tissue.				
	
	 	
60 
 
References:	Chapter	3	
	1.	 Koh,	D.-M.	&	Collins,	D.	J.	Diffusion-Weighted	MRI	in	the	Body:	Applications	and	Challenges	in	Oncology.	Am.	J.	Roentgenol.	188,	1622–1635	(2007).	2.	 Stejskal,	E.	O.	&	Tanner,	J.	E.	Spin	Diffusion	Measurements:	Spin	Echoes	in	the	Presence	of	a	Time-Dependent	Field	Gradient.	J.	Chem.	Phys.	42,	288–292	(1965).	3.	 Squillaci,	E.	et	al.	Diffusion-weighted	MR	imaging	in	the	evaluation	of	renal	tumours.	J.	Exp.	Clin.	Cancer	Res.	CR	23,	39–45	(2004).	4.	 Sandrasegaran,	K.	et	al.	Usefulness	of	Diffusion-Weighted	Imaging	in	the	Evaluation	of	Renal	Masses.	Am.	J.	Roentgenol.	194,	438–445	(2010).	5.	 Zhang,	J.	et	al.	Renal	masses:	characterization	with	diffusion-weighted	MR	imaging--a	preliminary	experience.	Radiology	247,	458–464	(2008).	6.	 Thoeny,	H.	C.,	De	Keyzer,	F.,	Oyen,	R.	H.	&	Peeters,	R.	R.	Diffusion-weighted	MR	imaging	of	kidneys	in	healthy	volunteers	and	patients	with	parenchymal	diseases:	initial	experience.	Radiology	235,	911–917	(2005).	7.	 Yalçin-Şafak,	K.	et	al.	The	relationship	of	ADC	values	of	renal	parenchyma	with	CKD	stage	and	serum	creatinine	levels.	Eur.	J.	Radiol.	Open	3,	8–11	(2015).	8.	 Yang,	L.,	Li,	X.-M.,	Zhao,	S.,	Hu,	Y.-J.	&	Liu,	R.-B.	Diffusion-Weighted	Imaging	of	the	Kidneys	and	Its	Relationship	With	Residual	Renal	Function	in	Continuous	Ambulatory	Peritoneal	Dialysis	Patients.	Am.	J.	Roentgenol.	204,	1008–1012	(2015).	9.	 Inoue,	T.	et	al.	Noninvasive	evaluation	of	kidney	hypoxia	and	fibrosis	using	magnetic	resonance	imaging.	J.	Am.	Soc.	Nephrol.	JASN	22,	1429–1434	(2011).	10.	 Le	Bihan,	D.	et	al.	Separation	of	diffusion	and	perfusion	in	intravoxel	incoherent	motion	MR	imaging.	Radiology	168,	497–505	(1988).	11.	 Koh,	D.-M.,	Collins,	D.	J.	&	Orton,	M.	R.	Intravoxel	Incoherent	Motion	in	Body	Diffusion-Weighted	MRI:	Reality	and	Challenges.	Am.	J.	Roentgenol.	196,	1351–1361	(2011).	12.	 Meeus,	E.	M.	et	al.	Evaluation	of	intravoxel	incoherent	motion	fitting	methods	in	low-perfused	tissue.	J.	Magn.	Reson.	Imaging	45,	1325–1334	(2017).	13.	 Cho,	G.	Y.	et	al.	Comparison	of	fitting	methods	and	b-value	sampling	strategies	for	intravoxel	incoherent	motion	in	breast	cancer.	Magn.	Reson.	Med.	74,	1077–1085	(2015).	14.	 Merisaari,	H.	et	al.	Fitting	methods	for	intravoxel	incoherent	motion	imaging	of	prostate	cancer	on	region	of	interest	level:	Repeatability	and	gleason	score	prediction.	Magn.	Reson.	Med.	77,	1249–1264	(2017).	
61 
 
15.	 Jalnefjord,	O.	et	al.	Comparison	of	methods	for	estimation	of	the	intravoxel	incoherent	motion	(IVIM)	diffusion	coefficient	(D)	and	perfusion	fraction	(f).	Magn.	
Reson.	Mater.	Phys.	Biol.	Med.	(2018).	doi:10.1007/s10334-018-0697-5	16.	 Shinmoto,	H.	et	al.	Biexponential	apparent	diffusion	coefficients	in	prostate	cancer.	
Magn.	Reson.	Imaging	27,	355–359	(2009).	17.	 Mulkern,	R.	V.	et	al.	Biexponential	characterization	of	prostate	tissue	water	diffusion	decay	curves	over	an	extended	b-factor	range.	Magn.	Reson.	Imaging	24,	563–568	(2006).	18.	 Lemke,	A.	et	al.	Differentiation	of	pancreas	carcinoma	from	healthy	pancreatic	tissue	using	multiple	b-values:	comparison	of	apparent	diffusion	coefficient	and	intravoxel	incoherent	motion	derived	parameters.	Invest.	Radiol.	44,	769–775	(2009).	19.	 Luciani,	A.	et	al.	Liver	cirrhosis:	intravoxel	incoherent	motion	MR	imaging--pilot	study.	Radiology	249,	891–899	(2008).	20.	 Wang,	M.	et	al.	Evaluation	of	Hepatic	Tumors	Using	Intravoxel	Incoherent	Motion	Diffusion-Weighted	MRI.	Med.	Sci.	Monit.	Int.	Med.	J.	Exp.	Clin.	Res.	22,	702–709	(2016).	21.	 Issa,	B.	In	vivo	measurement	of	the	apparent	diffusion	coefficient	in	normal	and	malignant	prostatic	tissues	using	echo-planar	imaging.	J.	Magn.	Reson.	Imaging	16,	196–200	(2002).	22.	 Sato,	C.	et	al.	Differentiation	of	noncancerous	tissue	and	cancer	lesions	by	apparent	diffusion	coefficient	values	in	transition	and	peripheral	zones	of	the	prostate.	J.	
Magn.	Reson.	Imaging	21,	258–262	(2005).	23.	 Müller,	M.	F.,	Prasad,	P.	V.	&	Edelman,	R.	R.	Can	the	IVIM	model	be	used	for	renal	perfusion	imaging?	Eur.	J.	Radiol.	26,	297–303	(1998).	24.	 Deng,	Y.	et	al.	Use	of	intravoxel	incoherent	motion	diffusion-weighted	imaging	to	detect	early	changes	in	diabetic	kidneys.	Abdom.	Radiol.	1–6	(2018).	doi:10.1007/s00261-018-1521-4	25.	 Mao,	W.	et	al.	Chronic	kidney	disease:	Pathological	and	functional	evaluation	with	intravoxel	incoherent	motion	diffusion-weighted	imaging.	J.	Magn.	Reson.	Imaging	
JMRI	47,	1251–1259	(2018).	26.	 Ding,	J.	et	al.	Assessment	of	renal	dysfunction	with	diffusion-weighted	imaging:	comparing	intra-voxel	incoherent	motion	(IVIM)	with	a	mono-exponential	model.	
Acta	Radiol.	Stockh.	Swed.	1987	57,	507–512	(2016).	
62 
 
27.	 Bane,	O.	et	al.	Assessment	of	renal	function	using	intravoxel	incoherent	motion	diffusion-weighted	imaging	and	dynamic	contrast-enhanced	MRI.	J.	Magn.	Reson.	
Imaging	JMRI	44,	317–326	(2016).	28.	 Bennett,	K.	M.	et	al.	Characterization	of	continuously	distributed	cortical	water	diffusion	rates	with	a	stretched-exponential	model.	Magn.	Reson.	Med.	50,	727–734	(2003).	29.	 Li,	H.	et	al.	Monoexponential,	biexponential,	and	stretched	exponential	diffusion-weighted	imaging	models:	Quantitative	biomarkers	for	differentiating	renal	clear	cell	carcinoma	and	minimal	fat	angiomyolipoma.	J.	Magn.	Reson.	Imaging	JMRI	46,	240–247	(2017).	30.	 Wang,	Y.	et	al.	Comparison	of	the	Diagnostic	Value	of	Monoexponential,	Biexponential,	and	Stretched	Exponential	Diffusion-weighted	MRI	in	Differentiating	Tumor	Stage	and	Histological	Grade	of	Bladder	Cancer.	Acad.	
Radiol.	(2018).	doi:10.1016/j.acra.2018.04.016	31.	 Hu,	Y.	et	al.	Assessment	of	different	mathematical	models	for	diffusion-weighted	imaging	as	quantitative	biomarkers	for	differentiating	benign	from	malignant	solid	hepatic	lesions.	Cancer	Med.	(2018).	doi:10.1002/cam4.1535	32.	 Feng,	Z.	et	al.	Evaluation	of	different	mathematical	models	and	different	b-value	ranges	of	diffusion-weighted	imaging	in	peripheral	zone	prostate	cancer	detection	using	b-value	up	to	4500	s/mm2.	PLOS	ONE	12,	e0172127	(2017).	33.	 Merisaari,	H.	&	Jambor,	I.	Optimization	of	b-value	distribution	for	four	mathematical	models	of	prostate	cancer	diffusion-weighted	imaging	using	b	values	up	to	2000	s/mm2:	Simulation	and	repeatability	study.	Magn.	Reson.	Med.	73,	1954–1969	(2015).	34.	 Kwee,	T.	C.	et	al.	Intravoxel	water	diffusion	heterogeneity	imaging	of	human	high-grade	gliomas.	NMR	Biomed.	23,	179–187	(2010).	35.	 Bai,	Y.	et	al.	Grading	of	Gliomas	by	Using	Monoexponential,	Biexponential,	and	Stretched	Exponential	Diffusion-weighted	MR	Imaging	and	Diffusion	Kurtosis	MR	Imaging.	Radiology	278,	496–504	(2016).	36.	 Liu,	X.,	Zhou,	L.,	Peng,	W.,	Wang,	H.	&	Zhang,	Y.	Comparison	of	stretched-Exponential	and	monoexponential	model	diffusion-Weighted	imaging	in	prostate	cancer	and	normal	tissues.	J.	Magn.	Reson.	Imaging	JMRI	42,	1078–1085	(2015).	37.	 Rosenkrantz,	A.	B.	et	al.	Body	diffusion	kurtosis	imaging:	Basic	principles,	applications,	and	considerations	for	clinical	practice.	J.	Magn.	Reson.	Imaging	42,	1190–1202	(2015).	
63 
 
38.	 Jensen,	J.	H.,	Helpern,	J.	A.,	Ramani,	A.,	Lu,	H.	&	Kaczynski,	K.	Diffusional	kurtosis	imaging:	the	quantification	of	non-gaussian	water	diffusion	by	means	of	magnetic	resonance	imaging.	Magn.	Reson.	Med.	53,	1432–1440	(2005).	39.	 Wu,	E.	X.	&	Cheung,	M.	M.	MR	diffusion	kurtosis	imaging	for	neural	tissue	characterization.	NMR	Biomed.	23,	836–848	(2010).	40.	 Steven,	A.	J.,	Zhuo,	J.	&	Melhem,	E.	R.	Diffusion	Kurtosis	Imaging:	An	Emerging	Technique	for	Evaluating	the	Microstructural	Environment	of	the	Brain.	Am.	J.	
Roentgenol.	202,	W26–W33	(2013).	41.	 Le	Bihan,	D.	Apparent	diffusion	coefficient	and	beyond:	what	diffusion	MR	imaging	can	tell	us	about	tissue	structure.	Radiology	268,	318–322	(2013).	42.	 Jensen,	J.	H.	&	Helpern,	J.	A.	MRI	Quantification	of	Non-Gaussian	Water	Diffusion	by	Kurtosis	Analysis.	NMR	Biomed.	23,	698–710	(2010).	43.	 Quentin,	M.	et	al.	Comparison	of	different	mathematical	models	of	diffusion-weighted	prostate	MR	imaging.	Magn.	Reson.	Imaging	30,	1468–1474	(2012).	44.	 Quentin,	M.	et	al.	Feasibility	of	diffusional	kurtosis	tensor	imaging	in	prostate	MRI	for	the	assessment	of	prostate	cancer:	preliminary	results.	Magn.	Reson.	Imaging	
32,	880–885	(2014).	45.	 Filli,	L.	et	al.	Whole-body	diffusion	kurtosis	imaging:	initial	experience	on	non-Gaussian	diffusion	in	various	organs.	Invest.	Radiol.	49,	773–778	(2014).	46.	 Mazzoni,	L.	N.	et	al.	Diffusion-weighted	signal	models	in	healthy	and	cancerous	peripheral	prostate	tissues:	Comparison	of	outcomes	obtained	at	different	b-values.	J.	Magn.	Reson.	Imaging	39,	512–518	(2014).	47.	 Pentang,	G.	et	al.	Diffusion	kurtosis	imaging	of	the	human	kidney:	a	feasibility	study.	Magn.	Reson.	Imaging	32,	413–420	(2014).	48.	 Huang,	Y.	et	al.	MRI	quantification	of	non-Gaussian	water	diffusion	in	normal	human	kidney:	a	diffusional	kurtosis	imaging	study.	NMR	Biomed.	28,	154–161	(2015).	49.	 Ries,	M.,	Jones,	R.	A.,	Basseau,	F.,	Moonen,	C.	T.	&	Grenier,	N.	Diffusion	tensor	MRI	of	the	human	kidney.	J.	Magn.	Reson.	Imaging	JMRI	14,	42–49	(2001).	50.	 Rosenkrantz,	A.	B.	et	al.	Assessment	of	hepatocellular	carcinoma	using	apparent	diffusion	coefficient	and	diffusion	kurtosis	indices:	preliminary	experience	in	fresh	liver	explants.	Magn.	Reson.	Imaging	30,	1534–1540	(2012).	51.	 Tamura,	C.	et	al.	Diffusion	kurtosis	imaging	study	of	prostate	cancer:	Preliminary	findings.	J.	Magn.	Reson.	Imaging	40,	723–729	(2014).	52.	 Suo,	S.	et	al.	Non-Gaussian	water	diffusion	kurtosis	imaging	of	prostate	cancer.	
Magn.	Reson.	Imaging	32,	421–427	(2014).	
64 
 
53.	 Roethke,	M.	C.	et	al.	Evaluation	of	Diffusion	Kurtosis	Imaging	Versus	Standard	Diffusion	Imaging	for	Detection	and	Grading	of	Peripheral	Zone	Prostate	Cancer.	
Invest.	Radiol.	50,	483–489	(2015).	54.	 Toivonen,	J.	et	al.	Mathematical	models	for	diffusion-weighted	imaging	of	prostate	cancer	using	b	values	up	to	2000	s/mm(2) :	correlation	with	Gleason	score	and	repeatability	of	region	of	interest	analysis.	Magn.	Reson.	Med.	74,	1116–1124	(2015).	55.	 Sun,	K.	et	al.	Breast	Cancer:	Diffusion	Kurtosis	MR	Imaging-Diagnostic	Accuracy	and	Correlation	with	Clinical-Pathologic	Factors.	Radiology	277,	46–55	(2015).	56.	 Goshima,	S.	et	al.	Diffusion	kurtosis	imaging	to	assess	response	to	treatment	in	hypervascular	hepatocellular	carcinoma.	AJR	Am.	J.	Roentgenol.	204,	W543-549	(2015).	57.	 Kjølby,	B.	F.	et	al.	Fast	diffusion	kurtosis	imaging	of	fibrotic	mouse	kidneys.	NMR	
Biomed.	29,	1709–1719	(2016).	
	
	 	
65 
 
Chapter	4:	MRI	in	Wilms’	Tumour	
	This	chapter	explores	the	use	of	MRI	specifically	in	Wilms’	tumour.	It	reviews	past	research	which	has	looked	at	differentiating	between	benign	and	malignant	tumours,	identifying	Wilms’	tumour	from	other	abdominal	tumours,	changes	due	to	chemotherapy,	and	subtype	separation.			
4.1:	Background	of	MRI	in	Wilms’	Tumour	MRI	has	been	used	in	Wilms’	tumour	for	many	years.	Some	of	the	earliest	work	dates	back	to	1986,	where	the	use	of	T1-weighted	(T1w)	and	T2-weighted	(T2w)	imaging	was	evaluated	in	Wilms’	tumour1,2.	In	general,	Wilms’	tumour	appears	hypointense	on	T1w	images,	and	hyperintense	on	T2w	images.	After	administration	of	gadolinium-based	contrast	agents	Wilms’	tumour	appears	heterogeneous	on	T1w	images,	with	areas	of	necrosis	appearing	darker	compared	to	more	viable	tumour	tissue.			Belt	et	al.	investigated	the	use	of	MRI	(0.15T)	in	14	Wilms’	tumour	patients;	12	of	whom	had	not	undergone	any	treatment	or	surgery	and	2	who	were	post-surgery1.	This	early	work	showed	the	potential	of	using	MRI	in	Wilms’	tumour.	In	all	of	the	pre-surgery	patients,	MRI	accurately	identified	the	primary	tumours	and	their	origins.	Furthermore,	in	9	of	the	12	pre-surgery	patients,	the	tumour	margins	were	also	well	defined.	Additional	research	from	the	same	time	period	evaluated	4	children	with	Wilms’	tumour	using	a	0.3T	scanner2.	This	work	also	showed	that	T1w	imaging	could	provide	excellent	depiction	of	the	Wilms’	tumour	anatomy,	and	also	identify	its	origins.	The	authors	highlighted	that	T1w	imaging	also	provided	the	ability	to	clearly	investigate	the	contralateral	unaffected	kidney.	Both	works	showed	the	promise	of	MRI	and	suggested	that	in	the	future	MRI	may	be	able	to	distinguish	Wilms’	tumour	from	other	solid	abdominal	tumours,	and	also	may	aid	in	staging,	and	reviewing	treatment	for	these	patients.	Following	on	from	this	in	1993,	12	Wilms’	tumour	patients	were	evaluated	using	a	1.5T	scanner3.	This	work	highlighted	that	T2w	imaging	was	able	to	distinguish	between	active	nephrogenic	rests	and	inactive	nephrogenic	rests,	and	also	between	Wilms’	tumour	and	inactive	nephrogenic	rests.	This	was	due	to	the	fact	that	both	active	nephrogenic	rests	and	Wilms’	tumour	appear	hyperintense	on	T2w	imaging,	whereas	inactive	nephrogenic	rests	appear	hypointense.	Furthermore,	the	authors	found	that	on	post-contrast	
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gadolinium-enhanced	T1w	images	Wilms’	tumours	were	heterogeneous,	whereas	nephrogenic	rests	appeared	more	homogeneous.			
4.2.1:	Diffusion-Weighed	Imaging	in	Wilms’	Tumour:	Benign	and	Malignant	
Tumour	Separation	DWI	has	the	potential	to	be	very	useful	in	the	separation	of	benign	and	malignant	tumours.	For	example,	solid	malignant	tumours	have	higher	cellularity	and	an	increased	number	of	cell	membranes	per	unit	volume,	thus	these	tumours	are	more	likely	to	have	restricted	diffusion4	.	However,	benign	tumours	have	higher	water	content,	decreased	cellularity	and	increased	diffusion4.		Previous	research	utilised	DWI	to	determine	whether	ADC	values	could	distinguish	between	benign	and	malignant	solid	abdominal	paediatric	tumours5.	Additionally,	the	authors	investigated	whether	there	was	a	link	between	ADC	and	cellularity.	Nineteen	patients	were	included;	8	with	benign	tumours	and	11	with	malignant	(3	of	which	were	Wilms’	tumour),	all	patients	were	scanned	on	a	1.5T	scanner	prior	to	receiving	any	treatment.	While	ADC	values	were	generally	higher	in	the	benign	patient	group,	the	difference	was	not	statistically	significant	(p	=	0.069).	However,	a	significant	relationship	was	found	between	ADC	and	cell	count;	with	an	increase	in	cell	count	being	related	to	a	decrease	in	ADC	(R2	=	0.541,	p	<0.001).	The	lack	of	a	significant	difference	between	malignant	and	benign	tumours	may	be	attributed	to	the	broad	range	of	tumours	included	and	the	small	cohort	size.	More	recently	another	study	investigated	whether	ADC	could	separate	malignant	from	benign	paediatric	solid	abdominal	tumours6.	This	study	had	a	much	larger	sample	size;	38	patients	with	39	benign	tumours,	and	30	children	with	34	malignant	tumours	(7	of	which	were	Wilms’).	This	study	found	that	there	was	a	significant	difference	in	ADC	values	between	benign	and	malignant	tumours,	with	benign	tumours	having	an	increased	ADC.	There	were	also	good-to-excellent	inter-observer	correlations.	Furthermore,	ROC	analysis	showed	that	using	a	threshold	of	ADC:	1.29×10−3	mm2/s	provided	high	levels	of	sensitivity	and	specificity	for	this	separation:	77%	and	82%	respectively.	These	results	were	based	on	all	the	tumours	and	when	the	analysis	was	limited	to	Wilms’	and	benign	tumours,	the	sensitivity	and	specificity	levels	were	higher.	While	this	study	indicated	the	benefits	of	ADC	in	identifying	malignant	tumours,	the	ADC	threshold	may	need	be	taken	with	caution.	A	range	of	tumours	with	different	cellular	compositions	from	different	abdominal	organs	were	included,	with	each	group	having	a	small	number	of	samples.	To	
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ascribe	a	single	threshold	value	may	be	premature	as	each	of	these	tumour	types	are	likely	to	have	a	range	of	ADC	values,	for	example	based	on	subtypes	and	presence	of	necrosis.	Furthermore,	only	a	few	slices	were	sampled,	not	full	tumour	coverage,	and	so	to	give	a	tumour	an	ADC	value	may	not	be	representative	of	the	whole	tumour	environment,	particular	in	the	case	of	heterogeneous	tumours	such	as	Wilms’.	With	this	in	mind,	one	could	conclude	that	ADC	is	useful	in	suggesting	malignancy,	but	a	more	accurate	threshold	would	need	to	be	determined	based	on	individual	tumour	types	using	full	tumour	coverage.			
4.2.2:	Diffusion	Weighed	Imaging	in	Wilms’	Tumour:	Separating	Wilms’	
Tumour	from	Neuroblastoma	Neuroblastoma	is	a	common	paediatric	tumour	which	can	be	found	in	the	abdomen.	Alongside	Wilms’,	these	two	are	the	most	common	paediatric	abdominal	malignant	tumours	of	adjacent	organs7.	As	neuroblastoma	can	display	radiological	findings	which	are	similar	to	Wilms’	tumour,	an	investigation	was	carried	out	using	ADC	to	distinguish	between	these	two	tumour	types8.		A	retrospective	study	included	17	patients;	7	Wilms’	tumours,	and	10	neuroblastomas;	this	diagnosis	was	confirmed	post	surgery8.	Each	patient	was	scanned	prior	to	chemotherapy	on	a	1.5T	scanner.	Two	independent	observers	found	that	mean	ADC	values	(based	on	a	collection	of	ROIs	spread	across	the	tumour,	avoiding	cystic	and	necrotic	regions)	were	significantly	greater	in	Wilms’	tumour	compared	to	neuroblastoma.	Furthermore,	an	ADC	threshold	of	0.65	x	10-3	mm2/s	was	deemed	to	have	high	sensitivity	(80%)	and	specificity	(100%)	for	this	separation.	Differences	were	not	observed	between	the	two	tumours	when	based	on	T1w	and	T2w	signal	intensities.	Therefore,	DWI	shows	promise	as	an	important	tool	in	clinical	abdominal	imaging.	The	difference	in	ADC	values	may	have	been	due	to	increased	levels	of	necrosis	in	Wilms’	tumour	and	a	lower	cellular	density	compared	to	neuroblastomas.	The	inclusion	of	two	observers	and	excellent	agreement	in	ADC	measurements	between	them	(intraclass	correlation	coefficient:	0.955)	increases	the	reliability	of	these	results	and	thus	further	supporting	the	use	of	ADC	in	abdominal	imaging.				
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4.2.3:	Diffusion-Weighted	Imaging	in	Wilms’	Tumour:	Chemotherapy	
Changes	DWI	has	also	been	used	to	investigate	chemotherapy-induced	changes	in	Wilms’	tumour.	While	in	the	past	a	change	in	tumour	volume	post-chemotherapy	may	have	indicated	response	to	therapy,	this	is	now	thought	to	be	unreliable	due	to	the	presence	of	necrosis;	for	example,	a	tumour	may	have	responded	to	chemotherapy	resulting	in	high	levels	of	necrotic	tissue	but	not	have	undergone	vast	changes	in	volume9.	Furthermore,	although	Wilms’	tumours	may	reduce	in	size,	high	volumes	of	malignant	cells	may	still	remain10,11.	Given	that	a	decrease	in	cellularity	is	indicative	of	chemotherapy	response,	and	ADC	is	correlated	with	cellularity5,	it	was	hypothesised	that	positive	shifts	in	ADC	distributions	may	be	reflective	of	chemotherapy	response9.		In	a	prospective	study	of	7	children	with	9	abdominal	tumours	(6	of	which	were	Wilms’	tumour),	ADC	distributions	were	compared	pre-	and	post-chemotherapy9.	As	necrotic	tissue	would	theoretically	have	higher	ADC	values,	due	to	the	decrease	in	cellularity,	necrotic	regions	were	excluded	from	analysis.	This	was	achieved	by	using	T1w	imaging	pre-	and	post-administration	of	gadolinium	contrast.	Pre-contrast	enhanced	T1w	images	were	subtracted	from	post-contrast	T1w	images,	and	voxels	which	displayed	intensities	less	than	the	mean	values	of	the	erector	spinae	muscles	were	classified	as	necrotic.	Viable	masks	were	then	used	on	the	ADC	images	to	calculate	median	values	and	distributions	of	ADC	pre-	and	post-chemotherapy.		The	ADC	distributions	post-treatment	deviated	from	a	normal	distribution	for	all	the	Wilms’	tumour	patients	(p<0.001),	and	the	median	ADC	values	increased	post-chemotherapy.	There	was	also	a	wider	range	of	ADC	values	following	therapy	compared	to	pre-treatment.	One	of	the	Wilms’	tumours	more	than	doubled	in	size	after	chemotherapy,	but	the	median	ADC	also	increased,	and	the	distribution	widened.	If	tumour	volume	was	relied	upon	as	the	only	measure	of	treatment	response,	this	tumour	would	have	been	classed	as	progressive.	However,	given	the	increase	in	ADC,	this	patient	did	have	some	response	to	chemotherapy	due	to	the	decrease	in	cellularity.	Two	other	Wilms’	tumours	(bilateral	tumours	from	a	single	patient)	showed	a	marked	decrease	in	tumour	volume	(62%	and	83%)	but	had	only	a	very	small	increase	in	ADC	and	a	high	volume	of	viable	tumour	tissue	remained	(around	95%).	This	ADC	pattern	suggested	that	perhaps	tumour	tissue	cellularity	was	unchanged,	thus	chemotherapy	may	not	have	had	as	much	of	an	affect	as	suggested	by	the	change	in	size.	It	should	be	noted	that	this	study	was	conducted	as	a	feasibility	investigation	and	thus	the	sample	size	was	very	small	and	definitive	
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conclusions	cannot	be	made,	however	it	does	highlight	the	potential	benefits	of	using	ADC	as	opposed	to	volume	change	to	monitor	chemotherapy	response.		The	precision	of	measuring	ADC	values	to	detect	chemotherapy	changes	has	also	been	investigated12.	In	a	retrospective	study,	13	pre-treatment	and	9	post-treatment	Wilms’	tumours	were	analysed.	Three	readers	drew	ROIs	and	calculated	the	median	ADC	for	each	tumour;	they	were	blind	to	each	other’s	responses	and	to	the	histopathology	reports	of	the	patients.	Additionally,	one	of	the	readers	provided	measurements	twice,	with	a	minimum	interval	of	4	weeks.	Areas	of	necrosis	were	excluded	using	the	method	described	previously9.	Median	ADC	values	had	very	low	intra-	and	inter-observer	variability;	both	had	no	suggestion	of	bias.	The	shift	in	distributions	of	ADC	values	following	chemotherapy	was	also	analysed,	and	again	showed	minimal	intra-	and	inter-observer	variability.	A	benefit	of	this	study	is	that	whole	tumours	were	sampled,	whereas	often	only	single	slice	or	a	small	collection	of	ROIs	are	analysed.	As	Wilms’	tumours	are	heterogenous	the	single	slice	approach	is	flawed.	Overall	one	can	conclude	that	not	only	may	ADC	be	useful	in	identifying	chemotherapy-induced	changes,	but	that	this	method	is	also	potentially	reliable.		Littooij	et	al13	investigated	the	value	of	excluding	necrotic	regions.	Median	ADC	values	from	whole	tumour	volumes	were	compared	to	those	where	necrotic	tissue	had	been	removed	(using	the	method	of	gadolinium-enhanced	T1w).	It	was	shown	that	in	Wilms’	tumours	which	had	not	undergone	chemotherapy,	median	ADC	values	generally	did	not	differ	whether	necrosis	was	included	or	not.	However,	in	post-chemotherapy	patients	the	difference	was	more	marked.	This	may	be	because	of	the	increased	presence	of	necrosis	within	the	tumour	as	a	response	to	chemotherapy,	resulting	in	a	decrease	in	cellularity	and	increase	in	ADC	in	parts	of	the	tumour5.	Therefore,	the	ADC	median	would	be	affected	due	to	the	inclusion	of	this	necrotic	tissue.	The	method	of	identifying	necrotic	tissue	is	reliant	on	gadolinium-enhancement	and	thus	is	it	difficult	to	conclude	that	truly	necrotic	regions	were	excluded	due	to	the	lack	of	histology.	However,	obtaining	full	coverage	histology	is	challenging	and	in	most	clinical	settings	only	a	single	section	would	be	evaluated,	therefore	imaging	the	entire	tumour	and	using	gadolinium	as	a	proxy	for	necrosis	identification	is	a	reasonable	method.					
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4.2.4:	Diffusion-Weighted	Imaging	in	Wilms’	Tumour:	Chemotherapy	and	
Subtypes	Identifying	necrotic	regions	post	chemotherapy	is	clearly	important,	and	while	enhancement	on	post-gadolinium	T1-weighted	images	represents	a	useful	method	of	doing	this,	not	all	Wilms’	tumour	patients	will	receive	gadolinium.	A	more	recent	study	used	the	gadolinium-based	method9	to	generate	necrotic	and	viable	tumour	masks	and	then	transferred	these	to	ADC	maps	in	15	Wilms’	tumours14.	They	then	performed	ROC	analysis	to	identify	an	ADC	threshold	which	best	separated	viable	and	necrotic	tissue.	The	threshold	was	identified	as	1.81	x	10-3	mm2/s	which	gave	a	sensitivity	of	67%,	specificity	of	75%	and	an	AUC	of	0.72.	This	threshold	then	allowed	necrotic	and	viable	tissue	to	be	identified	in	those	tumours	which	did	not	receive	gadolinium.	Given	the	potential	problems	with	gadolinium	(previously	discussed	in	Section	1.5)	this	method	enables	a	wider	range	of	patients	to	be	included	and	to	undergo	ADC	analysis.	However,	it	is	important	to	keep	in	mind	that	an	ADC	threshold	may	not	be	adequate	to	separate	viable	and	necrotic	tumour	tissue,	as	low	ADC	values	may	reflect	high	cellular	environments	but	actually	be	necrotic	due	to	coagulation.		After	establishing	the	threshold,	Hales	et	al.14	went	on	to	investigate	chemotherapy	changes	with	regards	to	Wilms’	tumour	subtypes.	Twenty-three	Wilms’	tumours	with	ADC	maps	pre-	and	post-chemotherapy	were	analysed	via	multi-Gaussian	model	fitting	to	histograms	of	the	ADC	distribution	within	a	given	tumour.	An	example	was	shown	of	a	blastemal	Wilms’	tumour	(Figure	4.1.);	prior	to	chemotherapy,	the	tumour	had	a	low	ADC	subpopulation	within	the	histogram,	thought	to	represent	a	highly	cellular	environment,	and	thus	more	viable	tumour	tissue.	There	was	also	a	small	peak	at	a	higher	ADC	value	(above	that	of	the	previously	established	ADC	threshold),	this	was	thought	to	represent	necrotic	tissue.	A	third	population	was	shown	in	between	these	two	areas	with	a	broad	distribution,	potentially	representing	tissue	with	a	mixture	of	viable	and	oedematous	tissue.	Following	chemotherapy,	the	high	ADC	peak	remained	in	the	same	location	with	a	similar	peak	height,	the	middle	distribution	shifted	slightly	to	the	right,	possibly	representing	an	increase	in	non-viable	components.	The	lower	ADC	peak	remained	at	the	same	value	but	greatly	reduced	in	height.	This	suggested	that	necrotic	/	oedematous	components	of	the	tumour	remained	relatively	unchanged	by	chemotherapy,	whereas	the	volume	of	malignant	(low-ADC)	tissue	was	reduced.				
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	The	study	went	on	to	explore	the	different	effects	of	chemotherapy	on	Wilms’	tumour	subtypes	(with	the	following	patient	numbers:	stromal:	6,	epithelial:	4,	blastemal:	4,	mixed:	7,	regressive:	2)14.	Using	the	mean	ADC	value	of	the	highest	peak	in	the	ADC	histogram	(excluding	values	above	the	necrotic	threshold)	it	was	shown	that	only	the	stromal	subtype	significantly	increased	in	ADC	following	chemotherapy.	Outside	of	Europe,	Wilms’	tumours	can	be	treated	by	immediate	surgery,	with	no	prior	chemotherapy.	It	has	been	suggested	that	chemotherapy	may	cause	differentiation	and	maturation	of	Wilms’	tumour	tissue	resulting	in	more	stromal	subtypes15.	This	was	suggested	as	the	incidence	of	stromal	subtypes	is	very	low	in	those	who	do	not	receive	chemotherapy	prior	to	surgery16,17.	In	the	study	by	Hales14	it	was	shown	that	all	stromal	subtypes	increased	in	ADC	following	chemotherapy.	This	may	be	because	prior	to	treatment	this	subtype	has	a	high	cellular	density,	potentially	being	immature	blastema	or	stroma,	and	the	cellular	density	decreases	post-chemotherapy	reflecting	a	shift	to	mature	stromal	tissue.		Blastemal	subtypes	have	previously	been	noted	to	be	the	most	responsive	to	chemotherapy18,	and	if	blastemal	tissue	remains	following	treatment	then	these	patients	are	more	likely	to	relapse15.	In	Hales’	study14	it	was	shown	that	the	blastemal	subtype	decreased	in	volume	following	chemotherapy,	demonstrating	the	responsiveness	to	treatment.	However,	the	remaining	chemotherapy-resistant	tissue	within	the	viable	tumour	retains	low	ADC	values,	indicating	its	high	cellularity.	
(A) (B) 
Figure	4.1.	An	example	of	ADC	values	in	a	blastemal	Wilms’	tumour	prior	to	chemotherapy	
(A),	and	post	chemotherapy	(B).	The	different	colours	highlight	the	different	underlying	sub-populations	in	the	distribution	of	ADC	values.	Taken	from	Hales	et	al	NMR	Biomed.	28,	948–957	(2015)	with	permission.			
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Hales’	study	also	investigated	whether	ADC	values	could	distinguish	between	the	Wilms’	tumour	subtypes14.	Using	post-chemotherapy	data	from	31	Wilms’	tumours	(stromal:	6,	epithelial:	4,	blastemal:	5	mixed:	11,	regressive:	5)	it	was	shown	that	the	previously	mentioned	ADC	mean	(highest	histogram	peak	excluding	necrosis),	and	the	lower	quartile	ADC	value	could	significantly	separate	blastemal	from	stromal,	blastemal	from	regressive	and	blastemal	from	mixed;	as	the	blastemal	subtypes	had	significantly	lower	ADC	values.	When	ADC	of	the	raw	data	was	used	(not	excluding	necrotic	tissue)	these	differences	disappeared.	This	again	highlights	how	necrosis	can	affect	ADC	values.		Littooij	used	histopathology	to	further	analyse	Wilms’	tumour	and	the	blastemal	subtype13.	Firstly,	there	was	a	significant	inverse	relationship	between	the	amount	of	enhancing	tissue	(as	assessed	via	T1w	gadolinium	contrast)	and	chemotherapy–induced	changes	assessed	by	histology.	The	relationship	between	chemotherapy	changes	and	enhancement	are	often	assumed,	and	non-enhancing	tissue	is	categorised	as	necrotic	and	removed	from	ADC	analysis,	as	mentioned	previously9,12,14.	However,	this	study	correlated	the	enhancement	with	histology,	thus	increasing	the	validity	and	strengthening	the	interpretation	of	this	method.	Furthermore,	ADC	was	once	again	shown	to	be	lower	prior	to	chemotherapy	(based	on	25	Wilms’	tumours	with	post-chemotherapy	ADC	maps	and	histology).	Thus,	once	more	highlighting	the	link	between	ADC,	cellularity	and	chemotherapy-induced	changes.			The	number	of	each	subtype	was	very	small	and	so	analysis	of	subtype	separation	based	on	diffusion	measurements	was	not	possible.	Nevertheless,	the	proportion	of	blastema	in	54	lesions	prior	to	chemotherapy	was	weakly	inversely	correlated	(R	=	–0.248,	p	=	0.026)	with	the	25th	percentile	of	ADC	(prior	to	chemotherapy),	however	the	proportion	of	blastema	in	the	25	lesions	post-chemotherapy	did	not	correlate	with	ADC	(p	=	0.072).	It	is	interesting	that	the	authors	attempted	to	measure	the	relationship	between	proportion	of	blastema	and	ADC	in	pre-chemotherapy	tumours,	as	whole	tumour	histology	is	not	performed	until	after	chemotherapy.	Therefore,	conclusions	drawn	between	histological	subtypes	and	diffusion	measurements	prior	to	treatment	are	limited	and	one	could	argue	that	emphasis	should	be	placed	on	the	post-chemotherapy	results	instead.	The	study	also	found	that	the	stromal	portion	of	the	tumours	was	correlated	with	median	ADC	both	pre-	and	post-chemotherapy13.	Additionally,	median	ADC	values	after	chemotherapy	in	lesions	in	which	the	viable	tumour	tissue	was	predominantly	stromal	were	significantly	higher	than	the	median	ADC	values	in	other	tumours.	Using	ROC	analysis,	an	ADC	value	of	1.362	x	10-3	mm2/s	was	able	to	differentiate	between	stromal	and	other	subtypes	with	a	sensitivity	of	100%,	specificity	of	78.9%,	and	an	AUC	of	0.895.	
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Therefore,	not	only	is	using	the	viable	parts	of	Wilms’	tumour	superior	to	using	whole	tumour	values,	but	also	determining	stromal	subtypes	using	ADC	may	aid	treatment	decisions.		The	authors	suggested	that	the	25th	percentile	of	ADC	was	the	most	promising	metric	for	identifying	the	proportion	of	blastema;	a	finding	which	is	similar	to	that	of	Hales14.	However,	as	previously	mentioned	this	was	only	for	the	pre-chemotherapy	tumours	and	even	this	correlation	was	weak	(R	=	–0.248,	p	=	0.026).	Furthermore,	the	number	of	post-chemotherapy	blastemal	tumours	in	the	cohort	was	very	small	(n	=	2)	and	so	despite	the	authors	claims	it	cannot	be	said	whether	this	marker	is	clinically	useful.	Additionally,	as	it	has	been	previously	shown	that	both	blastemal	and	epithelial	tumours	have	low	ADC	values	and	there	is	considerable	overlap	in	ADC	values	between	these	subtypes14,	relying	solely	on	ADC	is	not	enough	to	clinically	identify	blastemal	predominance13.		Another	study	by	Littooji19	tested	the	feasibility	of	correlating	DWI	with	post-resection	histopathology,	to	build	on	their	previous	work	and	that	of	Hales14.	Pathological	slices	were	matched	to	T2w	or	post-contrast	T1w	images	by	a	radiologist	and	a	pathologist.	Median	and	25th	percentile	ADC	values	were	calculated	for	each	slice	after	the	exclusion	of	necrosis.	ADC	values	were	then	correlated	with	the	percent	of	subtypes	in	the	slices.	Nine	Wilms’	tumours	from	8	patients	were	included	(mixed:	4,	stromal:	2,	regressive:	1,	blastemal:	2).	It	was	shown	that	there	was	a	strong	inverse	relationship	between	the	percent	of	blastema	and	25th	percentile	ADC.	Additionally,	median	ADC	was	strongly	positively	correlated	with	percent	stroma.	These	results	echo	previous	work	indicating	that	blastemal	tissue	has	lower	ADC	values	and	stromal	has	higher13,14.	Furthermore,	results	indicated	that	tumour	shrinkage	or	necrosis,	in	combination	with	low	ADC	values	in	viable	tissue,	was	suggestive	of	chemotherapy-resistant	blastemal	tissue.	This	is	an	interesting	result	as	remaining	blastemal	tissue	following	chemotherapy	is	related	to	increased	relapse15.	Thus,	ADC	values	and	necrotic	volume	change	may	be	useful	in	identifying	this	treatment-resistant	tissue.	While	this	work	suggests	that	there	is	potential	to	match	histological	slices	with	MRI	data	which	may	aid	future	work	in	terms	of	using	ADC	to	differentiate	subtypes,	the	lack	of	epithelial	tissue	should	be	noted.	In	this	cohort	none	of	the	tumours	were	classified	as	epithelial	and	there	was	a	very	low	proportion	of	epithelial	tissue	in	each	tumour.	Therefore,	one	cannot	conclude	that	ADC	would	be	able	to	identify	and	separate	epithelial	from	blastemal	tissue,	which	is	a	consistent	problem	in	subtype	identification13,14.				
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4.3:	Diffusion	Weighed	Imaging	in	Wilms’	Tumour:	Non-Gaussian	Models	There	is	a	lack	of	research	into	using	more	advanced	non-Gaussian	models	of	diffusion	in	Wilms’	tumour.	However,	one	study	investigated	the	use	of	IVIM	in	paediatric	solid	abdominal	masses,	which	included	8	Wilms’	tumours20.		The	retrospective	study	included	6	b	values	in	their	DWI	sequence:		0,	50,	100,	150,	600,	1000	s/mm2	and	employed	the	IVIM	model.	The	IVIM	model	was	fit	using	a	step-wise	approach	where	b	values	above	100	s/mm2	were	used	for	calculation	of	D,	and	f	was	then	calculated	by	extrapolating	a	linear	fit	back	to	b=0	and	taking	the	intercept,	following	this	D*	was	fit.	A	large	cohort	of	42	tumours	were	included	(10	benign,	32	malignant).	The	study	highlighted	that	Wilms’	tumours	(n	=	8)	could	be	distinguished	from	neuroblastoma	(n	=	11)	using	the	IVIM	model.		Neuroblastomas	had	a	higher	D*	and	f	compared	to	Wilms’	tumours.	As	previously	suggested	Wilms’	tumours	may	have	increased	necrosis	compared	to	neuroblastomas8.	Necrotic	tissue	would	have	lower	perfusion,	and	thus	lower	f	values,	which	may	explain	the	differences	between	these	two	tumours.	D*	and	f	were	also	further	investigated	by	conducting	ROC	analysis	to	determine	whether	a	threshold	could	separate	these	tumour	types.	The	mean,	median,	75th	and	90th	percentiles	of	D*	all	had	an	AUC	above	0.9	for	this	separation.	For	f,	the	mean,	median,	5th,	25th,	75th	and	90th	percentiles	also	all	had	high	AUCs,	with	all	but	the	5th	percentile	being	above	0.9	(5th	percentile	AUC:	0.784).		However,	some	results	from	this	study	were	at	odds	with	the	previously	mentioned	work	by	Aslan	et	al.8;	wherein	ADC	values	in	neuroblastoma	were	found	to	be	significantly	lower	than	in	Wilms’	tumour.	The	IVIM	study20	found	that	there	were	no	significant	differences	between	Wilms’	tumour	and	neuroblastoma	using	ADC,	or	D.	The	IVIM	study	included	the	whole	tumour,	including	areas	of	necrosis	and	cystic	tissue,	however	Aslan8	excluded	these	regions.	Therefore,	the	lack	of	significant	differences	in	the	IVIM	study	maybe	due	to	the	inclusion	of	these	regions	which	would	have	distorted	the	ADC	and	D	values.			
Summary	of	MRI	in	Wilms’	Tumour	MRI	has	been	used	in	Wilms’	tumour	for	many	years	and	there	is	currently	a	considerable	amount	of	literature	using	DWI.	DWI	has	been	used	to	identify	malignant	from	benign	tumours,	separate	Wilms’	from	other	abdominal	tumours,	and	to	investigate	changes	in	chemotherapy	and	identify	Wilms’	tumour	subtypes.	While	cohort	numbers	
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have	been	relatively	small,	particularly	when	looking	at	subtype	separation,	the	general	trend	has	shown	that	ADC	in	Wilms’	tumour	increases	following	chemotherapy	and	excluding	areas	of	necrosis	is	important	to	obtain	accurate	measurements	of	viable	tumour.	Furthermore,	separating	subtypes	using	ADC	has	been	shown	to	be	possible.	Stromal	subtypes	have	higher	ADC	values	whereas	blastemal	have	reduced	ADC	compared	to	other	subtypes,	apart	from	epithelial	where	there	is	considerable	overlap	in	values.	Additionally,	matching	histology	to	MRI	slices	may	also	be	feasible.	Taking	into	account	all	of	the	past	research,	diffusion	imaging	is	a	valuable	tool	in	investigating	Wilms’	tumour	biology	and	response	to	treatment.	Furthermore,	the	use	of	non-Gaussian	models	may	provide	further	information	regarding	the	diagnosis,	and	assessment	of	treatment	response	of	this	paediatric	tumour.	By	further	investigating	DWI	and	more	advanced	models,	identification	of	tissue	status,	such	as	necrosis,	and	subtypes	of	Wilms’	tumour	may	be	possible.						
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Chapter	5:	Thesis	Aims	and	Objectives	
This	thesis	contains	four	original	research	studies	which	are	detailed	in	Chapters	6	–	9.	Overall	this	thesis	aims	to	investigate	the	use	of	diffusion	MRI	in	Wilms’	tumours.	Currently	most	research	has	focused	on	ADC,	derived	from	a	mono-exponential	model;	thus,	this	thesis	will	expand	on	past	research	by	additionally	investigating	advanced	non-Gaussian	models	of	diffusion.	The	four	models	under	investigation	are:	mono-exponential	(ADC),	IVIM	(D,	D*,	f),	stretched	exponential	(DDC,	α)	and	kurtosis	(Dk,	K).			
This	thesis	will	first	investigate:	
1. The	reproducibility	of	the	derived	parameters	from	the	four	diffusion	models	in	healthy	renal	tissue			2. The	goodness	of	fit	of	the	four	diffusion	models	in	Wilms’	tumour	tissue	and	the	contralateral	normal	kidney	
The	thesis	will	then	investigate	clinical	questions:	
1. Can	any	of	the	parameters	derived	from	the	four	diffusion	models	identify	necrotic	tissue	in	Wilms’	tumour	tissue?	2. Can	any	of	the	parameters	derived	from	the	four	diffusion	models	separate	Wilms’	tumour	subtypes?			
5.1:	Aims	and	Hypotheses	
The	aims	and	hypotheses	are	based	on	past	research	which	is	described	in	the	introductory	sections	of	the	following	chapters.		
5.1.1:	Chapter	6:	Reproducibility	of	Diffusion	Parameters	in	Healthy	Adult	
Kidney	Tissue	
Each	parameter	from	the	four	diffusion	models	will	be	tested	to	see	if	they	are	reproducible	when	different	field	strengths	are	used	(1.5T	vs.	3T)	and	when	different	b	values	are	acquired.	This	will	be	tested	based	on	coefficients	of	variation,	parametric	and	non-parametric	tests,	and	Bland-Altman	analysis.		
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A	parameter	will	be	considered	to	have	low	variability	if	the	coefficients	of	variation	and	levels	of	bias	(as	assessed	by	the	mean	difference	from	Bland-Altman	analysis)	are	£15%.		
Aims	and	Hypotheses:		
- In	healthy	adult	kidneys	there	will	be	a	difference	in	reproducibility	between	the	derived	parameters	from	each	model.		- For	both	experiments	(field	strength	and	b	values)	it	is	expected	that	the	greatest	variability	will	be	seen	in	D*	and	f	(IVIM)	and	K	(kurtosis).	- The	other	parameters	ADC	(mono-exponential),	D	(IVIM),	DDC	and	α	(stretched	exponential)	and	Dk	(kurtosis)	will	have	lower	variability.		
5.1.2:	Chapter	7:	Comparison	of	Models	of	Diffusion	in	Wilms’	Tumour	and	
Contralateral	Renal	Tissue	
Each	model	will	be	fit	on	a	voxel-by-voxel	basis	and	the	Akaike	information	criterion	(AIC)	will	be	calculated	for	each	model	for	each	voxel.	The	lowest	AIC	value	will	determine	which	model	best	describes	the	diffusion	data	for	each	voxel.	The	model	which	best	describes	the	majority	of	the	tissue	will	be	classified	as	the	best	fit	model.		
Aims	and	Hypotheses:		- In	contralateral	renal	tissue	IVIM	will	provide	a	superior	fit	to	the	raw	diffusion	data	compared	to	the	mono-exponential	model.		- As	there	is	a	lack	of	research	into	stretched	exponential	and	kurtosis	models	in	normal	renal	tissue	and	a	lack	of	research	into	all	three	non-Gaussian	models	in	Wilms’	tumour,	specific	directional	hypotheses	cannot	be	made	on	these	models.	This	study	therefore	aims	to	identify	which	of	the	models	provide	the	best	fit	to	this	data.		- It	is	expected	that	the	different	Wilms’	tumour	subtypes	will	favour	different	models	as	they	have	different	cellular	environments.			
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5.1.3:	Chapter	8:	An	Alternative	Approach	to	Contrast-Enhanced	Imaging:	
Diffusion	Weighted	Imaging	and	T1weighted	Imaging	Identifies	and	
Quantifies	Necrosis	in	Wilms’	Tumour		
Multiple	regression	analysis	will	investigate	whether	a	combination	of	a	diffusion	parameter	and	T1weighted	imaging	is	related	to	gadolinium	enhancement	in	Wilms’	tumour	tissue.	Models	will	be	compared	based	on	adjusted	R2	values	with	the	highest	adjusted	R2	selecting	the	preferred	model.		
Aims	and	Hypotheses:	- There	will	be	a	relationship	between	mean	diffusion	values	and	mean	fractional	enhancement	(based	on	gadolinium	contrast)	in	Wilms’	tumours.		- An	inverse	relationship	will	be	seen	in	the	majority	of	parameters	with	an	increase	in	ADC	(mono-exponential),	D	and	D*(IVIM),	DDC	and	α	(stretched	exponential),	Dk	and	K	(kurtosis)	being	significantly	(p	<	0.05)	related	to	a	decrease	in	mean	fractional	enhancement,	the	parameter	f	x	D*	(IVIM)	will	also	be	investigated	and	the	same	relationship	will	be	seen.		- A	positive	relationship	will	be	seen	with	f,	with	an	increase	in	mean	f	being	significantly	(p	<	0.05)	related	to	an	increase	in	mean	fractional	enhancement.		- The	IVIM	parameters	are	expected	to	provide	the	highest	adjusted	R2	values.	- The	selected	model	from	the	regression	analysis	will	be	compared	to	the	gadolinium	method	and	will	have	little	bias.	A	small	bias	will	be	defined	as	below	10%	based	on	Bland-Altman	analysis.	- A	threshold	will	be	determined	which	can	separate	necrotic	and	viable	Wilms’	tumour	tissue	based	on	diffusion	and	T1weighted	imaging	
	
5.1.4:	Chapter	9:	Identification	of	Wilms’	Tumour	Subtypes	using	Non-
Gaussian	Models	of	Diffusion	
One-way	ANOVAs	will	investigate	whether	there	are	significant	differences	(p	<	0.05)	between	the	Wilms’	tumour	subtypes	(blastemal,	epithelial,	stromal,	mixed	and	regressive)	based	on	diffusion	values.	Post-hoc	testing	will	reveal	where	these	differences	
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lie.	Whole	tumour	values	will	be	compared	to	viable	tumour	values	to	determine	whether	limiting	the	analysis	to	just	the	viable	tumour	tissue	improves	the	subtype	separations.		
Aims	and	Hypotheses:	- There	will	be	significant	differences	between	the	subtypes	based	on	diffusion	values.		- The	non-Gaussian	models	will	provide	more	subtype	separations	compared	to	the	mono-exponential	model	- The	blastemal	and	epithelial	subtypes	will	have	lower	ADC	values	compared	to	the	other	subtypes.	- The	stromal	subtype	will	have	the	highest	ADC	values	compared	to	the	other	subtypes.		- Limiting	the	analysis	to	just	the	viable	tumour	tissue	will	provide	more	significant	differences	between	the	subtypes	compared	to	using	the	whole	tumour	values.		
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Chapter	6:	Reproducibility	of	Diffusion	Parameters	in	Healthy	Adult	
Kidney	Tissue	
	This	chapter	details	work	from	an	original	research	study.	It	describes	the	reproducibility	of	a	range	of	diffusion	parameters	from	mono-exponential	and	non-Gaussian	models	in	healthy	adult	renal	tissue.	This	was	a	prospective	study	that	investigated	whether	parameters	were	reproducible	when	compared	between	a	1.5T	and	3T	system	and	when	different	b	values	were	acquired.	Reproducibility	was	assessed	based	on	coefficients	of	variation,	parametric	and	non-parametric	tests	and	Bland-Altman	analysis.	It	found	that	ADC	(mono-exponential),	D	and	f	(IVIM),	α	(stretched	exponential),	and	Dk	(kurtosis)	had	lower	levels	of	variability	(assessed	by	coefficients	of	variation	and	levels	of	bias	-	the	mean	difference	from	Bland-Altman	analysis	-	≤15%)	compared	to	D*	(IVIM),	DDC	(stretched	exponential)	and	K	(kurtosis).			
6.1:	Background	of	the	Reproducibility	of	Diffusion	Parameters	Diffusion	weighted	imaging	(DWI)	has	been	shown	to	be	a	very	useful	technique	in	body	imaging.	ADC	has	proven	to	be	a	clinically	important	parameter	in	Wilms’	tumour1,2,	and	parameters	from	other	non-Gaussians	models	of	diffusion	(IVIM3,	stretched	exponential4	and	kurtosis5)	have	also	demonstrated	their	utility	in	a	range	of	body	pathologies	(full	details	on	these	diffusion	models	and	their	clinical	utility	are	given	in	Chapter	3).	Given	that	DWI	can	potentially	produce	a	range	of	clinically	useful	parameters	it	is	important	to	determine	whether	these	parameters	are	reproducible,	as	different	institutions	and	hospitals	are	likely	to	acquire	data	using	a	range	of	scanner	models,	magnetic	field	strengths,	and	DWI	protocols.		Multi	centre	studies	have	investigated	the	stability	of	diffusion	parameters	based	on	different	manufacturers	and	varying	b	values	in	the	brain6.	This	demonstrated	that	both	ADC	and	IVIM	parameters	are	largely	reproducible	across	scanners	and	field	strengths.	However,	in	body	imaging	the	literature	is	more	varied.	This	may	be	influenced,	in	part,	by	the	choice	of	whether	breath-hold,	free	breathing	or	respiratory	triggered	acquisitions	are	used.	Table	6.1	summarises	some	studies	which	have	investigated	reproducibility	of	diffusion	parameters	across	the	body.	Low	variability	is	defined	as	those	with	values		£15%.		
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Table	6.1.	A	summary	of	research	studies	which	have	investigated	reproducibility	of	diffusion	parameters.	In	this	table	‘Consistent	Acquisition’	means	there	were	no	differences	in	b	values,	field	strength	or	other	acquisition	methods	between	scans.			Study	Author	 Model	/Parameter	 Organ	 Methodology	 Main	Findings	Braithwaite	et	al.	20097	 ADC	 Healthy	abdominal	tissue:	Liver,	Spleen	Pancreas	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	Thoeny	et	al.	20058	 ADC	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	Cutajar	et	al.	20119	 ADC	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 No	significant	differences	in	ADC	between	scans	and	low	variability	(<15%)	Jakab	et	al.	201710	 IVIM	 Healthy	Foetal	MRI	(Kidneys,	Liver,	Lungs)	 Consistent	Acquisition	 D*	and	f	had	greater	variability	(14	–	25%),	D	was	more	reproducible	(12	–	14%)	
Sun	et	al.	201711	 IVIM	 Rectal	Cancer	and	Prostate	Tissue	 Consistent	Acquisition	 D*	and	f	showed	higher	variability	(126	–	197%)	than	D	(24.5%)	in	rectal	cancer,	in	prostate	tissue	all	IVIM	parameters	were	reproducible	(Bland-Altman	confidence	intervals:	<5%)	Reischauer	et	al.	201712	 IVIM	&	Stretched	Exponential	 Prostate	Cancer	Bone	Metastases	 Consistent	Acquisition	 D*	and	f	had	greater	variability	(20	–	43%),	D,	DDC	and	α	were	all	reproducible	(<10%)	Winfield	et	al.	201513	 Stretched	Exponential	 Ovarian	Cancer	 Consistent	Acquisition	 DDC	and	α	were	both	reproducible	(4.3	–	7%)	
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Jerome	et	al.	201714	
Mono-exponential,	IVIM,	Stretched	Exponential,	&	Kurtosis	
Range	of	paediatric	tumours,	(cranial	and	extra-cranial)	 Consistent	Acquisition	
Majority	of	parameters	showed	good	reproducibility	(ADC,	D,	
DDC,	α,	Dk	<	10%).	D*,	f	and	K	had	the	highest	variability	(>30%)	Pentang	et	al.	201415	 Kurtosis	(Dk)	 Healthy	Kidney	Tissue	 Consistent	Acquisition	 Dk	no	significant	differences,	however	this	was	based	on	one	volunteer	Kwee	et	al.	200816	 ADC	 Healthy	Liver	Tissue	 Breathing	Technique	Alteration	
Breath-hold	and	free	breathing	methods	provided	consistent	ADC	values.	Respiratory	triggering	gave	very	variable	ADC	values	Choi	et	al.	201317	 ADC	 Focal	Liver	Lesions	 Breathing	Technique	Alteration	 Breath-hold	and	free	breathing	methods	provided	consistent	ADC	values	Ye	et	al.	201418	 ADC	 Heathy	Pancreatic	Tissue	 Field	Strength	Alteration	 ADC	values	were	higher	when	acquired	on	1.5T	scanners	compared	to	3T	Barral	et	al.	201319	 ADC	 Heathy	Pancreatic	Tissue	 Field	Strength	Alteration	 No	significant	differences	in	ADC	between	1.5T	and	3T	
Dale	et	al.	201020	 ADC	 Healthy	Spleen,	Liver	and	Pancreatic	Tissue	 Field	Strength	and	b	value	Alteration	
No	significant	differences	in	ADC	were	found	when	field	strength	was	altered.	When	b	value	ranges	were	focused	on	lower	b	value	weightings,	ADC	values	increased.	When	the	maximum	b	value	was	kept	consistent	ADC	did	not	differ	despite	the	inclusion	of	different	lower	b	value	weightings	
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Cui	et	al.	201521	 IVIM	 Healthy	liver	tissue	and	Chronic	Liver	Disease	 Field	Strength	Alteration	 D*	and	f	had	greater	variability	(22	–	47%),	D	was	more	reproducible	(10.9%)	Barbieri	et	al.	201522	 IVIM	 Heathy	Upper	Abdominal	Organs	 Field	Strength	Alteration	 Greatest	variability	seen	in	D*	and	f	(8.7	–	36.7%)	in	renal	cortex	and	medulla,	D	was	reproducible	(<7%)	
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6.1.1:	Diffusion	Parameters	Reproducibility:	Consistent	Acquisition	Variations	in	the	acquisition	protocol	may	alter	the	measured	diffusion	parameters,	as	illustrated	in	Table	6.1;	however,	it	is	also	important	to	establish	whether	these	parameters	are	reproducible	when	the	acquisition	protocol	is	kept	constant,	which	may	be	more	indicative	of	reproducibility	within	a	single-centre	setting.	The	mono-exponential	model,	which	produces	ADC,	appears	to	be	stable	when	acquisition	is	unchanged.	For	example,	when	the	same	DWI	sequence	was	repeated	five	times	in	a	single	session	using	a	3T	scanner,	ADC	did	not	significantly	differ	within	a	given	healthy	subject	between	each	acquisition	when	obtained	in	the	liver,	spleen	and	pancreas7.	There	were	also	no	significant	changes	in	ADC	values	when	volunteers	returned	147	days	later.	This	has	also	been	demonstrated	in	the	kidneys;	5	healthy	volunteers,	underwent	the	same	DWI	acquisition	6	months	apart	on	a	1.5T	scanner,	and	it	was	shown	that	ADC	values	did	not	significantly	differ	between	these	sessions	based	on	student	t-tests8.	Furthermore,	another	study	on	healthy	kidneys	also	demonstrated	small	within	subjects	coefficients	of	variation	(CV)	for	ADC:	<10%	when	subjects	were	scanned	repeatedly	on	the	same	day,	and	when	they	returned	a	month	later	(CV:	<15%)9.		For	the	non-Gaussian	models	of	diffusion	there	appears	to	be	greater	variability	in	diffusion	parameters	even	when	acquisition	parameters	do	not	change.	Reproducibility	of	IVIM	parameters	have	been	tested	in	foetal	MRI10,	where	a	DWI	sequence	was	repeated	within	a	single	session	in	utero.	The	acquisition	protocol	consisted	of	16	b	values	(maximum	b	value	=	900	s/mm2)	and	the	IVIM	model	was	fit	using	a	2-step	method;	fitting	for	D	at	b	values	above	250	s/mm2	and	then	simultaneously	fitting	for	f	and	D*	with	a	fixed	
D.	The	kidneys,	liver	and	lungs	were	selected	as	volumes	of	interest,	and	IVIM	values	in	each	organ	were	compared	between	the	two	scans.	Across	the	three	organs	D*	and	f	had	higher	levels	of	variability	(14	–	36%)	compared	to	D	(13	–	17%)	which	remained	more	stable	between	the	scans.	It	was	suggested	that	the	large	range	and	well-spaced	high	b	value	weightings	improved	the	fitting	of	D,	resulting	in	better	repeatability.	The	higher	variability	of	D*	and	f	was	explained	due	to	the	limitations	of	hardware	to	achieve	a	useful	range	of	low	b	values,	furthermore	there	was	difficulty	in	identifying	organs	in	utero	which	may	have	also	contributed	to	the	variability	in	the	parameters.	It	should	also	be	noted	that	foetal	MRI	presents	unique	challenges,	and	the	reproducibility	values	obtained	in	this	study	may	be	elevated	as	a	result.	Further	research	has	supported	the	finding	that	D	has	higher	reproducibility	than	
D*	and	f.	In	a	clinical	population	of	patients	with	rectal	cancer11	it	was	shown	that	when	
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DWI	was	repeated	within	a	single	session,	D	remained	more	stable	(24.5%)	compared	to	
D*	and	f,	which	had	very	high	levels	of	variability	(197.4%	and	126.3%,	respectively),	and	thus	caution	should	be	taken	when	using	these	measurements.	It	was	suggested	that	the	motion	in	the	rectum	could	be	a	potential	reason	for	this	region	having	low	repeatability.	This	study	also	looked	at	prostate	tissue	and	found	that	in	this	organ	all	IVIM	parameters	had	better	repeatability,	with	no	significant	differences	between	scans,	and	Bland-Altman	analysis	also	revealed	little	variability	in	terms	of	bias	and	95%	CI:	D:	bias	=	0.8%,	(CI:	-12	to	+13.7),	D*:	bias	=	-4.7%,	(CI:	-92.4	to	+83),	and	f	:	bias	=	-3.9%,	(-49.1	to	+41.4).		The	reproducibility	of	the	stretched	exponential	model	has	also	been	investigated	in	body	imaging.	Patients	with	prostate	cancer	bone	metastases	were	analysed	pre-treatment	and	it	was	shown	that	both	DDC	and	α	were	highly	reproducible,	with	coefficients	of	variation	(CV):	<10%.	The	same	was	true	for	ADC,	and	D	(IVIM)12.	The	authors	also	highlighted	that	both	f	and	D*	were	far	less	reproducible	(CVs:	20%,	43%	respectively),	which	is	in	line	with	the	previously	reported	findings11,23.	Furthermore,	DDC	and	α	have	also	been	reported	to	have	very	low	CV	(4.3%	and	7%	respectively)	in	pre-treatment	patients	with	primary	ovarian	cancer13.			Research	into	the	reproducibility	of	the	kurtosis	model	is	limited,	particularly	in	body	imaging.	However,	a	study	of	children	(ages	6	to	15	years	old)	with	solid	tumours	investigated	the	repeatability	of	mono-exponential,	IVIM,	stretched	exponential	and	kurtosis	models;	this	study	included	both	cranial	and	extracranial	tumours14.	Comparing	parameters	from	two	scans	(24	hours	apart)	on	a	1.5T	scanner	it	was	shown	that	values	of	ADC,	D	(IVIM),	DDC	(stretched	exponential),	α	(stretched	exponential),	and	Dk	(kurtosis)	were	all	reproducible	with	CVs	below	10%,	however	K	(kurtosis),	f	(IVIM),	and	D*	(IVIM)	were	far	less	reproducible	with	CVs	>30%.	The	selection	of	b	values	(b	=	0,	50,	100,	300,	600,	1,000	s/mm2),	may	have	had	a	role	in	the	variability	of	these	parameters.	A	range	of	tissues	were	analysed	(including	brain	tissue),	thus	higher	b	values	may	have	been	needed	to	capture	the	effects	of	the	kurtosis	model.	Additionally,	there	was	a	limited	number	of	low	b	values	and	this	may	have	also	impacted	the	reproducibility	of	D*	and	f	which	are	influenced	by	lower	b	values.	The	scan	time	(6	minutes)	was	found	to	be	tolerable	for	these	patients	and	the	inclusion	of	more	b	values	would	have	lengthened	this,	which	may	have	caused	problems	for	this	paediatric	population.		Repeatability	of	Dk,	from	the	kurtosis	model,	has	also	been	demonstrated	in	the	kidneys15;	however	this	was	based	on	one	healthy	volunteer	who	was	scanned	twice,	14	days	apart,	using	the	same	acquisition	protocol.	Mean	values	of	Dk	from	within	the	kidneys	were	compared	between	the	two	scans	using	student’s	t-tests	and	no	significant	
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differences	were	found.	However,	as	this	result	is	based	on	very	limited	data	further	testing	of	Dk	in	the	kidneys	is	needed	to	draw	any	reliable	conclusions.			
6.1.2:	Diffusion	Parameters	Reproducibility:	Acquisition	Alterations	–	
Breathing	Techniques	When	acquiring	DWI	data	different	methods	can	be	used	to	account	for	respiratory	motion,	including	free	breathing,	breath-hold	or	respiratory	triggering.	Breath-hold	techniques	have	much	shorter	acquisition	times	and	as	such	the	signal-to-noise	ratio	(SNR)	is	generally	lower	compared	to	other	methods24.	It	has	been	suggested,	however,	that	using	breath-hold	techniques,	as	opposed	to	free	breathing,	may	provide	more	stable	ADC	values	of	small	lesions	as	there	would	be	fewer	partial	volume	artefacts	related	to	respiratory	motion25.	However,	it	has	been	shown	that	ADC	values	in	the	liver	were	not	significantly	different	when	obtained	via	breath-hold	or	free	breathing	methods;	this	has	been	shown	in	both	1.5T16	and	3T17	systems.	Respiratory	triggering	methods	require	longer	scan	times,	with	increased	SNR,	but	results	have	shown	that	ADC	values	were	more	variable	and	less	reproducible	than	free	breathing	and	breath-hold	methods,	when	measured	in	the	liver16.	The	higher	ADC	values	found	when	using	respiratory	triggering,	in	this	particular	study,	may	have	been	due	to	the	higher	blood	flow	rate	at	the	end	of	expiration,	and	the	authors	suggested	that	DWI	signal	should	be	evaluated	at	different	phases	of	the	respiratory	cycle16.		Overall	it	has	been	suggested	that	as	free	breathing	methods	are	easier	to	acquire,	more	time	efficient	than	respiratory	triggering,	and	are	reproducible,	thus	it	may	be	the	most	appropriate	acquisition	technique16,17.			
6.1.3:	Diffusion	Parameters	Reproducibility:	Acquisition	Alterations	–	Field	
Strength	Different	research	and	clinical	centres	are	likely	to	have	scanners	with	varying	field	strengths.	It	is	thus	important	to	determine	whether	this	will	impact	the	measured	diffusion	parameters.	The	impact	of	field	strength	on	the	reproducibility	of	ADC	in	the	body	has	been	investigated.	In	a	prospective	healthy	volunteer	study	of	the	pancreas,	it	was	shown	that	ADC	values	were	significantly	higher	in	a	1.5T	GE	scanner	compared	to	a	3T	Philips	scanner,	when	subjects	were	scanned	consecutively	using	the	same	b	values18.	
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This	difference	also	remained	when	ADC	values	from	a	1.5T	Siemens	scanner	were	compared	to	the	3T	Philips	scanner.	Previously	it	has	been	suggested	that	MRI	at	3T	has	larger	magnetic	field	inhomogeneities	and	greater	susceptibility	artefacts26,	and	the	this	may	have	contributed	to	the	differences	seen	in	pancreatic	ADC	values	between	the	1.5T	and	3T18.	However,	importantly,	the	differences	in	ADC	may	also	have	been	due	to	the	differences	in	vendors	and	the	different	echo	times	used,	as	the	sequences	were	not	identical.	Thus,	it	is	difficult	to	isolate	the	impact	of	field	strength	on	these	measurements.	Conversely,	another	study	showed	that	ADC	values	of	the	pancreas	did	not	significantly	differ	when	obtained	from	1.5T	and	3T	systems,	in	this	instance	the	vendor	remained	consistent19.	Furthermore,	another	study	also	demonstrated	no	significant	differences	in	ADC	between	1.5T	and	3T	(both	Siemens	scanners)	in	the	spleen20.	Stability	of	IVIM	parameters	in	the	body	have	also	been	tested	between	field	strengths.	It	was	shown	that	when	D,	D*,	and	f	were	measured	in	liver	tissue	on	a	1.5T	and	also	on	a	3T	(average	of	9	days	apart)	the	mean	CV	(comparing	1.5T	values	to	3T	values)	was	much	greater	in	f	(22.6%)	and	D*	(46.8%)	compared	to	D	(10.9%)21.	However,	it	should	be	noted	that	the	MR	systems	were	from	different	vendors;	Siemens	1.5T	and	GE	3T,	and	this	study	combined	healthy	volunteers	(n	=	2)	and	patients	with	chronic	liver	disease	(n	=	17).	Thus,	these	factors	may	have	also	affected	the	results.	Furthermore,	the	high	variability	in	D*	was	likely	to	be	due	to	fitting	errors,	and	as	mentioned	previously10,11	this	parameter	has	high	variability	when	repeated	on	the	same	system,	thus	it	is	unsurprising	that	it	differs	greatly	when	measured	across	different	field	strengths.		A	recent	study	into	the	effects	of	field	strength	and	MR	vendor	on	measured	IVIM	parameters	in	upper	abdominal	organs	also	provided	similar	findings22.	A	variety	of	vendors	of	1.5T	and	3T	systems	were	included.	It	was	shown	that	in	the	renal	cortex	significant	differences	were	found	in	D,	D*	and	f,	between	1.5T	and	3T	systems,	and	in	the	renal	medulla	significant	differences	in	D	and	f.	Between-subject	and	within-subject	variation	was	also	investigated,	combining	all	MR	systems.	Variations	in	D	were	smaller	(5.5-6.8%)	than	f	(8.7	–	23.4%)	and	D*	(28.0	–	36.7%)	in	the	renal	cortex	and	medulla.	These	variations	are	similar	to	the	previously	mentioned	coefficients21.	
	
6.1.4:	Diffusion	Parameters	Reproducibility:	Acquisition	Alterations	–	b	
values	The	range	of	b	values	used	in	the	DWI	acquisition	may	also	influence	reproducibility.	A	comparison	study	investigated	the	effect	of	different	b	value	ranges	on	
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the	measured	ADC	in	the	spleen,	liver	and	pancreas20.	Four	b	value	ranges	were	used:	0/50	s/mm2,	0/400	s/mm2,	0/800	s/mm2,	and	0/50/400/800	s/mm2	and	ADC	values	were	measured	using	each	range	in	the	three	abdominal	organs.	ADC	significantly	decreased	between	the	0/50	s/mm2,	0/400	s/mm2,	and	0/800	s/mm2	ranges	in	every	organ.	This	was	possibly	due	to	the	perfusion	effects	which	are	more	prominent	at	lower	b	value	weightings3.	It	was	suggested	that	b	value	ranges	which	focused	on	lower	b	values	would	artificially	elevate	the	ADC	due	to	the	perfusion	effects,	and	thus	ranges	which	included	more	acquisitions	at	higher	b	values	would	be	less	influenced	by	this20.	When	comparing	the	0/800	s/mm2	and	0/50/400/800	s/mm2	range	there	were	no	significant	differences	in	ADC	in	the	pancreas	and	the	spleen;	there	was,	however,	a	small	difference	in	the	liver.	Thus,	using	different	b	values	may	affect	the	measured	ADC,	however	if	the	maximum	b	value	is	constant,	then	these	differences	may	be	reduced.		
	
6.2:	Aims	and	Hypotheses		It	is	clear	that	different	diffusion	parameters	result	in	varying	levels	of	reproducibility.	While	research	into	ADC	variability	(including	changes	with	field	strength18–20,	and	b	values20)	has	been	well	studied,	the	literature	on	IVIM,	stretched	exponential	and	kurtosis	is	more	sparse	when	the	focus	is	on	body	imaging.		As	previously	mentioned	DWI	is	often	obtained	in	patients	with	Wilms’	tumour,	and	ADC	has	been	shown	to	provide	clinically	useful	information	regarding	treatment	response	and	subtype	idenfticaion1,2.	Non-Gaussian	models	of	diffusion	have	not	been	greatly	investigated	in	Wilms’	tumour,	but	these	parameters	may	also	provide	additional	information	regarding	tissue	status.	Before	diffusion	models	are	further	investigated	in	Wilms’	tumour	it	is	important	to	establish	how	reproducible	these	parameters	are	in	healthy	renal	tissue.		The	present	study	sought	to	determine	whether	diffusion	parameters	were	reproducible	in	healthy	adult	kidney	tissue.	The	study	focused	on	two	areas	of	reproducibility:	field	strength	and	b	value	selection.	Diffusion	parameters	from	the	four	previously	mentioned	diffusion	models	(mono-exponential,	IVIM,	stretched	exponential	and	kurtosis)	were	assessed	to	determine	which	remained	stable	when	calculated	based	on	different	scanners	of	different	field	strengths	(1.5T	vs.	3T),	and	also	when	different	b	values	were	used	within	the	same	scanner	(0,	50,	100,	150,	200,	250,	500,	1000	s/mm2	vs.	0,	50,	100,	250,	500,	750,	1000	s/mm2	on	the	3T	system.)	
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Low	variability	was	defined	as	coefficients	of	variation	and	levels	of	bias	(as	assessed	by	the	mean	difference	from	Bland-Altman	analysis)	being	£15%.	It	was	expected	that in	healthy	adult	kidneys	there	would	be	a	difference	in	reproducibility	between	the	derived	parameters	from	each	model.	For	both	experiments	(field	strength	and	b	values)	it	was	expected	that	the	greatest	variability	would	be	seen	in	D*	and	f	(IVIM)	and	K	(kurtosis)	based	on	previous	research11,12,14,21,23.	The	other	parameters	ADC	(mono-exponential),	D	(IVIM),	DDC	and	α	(stretched	exponential)	and	Dk	(kurtosis)	were	expected	to	have	lower	variability.				
6.3:	Methods		
6.3.1:	Study	Population	Data	was	prospectively	acquired	for	this	single	centre	reproducibility	study	(May	2017	–	January	2018).	All	volunteers	attended	Great	Ormond	Street	Hospital	(London,	UK)	on	two	separate	occasions	for	each	MRI	scan.	Volunteers	had	no	known	medical	conditions	and	where	possible	each	volunteer	came	at	a	similar	time	of	day	to	their	previous	scan,	having	eaten	and	drank	approximately	the	same	quantity	as	before.		
6.3.2:	MRI	Imaging	was	performed	on	a	1.5T	Siemens	Magnetom	Avanto	and	on	a	3T	Siemens	Magnetom	Prisma	both	located	at	Great	Ormond	Street	Hospital.	DWI	was	obtained	on	each	scanner.	The	1.5T	DWI	protocol	was	as	follows:	slice	thickness:	6mm,	TR/TE:	2700ms/89ms,	voxel	size:	1.4	x	1.4	x	6mm,	and	8	b	values	in	3	orthogonal	directions	(0,	50,	100,	150,	200,	250,	500,	1000	s/mm2),	in	an	axial	plane.	Two	DWI	protocols	were	obtained	on	the	3T,	each	using	identical	parameters,	except	for	the	number	of	b	values.	The	3T	protocol	was	as	follows:	slice	thickness:	5mm,	TR/TE:	5000ms/58ms,	voxel	size:	0.9	x	0.9	x	5mm,	and	either	7	(0,	50,	100,	250,	500,	750,	1000	s/mm2)	or	8	b	values	in	3	orthogonal	directions	(the	8	b	values	matched	that	of	the	1.5T	protocol).	Each	b	value	had	9	averages	and	trace	images	were	used	for	analysis.	The	acquisition	protocols	matched	the	clinical	acquisitions	used	at	Great	Ormond	Street	Hospital.				
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6.3.3:	Data	Processing	and	Regions	of	Interest		 Diffusion	data	was	processed	using	the	trace	images	on	in-house	routines	designed	in	Matlab	2015b	(MathWorks	Inc.,	Natick,	MA,	USA)	on	a	voxel-by-voxel	basis	using	four	different	models	of	diffusion:	mono-exponential,	IVIM3	(Equation:	3.4),	stretched-exponential4	(Equation:	3.5),	and	kurtosis5	(Equation:	3.6).	The	mono-exponential	model	was	fit	using	the	‘polyfit’	and	‘polyval’	functions	in	Matlab,	which	is	a	standard	method	of	fitting	a	polynomial.		For	the	non-Gaussian	models,	fitting	was	performed	using	the	Levenberg-Marquardt	nonlinear	least	squares	algorithm,	across	all	b	values	(except	for	the	IVIM	model).	In	each	case	S0	was	defined	at	the	signal	at	b=0.	For	the	IVIM	model,	firstly,	a	linear	fit	of	ln(S/S0)	against	b	was	calculated	at	high	b	values	(200	–	1,000	s/mm2)	to	determine	the	value	of	D.	Following	this	D*	and	f	were	fit	simultaneously	(with	a	fixed	D).	D*	had	no	constraints	on	upper	boundaries,	and	f	was	constrained	between	0	–	1.	For	the	stretched	exponential	model	DDC	had	no	upper	boundary	conditions,	and	α	was	constrained	between	0	–	1.	For	kurtosis	neither	Dk	nor	K	were	constrained	by	upper	boundaries,	and	K	had	a	lower	bound	of	0.		Regions	of	Interest	(ROIs)	were	generated	using	Mango	Software	(Research	Imaging	Institute,	UTHSCSA).	ROIs	were	drawn	on	b0	(non-diffusion	weighted)	images	around	each	kidney	for	each	volunteer.	Areas	of	high	flow	such	as	the	areas	which	surround	the	renal	pelvis	were	excluded,	an	example	can	be	seen	in	Figure	6.1.	All	reproducibility	analysis	was	based	on	data	within	the	ROIs.	
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6.3.4:	Analysis:	SNR	Signal-to-noise	ratio	(SNR)	was	calculated	for	each	volunteer	on	b0	images	and	then	averaged	across	volunteers	to	give	an	SNR	value	for	the	1.5T	and	3T	systems.		ROIs	were	placed	outside	of	the	abdomen	on	the	b0	images	to	represent	the	noise	and	the	kidney	ROIs	represented	the	signal.	SNR	was	calculated	according	to	Equation	6.1:		
SNR	=	 !.##∗%&'(	*+,('-%&'(	./+0&	*1'(2'32	4&5+'1+/(							[6.1]		As	magnitude	images	were	used,	the	value	of	0.66	in	Equation	6.1	was	used	as	the	Rayleigh	distribution	correction	factor.	
	
6.3.5:	Analysis:	Reproducibility	of	Diffusion	Parameters		Eight	diffusion	parameters	were	generated	from	the	four	diffusion	models:	ADC	(mono-exponential),	D	(IVIM),	D*	(IVIM),	f	(IVIM),	DDC	(stretched	exponential),	α	(stretched	exponential),	Dk	(Kurtosis)	and	K	(Kurtosis).	These	parameters	were	generated	on	voxel-wise	basis	for	each	participant;	one	set	of	parameters	from	the	1.5T	DWI	data,	and	two	sets	of	parameters	from	the	3T	DWI	data:	calculated	based	on	the	7	b	values	and	
Figure	6.1	A	central	axial	slice	of	a	b0	image	from	the	3T	scanner	displaying	the	abdomen	at	the	level	of	the	kidney	from	a	representative	healthy	control	volunteer	(male,	28.26	years).	ROIs	are	drawn	around	the	left	(blue)	and	right	(red)	kidneys	avoiding	areas	of	high	flow	such	as	the	areas	which	surround	the	renal	pelvis.	In	this	diagram	the	right	side	of	the	image	(white	R)	is	the	volunteers’	right	side.		
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the	8	b	values.	In	order	to	compare	reproducibility	of	diffusion	parameters	between	scanners,	parameters	generated	from	the	1.5T	were	compared	to	the	parameters	generated	from	the	3T	with	matching	b	values	(8	b	values).	To	investigate	the	effects	on	stability	of	diffusion	parameters	based	on	different	b	values,	diffusion	parameters	generated	from	the	8	b	value	3T	dataset	and	7	b	value	3T	dataset	were	compared.		Descriptive	statistics	of	the	parameter	of	interest	(means,	standard	deviations,	medians	and	interquartile	ranges),	using	voxels	within	the	kidney	ROIs,	were	calculated	for	each	participant.	The	reproducibility	of	parameters	was	assessed	based	on	coefficients	of	variation	(CV),	parametric	and	non-parametric	statistical	tests,	and	Bland-Altman	plots.		 	
6.3.6:	Analysis:	Reproducibility	of	Diffusion	Parameters	–	Coefficients	of	
Variation		For	each	volunteer,	mean	values	for	a	given	parameter	(such	as	ADC)	were	calculated	across	all	voxels	within	the	kidney	ROIs,	at	each	field	strength	(1.5T	and	3T).	The	mean	(μ)	and	standard	deviation	(σ)	of	these	two	values	were	used	to	calculate	the	coefficient	of	variation	(CV),	as	follows:			 67 = 9:;< ∗ 100				[6.2]		This	process	was	repeated	for	each	volunteer.	The	overall	CV	for	each	parameter,	based	on	field	strength,	was	then	generated	by	taking	the	mean	of	all	of	the	volunteers’	CV	values.			A	similar	process	was	used	to	calculate	the	CV	across	3T	acquisitions	acquired	using	different	b	values	(7	b	value	data	vs.	8	b	value	data).	For	each	volunteer,	the	mean	fitted	value	of	a	given	parameter	(across	all	kidney	voxels)	was	calculated	using	data	from	both	the	7	b	value	and	8	b	value	acquisitions.	The	mean	and	standard	deviation	of	these	were	used	in	Equation	6.2	to	calculate	a	subject-wise	CV	for	that	parameter,	which	was	then	averaged	across	all	subjects.			
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6.3.7:	Analysis:	Reproducibility	of	Diffusion	Parameters	–	Parametric	and	
Non-Parametric	Statistical	Tests	
	 To	determine	whether	parameters	differed	with	statistical	significance	(p	<	0.05)	between	scanners	or	when	based	on	different	b	values,	paired	parametric	and	non-parametric	tests	were	used.	Mean	values	of	one	diffusion	parameter	from	each	subject	from	the	1.5T	data	was	used	as	one	sample,	and	mean	values	of	the	same	diffusion	parameter	from	the	3T	data	was	used	as	the	second	sample.	The	Lilliefors	test	was	used	to	determine	whether	the	difference	between	the	two	samples	was	normally	distributed.	If	this	was	not	normally	distributed	(p	<	0.05)	then	a	Wilcoxon	Signed	Rank	test	was	used,	if	it	was	normally	distributed	then	a	paired	Students’	t-test	was	used.	The	same	methods	were	used	to	compare	parameters	generated	from	7	b	values	and	8	b	values.			
6.3.8:	Analysis:	Reproducibility	of	Diffusion	Parameters	–	Bland-Altman	Plots	Bland-Altman	plots	were	also	used	to	determine	the	reproducibility	coefficient	(1.96	x	standard	deviation	of	difference	in	measured	values)	and	level	of	bias	(mean	difference)	between	the	parameters	obtained	from	the	1.5T	and	3T	scanners,	and	also	between	those	based	on	7	b	values	and	8	b	values.				 	
96 
 
6.4:	Results	
6.4.1:	Study	Population			A	total	of	5	healthy	volunteers	were	included	in	the	final	cohort.	Number	of	cases	excluded	with	reasons	are	provided	in	a	flowchart	(Figure	6.2).	Volunteer	characteristics	can	be	seen	in	Table	6.2.	The	average	age	of	participants	on	their	1.5T	scan	was	33.01	years	(SD:	12.64),	and	on	their	3T	scan	was	33.10	(SD:	12.65).												
								
Figure	6.2.	Flowchart	highlighting	inclusions	and	exclusions	of	volunteers.	DWI	=	diffusion	weighted	imaging		
Volunteers	with	an	8	b	value	DWI	protocol	on	the	1.5T,	and	7	and	8	b	value	DWI	protocol	on	the	3T (n	=	6) 
	Exclusion: Severe	motion	artefacts (n	=	1) 	 Final	Cohort (n	=	5) 
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6.4.2:	SNR	The	average	signal	(defined	as	the	kidney	ROIs	on	b0	images)	across	the	five	volunteers	for	1.5T	=	188.66	(SD	=	2.82)	and	3T	=	216.43	(SD	=	13.35).	The	mean	noise	(defined	as	an	ROI	outside	of	the	abdomen	on	b0	images)	across	the	five	volunteers	for	1.5T	=	2.37(SD	=	0.27)	and	3T	=	4.64	(SD	=	0.28).	Equation	6.1	was	used	to	calculate	the	SNR	for	1.5T	and	3T.	The	above	average	signal	values	were	used	for	the	‘Mean	Signal’,	and	the	SD	for	the	noise	was	calculated	for	each	volunteer	and	then	the	averaged	across	the	five	volunteers	to	provide	the	measure	for	‘Mean	noise	SD’.		Using	equation	6.1,	the	SNR	for	the	1.5T	=	82.9,	and	SNR	for	the	3T	=	57.1.		
6.4.3:	Descriptive	Statistics		 Descriptive	statistics	were	calculated	for	each	participant	for	each	parameter.		These	descriptive	statistics	were	averaged	over	the	5	volunteers;	group	means,	medians	and	interquartile	ranges	can	be	seen	in	Tables	6.3	and	6.4.	It	can	be	seen	that	DDC	had	very	high	mean	values	and	comparatively	small	median	values.	This	was	due	to	the	fitting	methods	causing	some	voxels	to	have	extremely	high	values,	thus	causing	the	mean	to	have	high	values.	Further	details	of	this	are	given	in	Section	6.5.	
	
Volunteer	ID	 Gender	 Age	at	1.5T	Scan	(Years)	 Age	at	3T	Scan	(Years)	 Days	Between	Scans	01	 Male	 28.16	 28.26	 38	06	 Male	 55.50	 55.60	 38	07	 Female	 25.16	 25.27	 38	09	 Female	 27.63	 27.74	 38	10	 Male	 28.60	 28.62	 10	
Table	6.2.	Volunteer	characteristics		
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Table	6.3.	Descriptive	statistics	for	each	field	strength	(1.5T	or	3T)	for	eight	diffusion	parameters.	Data	is	averaged	across	5	healthy	adult	kidneys	Field	Strength	 	 ADC	(x	10-3	mm2/s)	 D	(x	10-3	mm2/s)	 D*	(mm2/s)	 f	 Dk	(x	10-3	mm2/s)	 K	 DDC	(mm2/s)	 α	1.5T	 Mean	(Std)	 1.81	(6.31	x	10-5)	 1.62	(5.35	x	10-5)	 0.11	(0.09)	 0.27	(0.02)	 3.39	(1.71	x	10-4)	 0.76	(0.04)	 1.94	(0.34)	 0.74	(2.01	x	10-2)	3T	 Mean	(Std)	 1.86	(1.58	x	10-4)	 1.63	(3.59	x	10-5)	 0.36	(0.10)	 0.33	(0.11)	 3.79	(1.66	x	10-3)	 0.61	(0.10)	 1.85	x	10+4	(3.2	x	10+5)	 0.79	(3.85	x	10-2)	1.5T	 Median	 1.81	 1.63	 11.65	x	10-3	 0.26	 3.16	 0.79	 2.37	x	10-3	 0.75	
3T	 Median	 1.84	 1.66	 8.72	x	10-3	 0.29	 3.20	 0.70	 2.46	x	10-3	 0.80	
1.5T	 Interquartile	Range	 0.15	 0.18	 1.3	x	10-2	 0.10	 0.81	 0.10	 4.25	x	10-4	 0.13	3T	 Interquartile	Range	 0.21	 0.18	 1.47	x	10-2	 0.21	 2.09	 0.29	 1.71	x	10-4	 0.21	
Note.		Eight	identical	b	values	are	used	for	each	field	strength.	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	D	=	’slow’	diffusion	coefficient	(IVIM),	D*	=	‘fast’	diffusion	coefficient	(IVIM),	f	=	perfusion	fraction	(IVIM),	Dk=	diffusion	kurtosis	Coefficient	(kurtosis),	K	=	diffusional	kurtosis	(kurtosis),	
DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	and	α	=	stretching	parameter	(stretched	exponential)	
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Table	6.4.	Descriptive	statistics	for	eight	diffusion	parameters	generated	from	either	7	or	8	b	values.	Data	is	averaged	across	5	healthy	adult	kidneys.		Number	of	b	values	 	 ADC	(x	10-3	mm2/s)	 D	(x	10-3	mm2/s)	 D*	(mm2/s)	 f	 Dk	(x	10-3	mm2/s)	 K	 DDC	(mm2/s)	 α	7	 Mean	(Std)	 1.73	(2.76	x	10-4)	 1.52	2.55	x	10-4)	 0.31	(0.19)	 0.32	(0.04)	 3.49	(3.32	x	10-4)	 2.51	(4.04)	 4.41	x	10+6	9.72	x	10+6	 0.74	(5.64	x	10-2)	8	 Mean	(Std)	 1.86	(1.58	x	10-4)	 1.63	(3.59	x	10-5)	 0.36	(0.10)	 0.33	(0.11)	 3.79	(1.66	x	10-3)	 0.61	(0.10)	 1.85	x	10+4	(3.2	x	10+5)	 0.79	(3.85	x	10-2)	7	 Median	 1.79	 1.58	 1.06	x	10-2	 0.28	 2.97	 0.79	 2.25	x10-3	 0.76	8	 Median	 1.84	 1.66	 8.72	x	10-3	 0.29	 3.20	 0.70	 2.46	x	10-3	 0.80	7	 Interquartile	Range	 0.27	 0.34	 2.16	x	10-2	 0.18	 1.27	 0.26	 7.13	x	10-4	 0.25	8	 Interquartile	Range	 0.21	 0.18	 1.47	x	10-2	 0.21	 2.09	 0.29	 1.71	x	10-3	 0.21	
Note.	7	b	values	=0,	50,	100,	250,	500,	750,	1000	s/mm2,	8	b	values	=0,	50,	100,	150,	200,	250,	500,	1000,	both	obtained	on	a	3T	scanner.	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	D	=	’slow’	diffusion	coefficient	(IVIM),	D*	=	‘fast’	diffusion	coefficient	(IVIM),	f	=	perfusion	fraction	(IVIM),	Dk=	diffusion	kurtosis	Coefficient	(kurtosis),	K	=	diffusional	kurtosis	(kurtosis),	DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	and	α	=	stretching	parameter	(stretched	exponential)	
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6.4.4:	Coefficients	of	Variation		 The	coefficients	of	variation	(calculated	according	to	Equation	6.2)	per	parameter	and	volunteer	can	be	seen	in	Table	6.5	as	a	function	of	field	strength,	and	Table	6.6	as	a	function	of	b	value.	D*	and	DDC	had	much	higher	CVs	(78.4%	and	108.4%,	respectively)	compared	to	the	other	parameters	when	field	strength	was	being	compared,	whereas	DDC	and	K	had	high	and	moderately	high	CVs	(116.4%	and	31.82%,	respectively)	when	b	values	were	being	compared.	DDC	had	near	identical	CV	for	each	volunteer,	this	was	due	to	the	very	high	mean	values	of	DDC,	which	were	highest	on	the	3T	system,	and	also	the	very	high	SD	of	this	parameter.	These	high	values	are	due	to	the	fitting	method	and	are	discussed	in	Section	6.5				
	
	
	
	
	
	
	
Coefficient	of	Variation	(%)	Between	1.5T	&	3T	Per	Volunteer	
Volunteer	
ID	
ADC	 D	 D*	 f	 Dk	 K	 DDC	 α	
01	 0.83	 4.44	 59.0	 5.28	 19.49	 31.62	 141.41	 12.10	06	 0.49	 1.58	 129.17	 3.10	 1.41	 4.83	 6.14	 1.44	07	 2.22	 0.88	 103.93	 0.66	 7.41	 8.92	 119.40	 4.15	09	 9.99	 3.12	 56.13	 44.58	 47.77	 25.69	 141.42	 3.82	10	 0.95	 0.46	 43.74	 12.40	 3.23	 9.63	 133.77	 3.33	
MEAN	CV	
(%)	
2.89	 2.10	 78.40	 13.20	 15.86	 16.14	 108.43	 4.97	
Table	6.5.	Coefficients	of	variation	for	all	fitted	diffusion	parameters,	when	generated	from	1.5T	and	3T	systems	using	matched	b-values,	based	on	data	from	5	healthy	subjects	
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6.4.5:	Parametric	and	Non-Parametric	Statistical	Tests	–	Field	Strength			For	comparisons	based	on	field	strength	the	difference	between	the	two	samples	for	all	parameters	other	than	ADC,	f,	and	Dk	were	normally	distributed	(p	>	0.05),	thus	Wilcoxon	Signed	Rank	tests	were	used	for	these	three	parameters;	all	other	parameters	were	tested	using	paired	t-tests.	Ladder	plots	for	field	strength	comparisons	can	be	seen	in	Figure	6.3.	All	parameters	other	than	D*	and	K	did	not	differ	significantly	(p	>	0.05)	between	the	1.5T	and	3T	scanners.	D*	was	significantly	higher	on	the	3T	(Mean:	0.36,	SD:	0.1)	compared	to	the	1.5T	(Mean:	0.11,	SD:	0.09),	t(4)	=	-6.08,	p	=	3.7	x	10-3.	K,	however,	was	significantly	higher	on	the	1.5T	(Mean:	0.76,	SD:	0.04)	compared	to	the	3T	(Mean:	0.61,	SD:	0.10),	t(4)	=	3.29,	p	=	3.01	x	10-2.	
	 Coefficient	of	Variation	(%)	Between	7	b	values	&	8	b	values	Per	Volunteer	
Volunteer	
ID	
ADC	 D	 D*	 f	 Dk	 K	 DDC	 a	
01	 23.17	 29.12	 13.57	 30.88	 33.45	 127.29	 141.19	 19.70	06	 0.80	 0.04	 14.91	 0.41	 0.38	 1.61	 141.42	 0.79	07	 0.40	 1.67	 17.60	 2.60	 2.72	 5.07	 141.42	 1.31	09	 6.39	 5.55	 28.35	 37.87	 47.92	 24.31	 16.53	 1.95	10	 0.59	 3.21	 64.92	 12.00	 3.50	 0.83	 141.42	 1.29	
MEAN	CV	
(%)	
6.27	 7.92	 27.87	 16.74	 17.60	 31.82	 116.40	 5.01	
Table	6.6.	Coefficients	of	variation	for	all	fitted	diffusion	parameters,	when	generated	based	on	7	b	values	and	8	b	values	acquired	at	3T,	based	on	data	from	5	healthy	subjects	
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Figure	6.3.	Ladder	plots	for	all	parameters,	comparing	mean	diffusion	parameters	on	1.5T	and	3T	systems.	*	=	significant	differences	p	<	0.05.	Error	bars	are	1SD.	Each	colour	bar	represents	one	volunteer	(blue	=	01,	green	=	06,	red	=	07,	black	=	09,	pink	=	10).	(A):	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	
(B):	D	=	’slow’	diffusion	coefficient	(IVIM),	(C):	D*	=	‘fast’	diffusion	coefficient	(IVIM),	(D):		f	=	perfusion	fraction	(IVIM),	(E):	Dk	=	diffusion	kurtosis	coefficient	(kurtosis),	(F):	K	=	diffusional	kurtosis	(kurtosis),	
(G):	DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	(H):	α	=	stretching	parameter	(stretched	exponential)	
A B 
C D 
E F 
G H 
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6.4.6:	Parametric	and	Non-Parametric	Statistical	Tests	–	b	Values			For	comparisons	based	on	b	values	the	difference	between	the	two	samples	for	most	parameters	(ADC,	f,	Dk,	K,	DDC,	α)	were	not	normally	distributed	(p	>	0.05),	thus	Wilcoxon	Signed	Rank	tests	were	used	for	these	parameters,	and	paired	t-tests	were	used	for	the	remaining	parameters.	There	were	no	significant	differences	for	any	of	the	parameters	when	they	were	compared	based	on	whether	they	were	calculated	from	7	or	8	b	values.	Ladder	plots	for	b	value	comparisons	can	be	seen	in	Figure	6.4.			 	
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	A B 
C D 
E F 
G H 
Figure	6.4.	Ladder	plots	for	all	parameters,	comparing	mean	diffusion	parameters	generated	from	7	b	values	and	8	b	values.	*	=	significant	differences	p<0.05.	Error	bars	are	1SD.	Each	colour	bar	represents	one	volunteer	(blue	=	01,	green	=	06,	red	=	07,	black	=	09,	pink	=	10).	(A):	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	(B):	D	=	’slow’	diffusion	coefficient	(IVIM),	(C):	D*	=	‘fast’	diffusion	coefficient	(IVIM),	
(D):		f	=	perfusion	fraction	(IVIM),	(E):	Dk	=	diffusion	kurtosis	coefficient	(kurtosis),	(F):	K	=	diffusional	kurtosis	(kurtosis),	(G):	DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	(H):	α	=	stretching	parameter	(stretched	exponential)	
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6.4.7:	Bland-Altman	Plots	–	Field	Strength		 Eight	Bland-Altman	plots	demonstrating	the	level	of	agreement	between	mean	parameter	values	calculated	on	the	1.5T	and	3T	systems	can	be	seen	in	Figure	6.5.		For	most	parameters	there	was	good	agreement	between	the	two	systems.	ADC,	D,	and	Dk	(Figures	6.3.A,	6.3.B,	6.3.E,	respectively),	all	had	biases	<1%	between	the	scanners	(a	positive	mean	difference	would	indicate	values	were	higher	at	3T	and	a	negative	mean	difference	would	indicate	values	were	higher	at	1.5T).	ADC:	Mean	difference	=	4.64	x	10-5,	95%	CI=	[-2.18	x	10-4,	3.11	x	10-4],	D:	Mean	difference	=	6.79	x	10-5,	95%	CI=	[-1.2	x	10-4,	1.34	x	10-4],	Dk:	Mean	difference	=	-4.01	x	10-4,	95%	CI=	[-2.92	x	10-3,	3.72	x	10-3].		There	were	also	very	small	bias	(5.41%)	in	f	and	α	(Figure	6.3.D	&	6.3.H),	f:	Mean	difference	=	0.0541,	95%	CI=	[-0.17,	0.27].	α:	Mean	difference	=	0.0541,	95%	CI=	[-3.65	x	10-2,	0.145].	There	was	a	moderate	level	of	bias	(15.03%)	in	K	(Figure	6.3.F)	whereby	the	1.5T	produced	higher	values:	Mean	difference	=	-0.1503	95%	CI=	[-0.35,	0.05].		There	was	a	larger	bias	(24.2%)	in	D*	values	(Figure	6.3.C)	where	the	3T	produced	higher	values;	mean	difference	=	0.242,	95%	CI=	[0.07,	0.42].	In	DDC	(Figure	6.3.G)	there	was	no	agreement	between	the	two	systems,	with	the	3T	producing	vastly	higher	values;	Mean	difference	=	18450.09,	95%	CI=	[-444345.8,	81245.97].	
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Figure	6.5.	Bland-Altman	analyses	showing	the	level	of	agreement	for	each	diffusion	parameter	when	calculated	on	1.5T	and	3T	systems.	(A):	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	(B):	D	=	’slow’	diffusion	coefficient	(IVIM),	(C):	D*	=	‘fast’	diffusion	coefficient	(IVIM),	(D):		f	=	perfusion	fraction	(IVIM),	(E):	Dk	=	diffusion	kurtosis	coefficient	(kurtosis),	(F):	K	=	diffusional	kurtosis	(kurtosis),	(G):	DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	(H):	α	=	stretching	parameter	(stretched	exponential)	
(+/-)	1.96*SD Mean Volunteers 
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6.4.8:	Bland-Altman	Plots	–	b	values		 Eight	Bland-Altman	plots	demonstrating	the	level	of	agreement	between	mean	parameter	values	calculated	based	on	7	b	values	and	8	b	values	can	be	seen	in	Figure	6.6.		For	most	parameters	there	was	good	agreement	between	the	two	b	value	ranges.	ADC,	D,	f	and	Dk	(Figures	6.4.A,	6.4.B,	6.4.D,	6.4.E,	respectively),	all	had	biases	<1%;	(a	positive	mean	difference	would	indicate	values	were	higher	when	calculated	based	on	8	b	values	and	a	negative	mean	difference	would	indicate	values	were	higher	when	calculated	based	on	7	b	values).	ADC:	Mean	difference	=	1.26	x	10-4,	95%	CI=	[-3.1	x	10-4,	5.59	x	10-4],	
D:	Mean	difference	=	1.08	x	10-4,	95%	CI=	[-4.1	x	10-4,	6.29	x	10-4],	f:	Mean	difference	=	-4.05	x	10-3,	95%	CI=	[-0.25,	0.26].		Dk:	Mean	difference	=	3.06	x	10-4,	95%	CI=	[-3.3	x	10-3,	3.91	x	10-3].		There	was	a	small	bias	in	D*	(4.05%)	and	α	(4.77%)	(Figures	6.4.C	and	6.4.H,	respectively),	with	both	parameters	being	higher	when	calculated	based	on	8	b	values;	D*:	Mean	difference	=	0.0406,	95%	CI=	[-0.25,	0.33],	α:	Mean	difference	=	0.0477,	95%	CI=	[-0.13,	0.23].		Both	K	and	DDC	showed	no	agreement	when	calculated	based	on	7	b	values	compared	to	8	b	values	(Figures	6.4.F	and	6.4.G	respectively).	Values	of	K	were	far	higher	when	based	on	7	b	values	(Mean	difference	=	-1.90,	95%	CI=	[-9.23,	6.13]).	DDC	values	were	also	greater	when	7	b	values	were	used	(Mean	difference	=	-4393023,	95%	CI=	[-2.3	x	10+7,	1.5	x	10+7]).	 	
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		 	(+/-)	1.96*SD Mean Volunteers 
Figure	6.6.	Bland-Altman	analyses	showing	the	level	of	agreement	for	each	diffusion	parameter	when	calculated	based	on	7	and	8	b	values.	(A):	ADC	=	apparent	diffusion	coefficient	(mono-exponential),	(B):	D	=	’slow’	diffusion	coefficient	(IVIM),	(C):	D*	=	‘fast’	diffusion	coefficient	(IVIM),	(D):		f	=	perfusion	fraction	(IVIM),	(E):	Dk	=	diffusion	kurtosis	coefficient	(kurtosis),	(F):	K	=	diffusional	kurtosis	(kurtosis),	(G):	DDC	=	distributed	diffusion	coefficient	(stretched	exponential),	(H):	α	=	stretching	parameter	(stretched	exponential)	
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6.4.9	–	DDC	Results	Mean	values	of	DDC	were	very	high,	this	was	due	to	a	subset	of	outlier	voxels	with	extremely	high	values.	The	reasoning	for	this	is	due	to	the	applied	fitting	method,	which	is	discussed	in	Section	6.5.	As	a	way	of	highlighting	the	number	of	voxels	with	these	high	values,	the	percent	of	voxels	within	the	ROIs	which	had	DDC	values	greater	than	the	diffusivity	of	free	water	at	body	temperature	(3	x	10-3	mm2/s)27	were	calculated	for	each	volunteer	for	the	1.5T	data,	and	the	two	b	value	ranges	at	3T.	Table	6.7	shows	these	results,	along	with	the	maximum	DDC	values.				
	 	An	example	of	a	DDC	map	and	fits	of	two	voxels	is	shown	in	Figure	6.7.	It	can	be	seen	that	in	one	voxel	the	signal	steadily	declines	with	increasing	b	value,	however	in	another	voxel	there	is	a	very	quick	decline	in	signal	followed	by	a	decrease	in	signal	attenuation.	By	applying	the	stretched	exponential	model	to	this	particular	voxel,	the	result	is	a	very	high	DDC	and	low	α.	This	may	be	due	to	high	inhomogeneity	within	the	voxel	and	a	more	complex	tissue	environment,	however	without	histology	this	only	speculation.							 		
Table	6.7.	Percent	of	voxels	within	the	kidney	ROIs	which	showed	DDC	values	above	diffusivity	of	free	water	at	body	temperature	and	maximum	DDC	values	within	the	ROIs			 1.5T	 3T	(8	b	values)	 3T	(7	b	values)	
Volunteer	ID	 %	High	Voxels	 Maximum	DDC	Value	(mm2/s)	 %	High	Voxels	
Maximum	DDC	Value	(mm2/s)	 %	High	Voxels	
Maximum	DDC	Value	(mm2/s)	01	 8.17	 1589.44	 5.16	 4.5	x	10+8	 15.57	 9.84	x	10+10	06	 6.29	 0.05	 9.0	 2.37	 7.57	 1.1	x	10+9	07	 16.45	 0.18	 13.71	 535.07	 15.12	 4.17	x	10+8	09	 12.15	 1.22	 55.55	 2.92	x	10+8	 10.32	 2.55	x	10+8	10	 8.86	 432.07	 12.59	 43.85	 15.59	 1.07	x	10+8	Mean		 10.38%	 404.59	 19.20%	 1.48	x	10+8	 12.83%	 2.01	x	10+10	
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6.5:	Discussion	
	This	study	compared	the	reproducibility	of	eight	diffusion	parameters	from	four	diffusion	models,	in	five	pairs	of	healthy	adult	kidneys.	Parameters	were	compared	based	on	differences	in	field	strength	and	different	b	values.	In	terms	of	field	strength,	it	was	demonstrated	that	DDC	was	highly	unstable,	showing	an	extremely	high	coefficient	variation	(108%)	and	no	agreement	between	scanners	when	assessed	via	Bland-Altman	analysis.	D*	and	K	were	also	unstable;	with	D*	being	significantly	greater	at	3T	compared	to	1.5T	and	K	being	significantly	higher	on	the	1.5T.	To	be	defined	as	having	a	low	variability	CV	and	bias	levels	needed	to	be	£	15%.	For	Bland-Altman	analysis	D*	showed	a	bias	of	24%	and	also	had	a	high	CV	(78%).	K	was	near	to	the	threshold	of	low	variability	with	a	bias	of	15%	and	a	CV	of	16%.			
Figure	6.7	A	central	axial	slice	of	a	DDC	map	(A)	and	the	corresponding	b0	image	(B)	from	the	3T	scanner	displaying	the	abdomen	at	the	level	of	the	kidney	from	a	representative	healthy	control	volunteer	(female,	27.74	years	at	time	of	scan).	An	ROI	is	shown	in	red	surrounding	the	healthy	renal	tissue.	The	raw	diffusion	data	and	stretched	exponential	fit	is	plotted	from	two	voxels	within	the	ROI	(C)	shows	a	voxel	with	a	DDC	=	2.2	x	10-3	mm2/s	and	α	=	0.9.	(D)	shows	a	voxel	with	a	DDC	=	3.27	mm2/s	and	α	=	0.1	
 
111 
 
Dk	and	f	showed	good	reproducibility	with	CV	≤	15%,	and	α	also	showed	low	variability	(CV:	<	5%).	ADC	and	D	had	very	low	variability	(CV	<	3%),	with	very	little	bias	seen	with	Bland-Altman	analysis	(<1%).		For	reproducibility	of	parameters	based	on	different	b	values,	DDC	and	K	were	the	most	unstable,	showing	no	agreement	between	b	value	ranges	and	had	high	CV	(DDC:	116%,	K:	32%).		The	remainder	of	parameters	showed	small	biases	(≤	5%)	when	assessed	with	Bland-Altman	analysis.		The	diffusion	parameters	ADC,	D,	Dk,	and	α	all	showed	good	reproducibility	between	different	field	strengths	and	b	values.	This	is	in	line	with	the	previously	reported	research7,10–14,19–21.	Therefore,	confidence	can	be	placed	in	these	parameters	when	measured	in	renal	tissue,	as	variations	in	b	values	and	field	strength	did	not	appear	to	affect	these	values.	
D*	had	high	levels	of	variability	when	calculated	between	different	field	strengths.	This	is	unsurprising	when	reviewing	past	literature10–12,14,21,	as	D*	has	been	shown	to	be	highly	variable	both	when	field	strength	was	unchanged,	and	when	it	was	altered.	The	instability	of	D*	has	been	attributed	to	the	need	for	lower	b	values10,	as	these	have	the	greatest	effects	on	this	parameter3.		Field	strength	may	impact	diffusion	measurements	for	several	reasons.	Firstly,	SNR	increases	linearly	with	field	strength;	in	a	3T	system	the	net	magnetisation	is	twice	that	compared	to	a	1.5T	system,	which	creates	the	potential	for	the	signal	to	be	twice	as	great28,29.	However,	due	to	various	alterations	of	relaxation	times	and	body	heating,	it	is	not	exactly	twice	as	great	and	is	more	likely	1.7	–	1.8	times	greater30,31.	Despite	the	increase	in	SNR,	there	are	some	disadvantages	to	imaging	this	higher	field	strength.	3T	imaging	compared	to	1.5T	increases	magnetic	susceptibility	artefacts,	which	can	give	rise	to	loss	of	image	quality28,29,32.	These	effects	are	doubled	between	1.5T	and	3T	and	cause	image	distortion	and	signal	loss	due	to	tissue	boundaries,	such	as	between	soft-tissue	and	gases,	which	are	common	in	the	abdomen28.	In	the	present	study	image	quality	was	not	assessed	as	the	focus	was	on	quantification	of	a	variety	of	parameters,	however,	for	certain	clinical	applications	this	may	be	an	important	consideration.	Investigations	into	diffusion	measurements	in	phantoms	have	indicated	that	ADC	measurements	are	more	uniform	in	the	isocentre	of	the	magnet	and	variability	occurs	with	distance	from	this	point32.	This	was	seen	more	at	3T	compared	to	1.5T	as	these	systems	tended	to	have	steeper	spatial	dependences.		Despite	the	aforementioned	effects	of	field	strength,	in	the	present	study	the	majority	of	parameters	were	still	highly	reproducible.	No	significant	differences	were	seen	in	ADC,	D,	f,	Dk,	and	α,	all	had	CV	≤	15%,	and	Bland-Altman	analyses	also	indicted	that	
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these	parameters	had	good	agreement	when	measured	at	1.5T	and	3T.	It	was	only	D*,	K	and	DDC	which	had	higher	variability.		The	variability	seen	in	DDC	(which	was	present	when	measured	between	field	strengths	and	different	b	value	ranges)	was	not	evident	in	previous	research12–14.	However,	the	reason	for	the	instability	in	the	present	study	may	be	due	to	the	fitting	technique	applied;	there	were	no	upper	limits	for	DDC.	Upper	bounds	can	be	applied	to	the	stretched	exponential	model	for	example,	10	x	10-3	mm2/s	was	set	as	the	maximum	value	for	DDC	in	it	the	first	description	of	this	model4,	however	this	value	is	still	very	high	as	free	water	diffusivity	at	body	temperature	is	3	x	10-3	mm2/s,	and	so	this	value	may	be	seen	as	a	more	appropriate	upper	boundary.	In	this	present	study	it	was	decided	that	no	upper	bounds	would	be	used,	to	prevent	data	hitting	the	maximum	limit,	this	means	that	several	voxels	with	extremely	high	fitted	parameter	values,	which	were	not	physically	valid,	may	have	skewed	the	distribution	and	increased	the	mean.	If	an	upper	bound	was	given	then	many	voxels	would	have	just	reached	this	limit,	thus	not	producing	meaningful	results.	Table	6.7	showed	that	maximum	values	of	DDC	were	greater	in	the	3T	data	compared	to	the	1.5T,	this	may	have	been	due	to	the	smaller	voxel	size	in	the	3T	system.	A	larger	voxel	could	contain	a	variety	of	diffusivities	and	thus,	the	mean	value	may	decrease	based	on	these	lower	values	in	this	range,	whereas	in	a	smaller	voxel	there	may	be	less	variation	and	thus	only	these	extreme	values	were	captured.	However,	despite	this	difference	the	1.5T	values	were	still	not	physically	valid.	Thus,	if	this	parameter	is	used	in	future	without	upper	bounds	then	it	may	be	better	to	use	the	median,	as	this	produced	more	physically	plausible	values	in	both	the	1.5T	and	3T	systems,	and	when	different	b	values	were	used	(Tables	6.3	and	6.4).		The	variability	of	K	(which	was	moderate	between	scanners	and	high	between	b	values)	may	also	be	explained	by	the	lack	of	upper	bounds,	furthermore	as	previously	mentioned	K	lacked	reproducibility	(CV	>	30%)	between	two	identical	protocols	measured	24	hours	apart14.		It	should	also	be	noted	that	this	study	used	a	voxel-by-voxel	fitting	method	and	then	the	mean	value	of	all	voxels	was	calculated	within	a	ROI,	as	opposed	to	fitting	the	entire	ROI.	Therefore,	variation	from	every	voxel	was	included.	This	means	that	each	voxel	equally	contributed	to	the	mean	providing	a	value	reflective	of	the	region	under	investigation.	However,	if	a	regional	fitting	method	was	used,	then	individual	voxels	with	extreme	values	may	have	had	less	of	an	impact	on	the	overall	mean.	This	alternative	approach	may	have	resulted	in	lower,	more	physical	valid,	DDC	results.		Past	research	has	highlighted	that	f	is	less	reproducible	than	D11,12,14,21–23,	and	this	was	also	demonstrated	in	this	present	study	when	compared	between	field	strengths.	However,	in	the	present	study	f	was	reproducible	(CV	=	13.2%)	when	based	on	field	
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strength	alterations	and	just	above	the	threshold	in	the	b	value	experiment	(CV	=	16.74%).	Past	research	has	cast	doubt	over	the	use	of	IVIM	in	the	kidneys,	suggesting	that	perfusion-related	information	cannot	be	obtained	by	this	method33.	However,	more	recent	research	has	shown	f	to	be	clinically	useful,	with	it	being	significantly	related	to	renal	function	in	those	who	had	undergone	partial	nephrectomy34.	Given	the	reasonable	reproducibility	in	the	current	study	and	potential	clinical	utility,	the	evidence	suggests	that	f	should	be	considered	for	clinical	use	despite	past	concerns.		In	this	study	the	selection	of	b	values	had	the	greatest	effect	on	K	and	DDC	compared	to	the	other	parameters.	As	already	stated,	this	may	have	been	due	to	lack	of	upper	bounds	during	the	fitting	process.	Interestingly,	both	D*	and	f	had	very	little	bias	(<	5%)	when	assessed	using	Bland-Altman	analysis	based	on	b	value	alterations.	This	is	interesting	as	optimum	b	value	selection	within	the	IVIM	model	is	often	discussed;	the	main	finding	being	that	a	wide	range	of	b	values	with	many	lower	values	are	needed	to	get	reproducible	IVIM	parameters	(specifically	D*	and	f).	This	has	been	shown	through	simulations35,	in	prostate	cancer36	and	in	renal	tissue35,37.	In	the	present	study	little	variation	was	seen	in	D*	and	f	despite	fewer	low	b	values	being	part	of	the	7	b	value	acquisition.	This	may	be	due	to	the	step-wise	fitting	technique	of	first	fitting	D	at	high	b	values	≥200	s/mm2	and	then	fitting	for	f	and	D*,	which	is	likely	to	have	contributed	to	the	stability	of	these	parameters.		There	were	a	few	limitations	with	this	study.	Firstly,	the	sample	size	was	small;	to	be	able	to	generalise	these	findings	and	accurately	determine	which	parameters	are	reproducible	in	renal	tissue,	a	much	larger	cohort	is	needed.	Secondly,	voxel	size	differed	between	the	1.5T	and	3T	systems,	which	impacted	the	SNR	and	may	have	been	a	confounding	variable	in	field	strength	comparisons.	The	acquisitions	were	matched	to	the	clinical	sequences	used	to	assess	paediatric	abdominal	tissue,	and	in	these	sequences	different	voxels	sizes	are	used	at	different	field	strengths.	The	acquisitions	were	not	altered	as	this	study	aimed	to	reflect	clinical	outcomes.	Furthermore,	these	results	can	be	used	to	assess	how	reliably	clinically	acquired	DWI	data	could	be	combined	from	the	different	scanners	at	our	institution.	Therefore,	although	voxel	size	differences	impacted	on	the	results	acquired	at	different	field	strength,	it	can	be	concluded	that	the	majority	of	diffusion	parameters	under	investigation	were	reproducible,	when	generated	using	optimised	clinical	protocols	at	1.5T	and	3T.	This	is	promising	for	further	investigations	and	clinical	transference,	as	it	highlights	that	many	diffusion	parameters	do	not	greatly	differ	if	they	are	generated	with	slight	variations	in	acquisitions	or	field	strength.	Furthermore,	although	the	effect	of	altering	the	range	of	b	values	was	tested	at	3T,	only	two	sets	of	b	values	were	investigated.	Again,	these	sets	were	chosen	to	match	those	used	
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in	clinical	acquisitions	at	our	institution,	and	in	the	8	b	value	set	additional	measurements	in	the	low-b-value	range	(<250	s/mm2)	were	included,	in	order	to	increase	sensitivity	to	the	pseudo-random	flow	driven	component	of	the	DWI	signal.		Additionally,	the	kidney	ROIs	were	not	separated	into	cortex	and	medulla.	It	has	been	previously	shown	that	ADC	values	in	the	cortex	are	higher	than	in	the	medulla,	regardless	of	b	values	used38.	This	may	be	related	to	the	higher	perfusion	in	the	cortex,	which	can	artificially	elevate	ADC	in	the	mono-exponential	model,	which	will	also	influence	fitted	values	of	IVIM	parameters	such	as	D*	and	f	in	these	regions.	However,	it	is	challenging	to	accurately	separate	these	regions	in	the	axial	plane,	particularly	given	the	limited	spatial	resolution	of	the	DWI	acquisitions.	Finally,	the	left	and	right	kidneys	were	not	analysed	separately.	Previous	work	has	shown	D	to	be	higher	in	the	right	kidney	compared	to	the	left	in	healthy	volunteers	and	diabetic	patients39.	The	reason	for	this	may	have	been	due	to	the	gastrointestinal	motility	on	the	left	side	compared	to	the	bowl	motility	on	the	right.	Additionally,	the	right	kidney	is	often	slightly	lower	than	the	left	due	to	the	location	of	the	liver.	These	slight	physiological	differences	may	have	contributed	to	the	differences	found	in	D,	however,	the	exact	nature	of	why	this	parameter	increased	on	the	right	side	is	unclear.	The	authors	found	no	differences	in	D*	or	f	and	no	other	models	were	tested,	but	it	is	possible	that	some	of	the	variability	seen	in	the	present	study	may	have	been	due	to	the	left/right	differences	as	kidneys	were	not	analysed	independently.	However	this	variability	is	likely	to	have	been	a	small	factor	and	other	research	has	failed	to	find	significant	differences	in	D,	D*	and	f	between	left	and	right	kidneys40.	Furthermore,	the	primary	aim	of	this	chapter	was	to	investigate	the	reproducibility	of	fitted	DWI	parameters,	rather	than	investigate	left/right	asymmetries	in	their	absolute	values.			
6.6:	Conclusions	and	Summary	
	Research	into	the	use	of	DWI	in	the	kidneys	is	growing	and	more	advanced	models	of	diffusion	(non-Gaussian	models)	are	starting	to	be	used	in	the	clinic.	This	study	investigated	the	reproducibility	of	eight	diffusion	parameters	from	four	models	based	on	5	pairs	of	healthy	adult	kidneys.	The	parameters	were	compared	when	measured	at	different	field	strengths	(1.5T	&	3T)	and	different	b	values.		The	hypothesis	was	that	ADC,	D,	DDC,	α	and	Dk,	would	be	reproducible	in	both	experiments	and	that	the	greatest	variability	would	be	seen	in	D*	and	f	and	K.		
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As	predicted,	ADC,	D,	α	and	Dk	were	shown	to	be	reproducible	in	both	experiments.	In	addition	to	these	parameters,	f	was	also	found	to	be	reproducible	despite	previous	concerns	over	this	parameter.	
D*	and	K	were	both	found	to	have	high	levels	of	variability	and	were	not	reproducible	in	either	experiment,	this	was	also	true	for	DDC	which	was	not	predicted.		These	findings	help	place	confidence	in	the	clinical	utility	of	certain	parameters	(ADC,	D,	f,	Dk,	and	α)	as	they	were	reproducible	despite	acquisition	alterations.	This	finding	helps	with	generalising	and	interpreting	results	from	other	centres	with	different	protocols.	This	study	also	suggested	that	more	caution	should	be	taken	when	interpreting	
D*,	K	and	DDC	as	these	measurements	lacked	stability.	This	aids	future	research	as	certain	findings	may	not	be	able	to	be	replicated	if	different	acquisitions	are	used.			
Main	Finding:	Most	parameters	(ADC,	D,	Dk,	and	α)	are	reproducible	across	field	strengths	and	when	different	b	values	are	acquired.	More	caution	needs	to	be	taken	when	interpreting	D*,	K	and	DDC	as	these	parameters	have	higher	levels	of	variability.			 	
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Chapter	7:	Comparison	of	Models	of	Diffusion	in	Wilms’	Tumour	and	
Contralateral	Renal	Tissue	
		 This	chapter	describes	an	original	research	study	which	explores	the	fitting	of	various	diffusion	models	in	Wilms’	tumour	and	healthy	renal	tissue.	This	retrospective	study	compared	the	fits	of	four	models	of	diffusion	using	the	Akaike	information	criterion.	It	was	found	that	in	both	Wilms’	tumours	and	the	contralateral	normal	renal	tissue,	non-Gaussian	models	provided	superior	fits	compared	to	the	mono-exponential	model.	Wilms’	tumours	were	shown	to	be	heterogenous	with	many	different	non-Gaussian	models	providing	good	fits	across	a	single	tumour.			
7.1:	Background:	Comparing	the	Fits	of	Diffusion	Models	to	Raw	DWI	data	in	
the	Body		It	has	previously	been	shown	that	ADC	can	be	a	very	useful	parameter	in	Wilms’	tumour	(see	Chapter	4.2	for	full	details).	Furthermore,	although	there	is	only	limited	research	into	the	use	of	non-Gaussian	models	of	diffusion	in	Wilms’	(see	Chapter	4.3),	these	models	have	the	potential	to	provide	additional	information	regarding	tissue	biology,	as	has	been	seen	in	renal	tissue	and	other	body	pathologies	(see	Chapter	3	for	full	details).	While	previously	the	reproducibility	of	multiple	diffusion	parameters	has	been	explored	in	healthy	renal	tissue	(Chapter	6),	it	still	needs	to	be	established	if	these	models	provide	a	good	representation	of	the	raw	diffusion	data	in	Wilms’	tumour.			There	are	many	models	which	could	be	applied	to	multiple	b	value	diffusion	data,	and	so	model	selection	is	an	important	point	of	consideration.	There	are	various	methods	for	selecting	the	most	appropriate	model;	such	as	R2	selection,	the	Akaike	information	criterion	(AIC)1	and	bayesian	information	criterion	(BIC)2.	A	model’s	R2	value	refers	to	the	coefficient	of	determination,	and	it	describes	the	proportion	of	variance	in	the	dependent	variable	that	is	predicted	from	the	independent	variable	or	variables.	In	terms	of	model	selection,	one	could	compare	R2	values	from	different	models	and	then	select	the	model	with	the	highest	R2.		The	aim	of	both	AIC	and	BIC	techniques	is	to	determine	which	model	best	approximates	the	data3.	Complex	models	with	many	fitted	parameters	can	result	in	overfitting	the	data,	and	so	both	AIC	and	BIC	minimise	this	problem	by	accounting	for	the	
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number	of	fitted	parameters	in	the	models.	In	both	methods	a	value	is	produced	per	model,	and	it	is	the	comparison	of	these	values	between	different	models	which	provides	the	relevant	information.	In	both	cases,	the	smallest	AIC,	or	BIC	value	suggests	the	model	is	the	most	appropriate	for	the	given	data.	The	main	difference	between	these	two	techniques	is	that	BIC	has	a	larger	penalty	for	the	number	of	fitted	parameters	compared	to	AIC.		Research	into	model	comparisons	has	been	explored	in	body	imaging;	in	breast	cancer4,	rectal	cancer5,6,	prostate	cancer	bone	metastases7,	ovarian	cancer8	and	renal	investigations6,9–11.	The	following	sections	summarise	this	literature;	it	can	be	seen	that	model	preferences	vary	depending	on	the	organ	and	pathology.		Mono-exponential	and	IVIM12	models	have	been	compared	in	breast	cancer	using	AIC4.	It	was	shown	that	out	of	29	tumours	IVIM	was	favoured	by	just	over	half	(15)	and	mono-exponential	was	the	preferred	model	for	the	remaining	14.	As	this	difference	is	not	great	it	suggests	that	both	models	produce	adequate	fits	to	the	data.	However,	the	more	advanced	invasive	tumours	tended	to	prefer	the	IVIM	model,	whereas	the	precursor	tumours	favoured	the	mono-exponential	model.	It	was	suggested	that	the	presence	of	bi-exponential	decay	may	indicate	increased	micro-vascularity	which	is	seen	in	the	more	advanced	tumours	compared	to	the	precursor	tumours.	However,	this	distinction	in	model	preference	was	not	seen	in	all	tumours,	and	the	numbers	of	each	tumour	group	were	very	low,	therefore	without	further	analysis	and	an	increased	cohort	this	cannot	be	confirmed.		A	slight	preference	for	the	mono-exponential	model	over	IVIM	was	seen	in	rectal	cancer5.	Lesions	were	assessed	based	on	which	model	the	raw	data	in	the	majority	of	voxels	was	best	described	by,	according	to	AIC.	Out	of	19	lesions,	12	showed	a	voxel-based	majority	for	the	mono-exponential	model.	However,	there	was	high	heterogeneity	within	the	lesions,	with	many	voxels	also	favouring	the	IVIM	model.	Thus,	although	the	majority	selected	mono-exponential,	a	large	proportion	of	the	tumour	was	also	well	described	by	the	IVIM	model.	In	another	study	of	rectal	cancer6,	these	models	were	again	compared,	along	with	the	stretched	exponential	model13.	Model	comparisons	were	based	on	R2	values	and	it	was	revealed	that	stretched	exponential	provided	the	best	description	of	the	data	in	both	rectal	cancer	and	healthy	rectal	tissue.	IVIM	had	the	smallest	R2	values	(cancer	tissue:	0.7,	healthy	tissue:	0.83)	compared	to	mono-exponential	(cancer	tissue:	0.94,	healthy	tissue:	0.95)	and	stretched	exponential	(cancer	tissue:	0.998,	healthy	tissue:	0.999),	and	provided	a	significantly	poorer	fit	to	the	data.			
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In	a	study	of	patients	with	prostate	cancer	bone	metastases,	the	three	previously	mentioned	models	were	compared7.	This	study	investigated	the	reproducibility	of	the	parameters	(see	Chapter	6.1.2),	but	it	also	compared	which	model	provided	the	best	fit	to	the	raw	diffusion	data.	Model	comparisons	were	based	on	BIC	and	it	was	shown	that	prior	to	and	post-	treatment,	IVIM	and	stretched	exponential	were	superior	to	mono-exponential.	In	85%	of	the	pre-treatment	tumours	non-Gaussian	models	were	preferred,	this	was	also	found	in	91-97%	of	post-treatment	tumours	(assessed	at	3	time-points	after	treatment).	Overall,	the	stretched	exponential	model	was	found	to	provide	the	best	fit	to	the	data	in	the	majority	of	pre	and	post-treatment	tumours.		An	investigation	into	ovarian	cancer	also	explored	the	mono-exponential,	IVIM	and	stretched	exponential	models8.	The	IVIM	model	showed	low	repeatability	for	f	and	D*	and	was	excluded	from	AIC	analysis,	the	two	remaining	models,	however,	were	compared.	It	was	shown	that	in	pre-treatment	patients	the	stretched	exponential	model	was	preferred	in	64%	of	tumours,	and	in	65%	of	tumours	post-treatment.	The	presence	of	an	extra	parameter	provided	by	the	stretched	exponential	model,	its	low	variability,	and	its	goodness	of	fit	suggested	that	this	model	may	be	more	useful	in	ovarian	cancer	compared	to	both	mono-exponential	and	IVIM.	There	is	limited	research	into	model	comparisons	using	kurtosis14	in	body	imaging.	However,	one	feasibility	study	did	demonstrate	that	the	R2	from	the	kurtosis	model	was	higher	than	the	R2	from	mono-exponential	in	healthy	renal	tissue10.	However,	this	was	only	a	marginal	improvement	(mono-exponential:	R2	=	0.96,	kurtosis:	R2	=	0.99).	Therefore,	much	further	research	is	needed	to	determine	the	goodness	of	fit	of	kurtosis	modelling	compared	to	other	diffusion	models.		From	the	described	research	it	seems	that	the	stretched	exponential	model	provides	a	good	fit	to	diffusion	data	in	a	variety	of	organs.	The	IVIM	model,	however,	appears	to	be	more	variable	and	does	not	always	describe	the	data	better	than	a	mono-exponential	fit.	When	it	comes	to	renal	imaging,	however,	IVIM	does	seem	superior	to	mono-exponential9,11.	Diffusion	values	within	the	renal	cortex	and	medulla	vary	according	to	different	studies	and	thus	an	investigation	into	mono-exponential	fitting	sought	to	determine	whether	the	model	was,	in	part,	responsible11.	By	acquiring	data	in	three	healthy	volunteers	and	resampling	the	signal	decay	curves	based	on	different	b	values,	it	was	shown	that	variation	in	diffusivity	coefficients	was	largely	due	to	the	choice	of	b	values,	and	that	the	signal	decay	was	bi-exponential	and	not	mono-exponential.	The	authors	suggested	that	future	work	should	use	the	bi-exponential	model	as	this	provided	a	better	description	of	the	diffusion	signal	in	healthy	renal	tissue.	Furthermore,	they	
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highlighted	that	IVIM	produced	more	reproducible	values	of	D	compared	to	ADC11,	and	the	additional	parameters	D*	and	f		may	provide	further	insight	into	kidney	status	and	function,	as	these	parameters	potentially	reflect	vascular	perfusion	and	tubular	flow15.		Another	study	also	showed	that	in	healthy	renal	tissue	IVIM	was	superior	than	a	mono-exponential	model9.	It	was	shown	that	<8%	of	pixels	from	whole	kidney	volumes	of	five	volunteers	were	best	described	by	the	mono-exponential	model.	Therefore,	in	healthy	renal	tissue,	it	appears	that	IVIM	may	be	the	best	descriptor	of	diffusion	data.			
7.2:	Aims	and	Hypotheses	Mono-exponential,	IVIM,	stretched	exponential	and	kurtosis	have	the	potential	to	be	useful	in	Wilms’	tumour.	All	of	these	models	provide	diffusion	parameters	which	have	shown	promise	in	a	variety	of	organs	including	the	kidneys.	The	following	investigation	sought	to	determine	which	models	best	described	the	raw	diffusion	signal	in	Wilms’	tumours	and	the	contralateral	unaffected	renal	tissue.	It	was	expected	that	IVIM	may	be	superior	to	mono-exponential	in	the	unaffected	renal	tissue	based	on	previous	research9,11.	Within	Wilms’	tumour,	however,	no	predications	were	made	as	there	is	little	literature	on	this	topic	in	this	specific	pathology	and	no	clear	model	preferences	have	been	shown	in	other	body	cancers4,5,7,8,16.	However,	it	was	expected	that	as	Wilms’	tumour	subtypes	have	different	cellular	environments,	different	models	may	favour	different	subtypes.			 	7.3:	Methods	
	
7.3.1:	Study	Population	Institutional	ethical	approval	was	granted	for	all	studies	within	this	thesis.	A	10-year	retrospective	review	(April	2007	–	March	2017)	of	the	radiology	imaging	system	at	Great	Ormond	Street	Hospital,	London,	UK,	was	performed	for	all	abdominal	MRI	data	in	children	with	a	proven	histological	diagnosis	of	Wilms’	tumour.	Inclusion	criteria	were	those	with	multiple	b	value	DWI	data	(with	a	maximum	b	value	of	1,000	s/mm2),	and	tumour	size	covering	at	least	2	axial	slices	on	DWI.	Data	was	collected	from	Wilms’	tumour	patients	both	pre-	and	post-chemotherapy.	For	normal	kidney	data,	the	contralateral	unaffected	kidney	was	used.		
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7.3.2:	MRI	All	imaging	was	performed	on	a	1.5T	Siemens	Magnetom	Avanto	scanner	equipped	with	40 mT/m	gradients.	Depending	on	patient	size,	one	or	two	body	matrix	coils	were	used	to	obtain	full	coverage	(6	element	design,	Siemens).	Patients	were	either	awake	or	anaesthetised	depending	on	their	age.		Multiple	b	value	DWI	was	obtained	for	all	patients	and	was	acquired	during	free	breathing.	The	DWI	protocol	was	as	follows:	7	or	8	b	values	in	3	orthogonal	directions	(0,	50,	100,	250,	500,	750,	1000	s/mm2	or	0,	50,	100,	150,	200,	250,	500,	1000	s/mm2)	slice	thickness:	6mm,	TR/TE:	2800ms/89ms,	field	of	view:	350mm2,	voxel	size:	1.4	x	1.4	x	6mm,	number	of	slices:	19,	matrix	size:	128	x	96	x	19.		Each	b	value	had	9	averages	and	trace	images	were	used	for	analysis.	
	
7.3.3:	Processing	and	ROIs	Diffusion	data	was	processed	four	times	using	the	trace	images	from	each	Wilms’	tumour	patient	using	four	models	of	diffusion:	mono-exponential,	IVIM,	stretched	exponential,	and	kurtosis.	The	details	of	these	fitting	methods	are	described	in	Chapter	6.3.3.	 ROIs	were	generated	using	Mango	Software	(Research	Imaging	Institute,	UTHSCSA).	ROIs	were	drawn	on	the	b0	images	around	the	entire	tumour	volume,	these	were	edited	and	verified	by	a	radiologist	specialising	in	paediatric	radiology	(2	years’	experience	in	paediatric	radiology).	Normal	kidney	tissue	was	also	defined	on	the	b0	images	and	areas	of	high	flow	such	as	the	areas	which	surround	the	renal	pelvis	were	excluded;	an	example	can	be	seen	in	Figure	7.1.	All	analysis	regarding	model	comparisons	was	confined	to	these	ROIs.							
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7.3.4:	Model	Comparison	Analysis	AIC	was	used	to	compare	the	four	models.	For	every	voxel	within	the	tumour	ROIs	and	normal	kidney	ROIs,	AIC	was	calculated	for	each	model.	The	model	with	the	lowest	AIC	value	within	that	voxel	was	classified	as	the	‘winner’.	The	voxel	was	then	labelled	based	on	which	model	‘won’;	1	=	mono-exponential,	2	=	IVIM,	3	=	stretched	exponential,	4	=	kurtosis.	This	process	was	repeated	across	the	entire	ROI	volumes.	The	modal	value	was	then	calculated	per	tumour	and	normal	kidney	tissue.	This	value	therefore	represented	the	model	which	provided	the	best	overall	fit	for	the	tissue.	A	diagram	for	these	methods	can	be	seen	in	Figure	7.2.	Additionally,	models	were	compared	between	Wilms’	tumour	subtypes	to	determine	whether	a	certain	subtype	favoured	a	particular	model.									
Figure	7.1.	An	example	of	a	representative	Wilms’	tumour.	Displayed	is	a	central	axial	slice	of	a	T1w	image	(A)	and	b0	image	(B).	Shown	is	the	abdomen	at	the	level	of	the	kidney	of	a	Wilms’	tumour	patient	post-chemotherapy	(age	at	time	of	scan:	1.22	years).	ROIs	are	shown	surrounding	the	tumour	(red)	and	normal	renal	tissue	(green).	In	this	diagram	the	right	side	of	the	image	(white	R)	is	the	patients’	right	side.	
Figure	7.2.	Diagram	detailing	methodology	for	comparing	models.	AIC	=	Akaike	information	criterion		
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7.4:	Results	
	
7.4.1:	Study	Population		A	total	of	50	pre-chemotherapy	and	62	post-chemotherapy	Wilms’	tumours	were	included	for	diffusion	model	comparison	analysis.	A	flow	chart	detailing	reasons	and	numbers	of	excluded	cases	can	be	seen	in	Figure	7.3.	The	mean	age	of	patients	at	their	pre-chemotherapy	scan	was	2.5	years	(SD:	2.2),	and	the	mean	age	at	their	post-chemotherapy	scan	was	3.1	years	(SD:	2.7).		The	diffusion	data	was	acquired	from	either	7	or	8	b	values	(0,	50,	100,	250,	500,	750,	1000	s/mm2	or	0,	50,	100,	150,	200,	250,	500,	1000	s/mm2).	Fifty-one	tumours	had	the	7	b	value	protocol	(23	pre-chemotherapy	and	28	post-chemotherapy),	and	61	tumours	had	the	8	b	value	protocol	(27	pre-chemotherapy	and	34	post-chemotherapy).		Of	the	62	post-chemotherapy	tumours,	57	had	histologically	confirmed	subtypes:	7	blastemal,	9	epithelial,	13	stromal,	8	regressive,	19	mixed	and	1	completely	necrotic.	Subtypes	were	defined	according	to	SIOP-2001	protocol,	for	details	on	this	process	please	see	Chapter	1.5.		The	contralateral	unaffected	kidney	was	used	as	the	normal	kidney	data,	due	to	bilateral	cases	this	gave	a	total	of	77	normal	kidney	datasets;	39	from	patients	who	had	received	chemotherapy	and	38	from	patients	who	had	not.	Of	the	77	normal	kidney	datasets	33	had	the	7	b	value	protocol	(16	pre-	chemotherapy	and	17	post-chemotherapy),	and	44	had	the	8	b	value	protocol	(22	pre-	and	22	post-chemotherapy).									
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Figure	7.3.	Flowchart	of	study	population	showing	exclusion	criteria.	DWI	=	diffusion	weighted	imaging.	np	=	number	of	patients,	nt	=	number	of	tumours.	 
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7.4.2:	Wilms’	Tumour	AIC	Results	Combining	both	the	pre-	and	post-chemotherapy	datasets	it	was	shown	that	the	stretched	exponential	model	provided	the	best	fit	to	the	majority	of	the	raw	diffusion	data.	Of	the	112	Wilms’	tumours	analysed,	the	stretched	exponential	model	provided	the	best	fit	to	61/112	of	the	tumours	(54.5%).	The	kurtosis	model	provided	the	best	fit	to	29/112	(25.9%),	IVIM	provided	the	best	model	for	21/112	(18.8%),	and	mono-exponential	provided	the	best	fit	to	1/112	of	the	Wilms’	tumours	(0.9%).		When	the	data	was	separated	by	pre-and	post-chemotherapy,	a	similar	pattern	appeared.	For	pre-chemotherapy	data	stretched	exponential	provided	the	best	fit	for	the	majority	of	the	data:	31/50,	(62%).	Kurtosis	provided	the	best	fit	for	14/50	(28%),	IVIM	for	5/50	(10%)	and	mono-exponential	did	not	provide	the	best	fit	for	any	of	the	pre-chemotherapy	Wilms’	tumour	data.	For	the	post-chemotherapy	Wilms’	tumour	data,	stretched	exponential	was	the	most	common	best	fit	model:	30/62	(48.4%).	IVIM	provided	the	best	model	for	16/62	(25.8%)	and	Kurtosis	provided	the	best	model	for	15/62	(24.2%).	Mono-exponential	provided	the	best	fit	to	1/62	of	the	post-chemotherapy	Wilms’	tumours	(1.6%).		As	it	could	be	suggested	that	the	number	of	b	values	might	have	affected	the	fits	to	the	diffusion	data,	tumours	were	separated	into	7	and	8	b	value	groups.	Overall,	stretched	exponential	was	the	preferred	model	for	the	7	b	value	group:	22/51	(43.2%).	Kurtosis	provided	the	best	fit	for	16/51	(31.4%),	and	IVIM	for	13/51	(25.5%).	Mono-exponential	did	not	provide	the	best	fit	for	any	of	the	7	b	value	tumours.		For	the	8	b	value	Wilms’	tumour	data,	a	similar	pattern	emerged:	stretched	exponential	provided	the	best	fit	for	the	majority	of	the	tumours:	39/61	(63.9%).	Kurtosis	provided	the	best	for	13/61	(21.3%),	IVIM	for	8/61	(13.1%),	and	mono-exponential	was	the	best	fit	for	one	of	the	8	b	value	tumours	(1.6%).		Table	7.1	shows	the	comparisons	based	on	b	values	and	whether	or	not	chemotherapy	was	administered,	in	each	instance	stretched	exponential	was	the	preferred	model.	Figure	7.4	provides	an	example	of	the	model	fits	to	the	raw	diffusion	data	in	a	post-chemotherapy	7	b	value	Wilms’	tumour,	and	similar	patterns	were	seen	for	the	untreated	and	8	b	value	tumours.		It	was	also	tested	to	see	if	the	best	fit	model	was	related	to	Wilms’	tumour	subtype.	For	subtypes	which	have	been	confirmed	post-surgery,	the	best	fit	models	were	compared	using	the	post-chemotherapy	data	(nearest	time	point	to	histology).	However,	it	was	
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shown	that	models	did	not	particularly	favour	certain	subtypes;	with	the	stretched	exponential	model	performing	well	across	most	subtypes.	Full	details	can	be	seen	in	table	7.2.	 	
			
				
Table	7.1.	Model	comparisons	based	on	Akaike	information	criterion	for	Wilms’	tumours,	separated	by	number	of	b	values	used	in	the	diffusion	acquisition,	and	whether	or	not	chemotherapy	had	been	administered.	The	percentages	refer	to	the	percent	of	tumours	which	favoured	each	model			 Pre-chemotherapy	 Post-chemotherapy	
	 7	b	values	n	=	23	 8	b	values	n	=	27	 7	b	values	n	=	28	 8	b	values	n	=	34	Mono-exponential	 0%	 0%	 0%	 2.9%	IVIM	 21.7%	 0%	 28.6%	 23.5%	Stretched	exponential	 52.2%	 70.4%	 35.7%	 58.8%	Kurtosis	 26.1%	 29.6%	 35.7%	 14.7%	
Table	7.2.	Model	comparisons	based	on	Akaike	information	criterion	per	tumour	subtype.		The	percentages	refer	to	the	percent	of	tumours	which	favoured	each	model		 Blastemal	(n	=	7)	 Epithelial	(n	=	9)	 Stromal	(n	=	13)	 Regressive	(n	=	8)	 Mixed		(n	=	19)	 Necrotic	(n	=1)	Mono-exponential	 0%	 0%	 0%	 12.5%	 0%	 0%	IVIM	 28.6%	 11.1%	 15.4%	 37.5%	 26.3%	 0%	Stretched	exponential	 71.4%	 77.8%	 46.2%	 25%	 36.8%	 100%	Kurtosis	 0%	 11.1%	 38.5%	 25%	 36.8%	 0%	
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Figure	7.4.	A	central	axial	slice	of	a	b0	image	(left)	and	the	clinical	T1w	image	(right)	is	shown	of	the	abdomen	at	the	level	of	the	kidney.	This	is	a	representative	post-chemotherapy	patient	(Age:	2.44	years).	The	Wilms’	tumour	ROI	is	highlighted	and	is	colour-coded	according	to	which	model	provided	the	best	fit	to	the	raw	diffusion	data,	based	on	the	Akaike	information	criterion;	yellow	=	mono-exponential,	red	=	IVIM,	green	=	stretched	exponential,	blue	=	kurtosis.	The	graph	shows	the	fits	of	four	models	to	the	raw	diffusion	data	across	the	ROI	volume.	Normalised	signal	is	shown	on	the	y	axis	(Sb	=	signal	at	a	given	b	values,	S0	=	signal	where	b	=	0)	and	b	values	are	shown	on	the	x	axis. 	
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7.4.3:	Normal	Kidney	AIC	Results	The	normal	kidney	data	(contralateral	unaffected	kidney)	showed	that	IVIM	provided	the	best	model	for	the	majority	of	the	data:	47/77	(61%).	Stretched	exponential	was	the	only	other	model	which	provided	the	best	fit:	30/77(39%).			Even	though	normal	kidney	tissue	was	being	investigated,	the	data	was	separated	into	pre-	and	post-chemotherapy	groups	in	case	the	treatment	affected	the	normal	kidney.	There	was	a	slight	discrepancy	between	the	pre-	and	post-chemotherapy	scans.	For	pre-chemotherapy	data	half	of	the	contralateral	kidneys	favoured	IVIM	as	the	best	model	and	the	other	half	favoured	stretched	exponential	(19/38,	50%).	Whereas	in	the	post-chemotherapy	data	IVIM	provided	the	best	model	for	the	majority	of	the	contralateral	kidneys	(28/39,	71.8%),	and	stretched	exponential	provided	the	best	fit	for	the	remaining	data	(11/39,	28.2%).	The	normal	kidney	data	was	also	separated	into	b	values,	and	it	was	shown	that	stretched	exponential	was	favoured	by	the	7	b	value	data	in	the	majority	of	contralateral	kidneys:	19/33	(57.6%),	with	IVIM	being	favoured	by	the	remaining	contralateral	kidneys:	14/33	(42.4%).	For	the	8	b	value	data	IVIM	provided	the	best	fit	to	the	majority	of	the	contralateral	kidneys:	33/44	(75%),	and	stretched	exponential	was	the	best	model	for	the	remaining	contralateral	kidneys:	11/44	(25%).		Table	7.3	shows	the	comparisons	based	on	b	values	and	whether	or	not	chemotherapy	was	administered.	It	can	be	seen	that	regardless	of	whether	the	patients	had	undergone	treatment,	the	8	b	value	range	favoured	the	IVIM	model.	However,	the	7	b	value	range	showed	a	preference	for	stretched	exponential	prior	to	treatment	and	a	slight	preference	for	IVIM	post-treatment.	Figure	7.5	and	7.6	show	examples	of	the	model	fits	to	the	raw	diffusion	data	for	both	a	7	b	value	and	8	b	value	pre-chemotherapy	normal	kidney.									
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Table	7.3.	Model	comparisons	based	on	Akaike	information	criterion	for	contralateral	normal	kidney	tissue,	separated	by	number	of	b	values	used	in	the	diffusion	acquisition,	and	whether	or	not	chemotherapy	had	been	administered.	The	percentages	refer	to	the	percent	of	tumours	which	favoured	each	model		 Pre-chemotherapy	 Post-chemotherapy	
	 7	b	values	n	=	16	 8	b	values	n	=	22	 7	b	values	n	=	17	 8	b	values	n	=	22	Mono-exponential	 0%	 0%	 0%	 0%	IVIM	 31.3%	 63.6%	 52.9%	 86.4%	Stretched	exponential	 68.8%	 36.4%	 47.6%	 13.6%	Kurtosis	 0%	 0%	 0%	 0%	
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Figure	7.5.	A	central	axial	slice	of	a	b0	image	(left)	and	the	clinical	T1w	image	(right)	is	shown	of	the	abdomen	at	the	level	of	the	kidney,	the	normal	kidney	ROI	is	shown	in	green.	The	ROI	is	highlighted	and	is	colour-coded	according	to	which	model	provided	the	best	fit	to	the	raw	diffusion	data,	based	on	the	Akaike	information	criterion;	yellow	=	mono-exponential,	red	=	IVIM,	green	=	stretched	exponential,	blue	=	kurtosis.	This	is	a	representative	pre-chemotherapy	patient	(Age:	2.8	years)	with	a	7	b	value	acquisition.	The	graph	shows	the	fits	of	four	models	to	the	raw	diffusion	data	across	the	ROI	volume.	Normalised	signal	is	shown	on	the	y	axis	(Sb	=	signal	at	a	given	b	values,	S0	=	signal	where	b	=	0)	and	b	values	are	shown	on	the	x	axis.		
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Figure	7.6.	A	central	axial	slice	of	a	b0	image	(left	side)	and	the	clinical	T1w	image	(right	side)	is	shown	of	the	abdomen	at	the	level	of	the	kidney,	the	normal	kidney	ROI	is	shown	in	green.	The	ROI	is	highlighted	and	is	colour-coded	according	to	which	model	provided	the	best	fit	to	the	raw	diffusion	data,	based	on	the	Akaike	information	criterion;	yellow	=	mono-exponential,	red	=	IVIM,	green	=	stretched	exponential,	blue	=	kurtosis.	This	is	a	representative	pre-chemotherapy	patient	(Age:	4.47	years)	with	an	8	b	value	acquisition.	The	graph	shows	the	fits	of	four	models	to	the	raw	diffusion	data	across	the	ROI	volume.	Normalised	signal	is	shown	on	the	y	axis	(Sb	=	signal	at	a	given	b	values,	S0	=	signal	where	b	=	0)	and	b	values	are	shown	on	the	x	axis.				
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7.5:	Discussion		 This	study	compared	four	models	of	diffusion	based	on	how	well	they	fit	to	the	raw	DWI	data,	according	to	AIC.	These	comparisons	were	made	in	Wilms’	tumours,	both	pre-	and	post-chemotherapy,	and	on	the	contralateral	unaffected	kidney,	as	a	measure	of	normal	renal	tissue.	The	diffusion	data	came	from	both	7	and	8	b	value	ranges.	For	the	Wilms’	tumour	datasets,	it	was	shown	that	the	stretched	exponential	model	provided	the	best	fit	to	the	majority	of	the	data.	This	result	was	maintained	in	both	b	value	groups,	and	in	both	treatment	groups.	There	was	no	particular	model	preference	when	the	tumours	were	investigated	according	to	subtype.	Mono-exponential	was	shown	to	be	the	least	appropriate	model	according	to	AIC,	with	only	one	post-chemotherapy	tumour	favouring	this	model.	Overall,	the	normal	kidney	tissue	favoured	the	IVIM	model,	however	when	this	data	was	separated	into	b	value	ranges,	it	was	shown	that	stretched	exponential	was	slightly	favoured	by	the	7	b	value	range,	and	IVIM	by	the	8	b	value	range.	No	other	models	were	found	to	be	appropriate	for	the	normal	kidney	data.			 The	main	finding	from	this	investigation	was	that	non-Gaussian	models	provided	better	descriptions	of	the	diffusion	data	compared	to	the	mono-exponential	model	in	Wilms’	tumour	and	normal	renal	tissue.	This	finding	was	observed	in	all	of	the	normal	renal	tissue	data,	and	all	of	the	pre-chemotherapy	Wilms’	tumour	data.	Only	a	single	post-chemotherapy	Wilms’	tumour	favoured	the	mono-exponential	model,	thus	highlighting	that	it	is	very	uncommon	for	diffusion	signal	to	exhibit	mono-exponential	behaviour	in	normal	renal	tissue	and	Wilms’	tumours.	The	deviation	from	a	mono-exponential	decay	has	been	previously	highlighted	and	explored,	it	has	been	shown	that	there	was	a	rapid	decline	in	signal	at	lower	b	values	followed	by	a	more	gradual	decline	at	higher	b	values	in	the	liver17.	This	initial	decline	was	suggested	to	be	due	to	vascular	perfusion,	and	thus	lower	b	values	are	thought	to	be	sensitive	to	signal	attenuation	from	perfusion12,	giving	rise	to	the	IVIM	model.	This	has	been	shown	to	be	the	case	in	healthy	renal	tissue9,11,	where	signal	was	shown	to	be	bi-exponential	as	opposed	to	mono-exponential;	as	the	kidney	is	a	well-perfused	organ.		 No	particular	subtype	appeared	to	favour	a	certain	model,	however,	the	numbers	in	each	group	were	small.	Additionally,	it	is	important	to	remember	that	subtypes	are	defined	based	on	only	analysing	a	subsection	of	the	tumour.	Wilms’	tumours	are	very	heterogeneous	and	across	a	single	tumour	or	even	slice,	there	will	be	areas	of	distinct	cellular	environments.	If	these	tumours	had	been	analysed	on	a	slice-by-slice	basis,	
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indicating	regions	of	different	cellular	subtypes	then	they	could	have	been	matched	to	the	MRI	scans.	In	this	instance	it	may	have	then	been	possible	to	see	that	the	voxels	which	favoured	certain	models	belonged	to	certain	subtypes.	However,	due	to	the	lack	of	advanced	histology	this	was	not	possible	and	thus	it	appeared	that	subtypes	had	no	model	preference.			 While	the	mono-exponential	model	did	not	provide	the	best	fit	to	the	DWI	data,	it	does	not	mean	that	it	should	not	be	used	clinically.	In	Wilms’	tumour	ADC	has	been	useful	in	distinguishing	between	benign	from	malignant	tumours18,19,	investigating	chemotherapy-induced	changes20	and	analysing	subtypes21,22.	Furthermore,	ADC	values	have	been	shown	to	be	reproducible	between	a	1.5T	and	3T	scanner	(coefficient	of	variation	[CV]:	1.03%)	and	when	calculated	based	on	different	b	value	ranges	(CV:	11.05%),	when	measured	in	healthy	adult	renal	tissue	(see	Chapter	6	for	full	details).	Additionally,	ADC	does	not	require	multiple	b	values,	which	is	beneficial	as	many	centres	may	not	acquire	DWI	with	multiple	b	values	as	standard.	Therefore,	despite	the	present	study	showing	a	deviation	from	a	mono-exponential	signal	decay,	it	is	important	to	be	aware	that	while	the	model	may	not	be	the	best	descriptor	of	the	DWI	data,	it	is	nonetheless	reproducible	and	clinically	useful.			 The	stretched	exponential	model	provided	the	best	fit	to	the	DWI	Wilms’	tumour	data.	The	previously	mentioned	studies	in	rectal	cancer	and	healthy	rectal	tissue16,	prostate	cancer	bone	metastasis7	and	ovarian	cancer8,	all	showed	this	model	to	provide	the	best	fit	to	DWI	data	when	compared	to	IVIM	and	mono-exponential.	The	stretched	exponential	model	provides	two	parameters,	α	and	DDC;	while	the	exact	physiological	basis	of	α	is	unknown,	it	is	thought	to	represent	tissue	heterogeneity,	with	a	lower	value	suggesting	a	more	heterogenous	environment13.	As	tumour	tissue	is	very	heterogenous,	it	is	unsurprising	that	the	stretched	exponential	model	describes	this	data	well.	Previous	work	has	shown	both	α	and	DDC	to	be	reproducible7,8,	however	DDC	was	found	to	have	high	variability	in	healthy	kidneys	(CV:	108	–	116%),	(Chapter	6).	This	finding	was	likely	to	be	due	to	fitting	methods,	and	a	lack	of	boundary	conditions	(for	full	details	see	Chapter	6.5).	Therefore,	despite	the	goodness	of	fit	according	to	AIC,	the	fitted	parameter	DDC	should	be	used	with	caution	as	values	may	just	converge	on	the	boundary	limit	or	be	highly	variable.	The	α	parameter	however,	has	the	potential	to	be	a	useful	parameter	in	Wilms’	and	normal	renal	tissue,	as	it	has	lower	variability	(CV:	5%	in	healthy	renal	tissue,	Chapter	6)	and	is	generated	from	a	model	which	describes	the	data	well.		The	IVIM	model	was	favoured	over	the	four	other	models	by	normal	renal	tissue;	this	is	supported	by	previous	work	where	IVIM	was	preferred	over	mono-exponential	in	
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healthy	renal	tissue9,11.	When	the	data	was	separated	into	b	value	ranges	there	was	a	slight	preference	for	the	7	b	value	range	to	favour	the	stretched	exponential	model,	and	the	8	b	value	range	to	favour	IVIM.	The	reason	for	this	may	be	due	to	inclusion	of	lower	b	value	weightings	in	the	8	b	value	range	(0,	50,	100,	150,	200,	250,	500,	1000	s/mm2),	compared	to	the	7	b	value	range,	which	focused	on	higher	diffusion	weightings	(0,	50,	100,	250,	500,	750,	1000	s/mm2).	Lower	b	values	are	needed	to	capture	the	fast	pseudo	random	diffusion/perfusion	effects23,	and	thus	the	8	b	value	range	is	more	suited	to	an	IVIM	model	than	the	7	b	value	range.	The	normal	kidney	data	was	separated	in	the	pre-	and	post-treatment	groups	as	although	the	treatment	is	not	intended	for	this	tissue,	chemotherapy	affects	the	entire	body	and	thus	would	likely	influence	the	contralateral	kidney.	Only	a	slight	change	in	model	selection	was	seen	between	these	groups,	with	the	pre-treatment	group	showing	equal	preference	for	either	IVIM	or	stretched	exponential,	whereas	in	the	post-treatment	group	72%	of	the	kidneys	favoured	IVIM.	This	may	be	due	to	the	effects	of	chemotherapy	changing	the	tissue.	However,	this	is	only	a	minor	change	in	model	selection	and	when	the	pre-treatment	group	is	separated	into	b	value	ranges,	majority	of	kidneys	in	the	8	b	value	group	favoured	IVIM	as	well.	Therefore,	it	is	unlikely	that	the	treatment	had	a	great	effect	on	model	selection	in	the	normal	renal	tissue.		 The	method	for	selecting	the	model	which	provided	the	best	fit	is	a	potential	weakness	of	this	study.	AIC	takes	into	account	the	complexity	of	the	model	and	goodness	of	fit,	and	therefore	seemed	an	appropriate	choice	for	model	comparison	and	selection.	However,	this	process	was	completed	on	a	voxel-by-voxel	basis	and	the	model	which	most	frequently	‘won’	across	the	entire	tissue	volume	was	chosen.	This	does	not	take	into	account	the	fact	that	the	best	fit	model	may	have	only	been	the	best	in	a	few	more	voxels	than	the	next	best	fit	model.	It	is	important	to	consider	if	one	model	is	clearly	the	best	for	the	entire	tissue	or	if	there	is	only	a	small	difference	between	the	models.	This	was	previously	highlighted	by	Manikis	et	al.5	in	rectal	cancer,	where	although	overall	mono-exponential	was	preferred	to	IVIM,	there	was	high	heterogeneity	across	the	tissue.	An	example	of	this	can	be	seen	in	Figure	7.7.	It	shows	a	pre-chemotherapy	Wilms’	tumour	which	favoured	the	IVIM	model,	however,	it	can	be	seen	that	there	was	very	little	difference	between	the	number	of	voxels	selecting	stretched	exponential,	and	the	number	of	voxels	selecting	IVIM,	(difference	of	103	voxels).	With	this	in	mind,	one	should	be	cautious	before	claiming	a	particular	model	best	fits	the	data,	as	it	may	be	that	many	models	are	near	equal	in	fitting	quality.	This	once	again	highlights	the	highly	heterogenous	nature	of	Wilms’	tumours.	Thus,	it	is	important	to	always	be	mindful	when	making	
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conclusions	about	Wilms’s	tumour	tissue,	whether	it	is	in	terms	of	model	preference,	necrotic	regions	or	subtype.										
		
7.6:	Conclusions	and	Summary			 Non-Gaussian	models	of	diffusion	have	the	potential	to	provide	additional	clinical	information	as	opposed	to	standard	ADC.	This	study	investigated	how	well	non-Gaussian	and	mono-exponential	models	describe	DWI	data,	according	to	AIC,	in	Wilms’	tumours	and	normal	renal	tissue.	It	was	shown	that	the	mono-exponential	model	does	not	fit	the	DWI	data	as	well	as	IVIM,	stretched	exponential	or	kurtosis	in	Wilms’	tumour	tissue	and	normal	renal	tissue.	Stretched	exponential	was	the	best	model	for	describing	the	Wilms’	data,	but	specific	subtypes	did	not	show	a	preference	for	different	models.	It	is	important	to	acknowledge	that	Wilms’	tumours	are	very	heterogenous	and	that	within	a	single	tumour	many	non-Gaussian	models	provided	good	descriptions	of	the	data.	As	expected	in	the	contralateral	normal	renal	tissue	IVIM	was	the	best	descriptor	of	the	DWI	data.		
Figure	7.7.		An	example	of	a	central	axial	slice	(b0)	of	the	abdomen.	Each	voxel	within	the	Wilms’	tumour	(pre-chemotherapy	tumour,	age	at	scan:	6.45	years)	is	colour-coded	according	to	which	model	provided	the	best	fit	to	the	raw	diffusion	data,	based	on	the	Akaike	Information	Criterion;	yellow	=	mono-exponential,	red	=	IVIM,	green	=	stretched	exponential,	blue	=	kurtosis.	A	graph	is	shown	detailing	the	number	of	voxels	assigned	to	each	model	across	the	entire	tumour	volume.		
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	 ADC	is	frequently	used	in	clinical	research	and	therefore	the	assumption	is	that	the	signal	decay	is	mono-exponential.	However,	these	results	suggest	that	in	Wilms’	tumour	and	normal	renal	tissue,	the	DWI	signal	does	not	exhibit	a	mono-exponential	decay.	Therefore,	utilising	other	models	may	provide	more	accurate	representations	of	the	underlying	tissue	environment.	Thus,	potentially	improving	our	interpretation	of	research	and	our	understanding	of	what	the	MRI	signal	is	reflecting.	However,	one	does	need	to	keep	in	mind	that	these	fits	may	be	dependent	on	the	acquisition,	for	example	number	of	b	values,	and	it	is	also	important	to	consider	if	the	fitted	parameters	are	reproducible	and	clinically	useful.		
Main	Finding:	Non-Gaussian	models	provide	superior	fits	to	diffusion	data	in	Wilms’	tumours	and	contralateral	normal	kidney	tissue	compared	to	a	mono-exponential	model.	Out	of	112	tumours	only	1	favoured	the	mono-exponential	model,	and	out	of	77	contralateral	kidneys	none	favoured	the	mono-exponential	model.			 	
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Chapter	8:	An	Alternative	Approach	to	Contrast-Enhanced	Imaging:	
Diffusion	Weighted	Imaging	and	T1-weighted	Imaging	Identifies	and	
Quantifies	Necrosis	in	Wilms’	Tumour	
	This	chapter	describes	a	retrospective	study	which	aimed	to	identify	necrotic	tissue	in	Wilms’	tumours,	without	using	contrast-enhanced	imaging,	but	rather	combining	DWI	and	T1w.	It	found	that	combining	ADC	and	T1w,	maps	could	be	created	which	were	visually	similar	to	gadolinium-enhanced	images.	Furthermore,	a	threshold	was	created	which	could	separate	viable	and	necrotic	Wilms’	tumour	tissue	with	high	specificity	(90%)	and	sensitivity	(85%).		This	investigation	led	to	a	publication:		H.	J.	Rogers,	M.	V.	Verhagen,	S.	C.	Shelmerdine.	C.	A.	Clark,	&	P.	W.	Hales.	An	Alternative	Approach	to	Contrast-Enhanced	Imaging:	Diffusion	Weighted	Imaging	and	T1-weighted	Imaging	Identifies	and	Quantifies	Necrosis	in	Wilms	Tumour.	European	Radiology.	(2018).		doi:	10.1007/s00330-018-5907-z.		
8.1:	Background		In	Europe	Wilms’	tumour	patients	are	treated	under	the	SIOP	approach	in	which	they	undergo	pre-operative	chemotherapy	to	reduce	tumour	size	prior	to	surgery1.	Furthermore,	those	with	higher	stage	tumours	and	higher	risk	subtypes	will	have	more	intense	chemotherapy	prior	to	surgery	and	additional	chemotherapy	post-surgery	(for	further	details	please	see	Chapter	1.5).		Chemotherapy	can	cause	an	increase	in	necrotic	tissue	within	the	tumour.	The	volume	of	necrosis	post-chemotherapy	is	informative	of	treatment	response.	It	has	been	suggested	that	patients	with	100%	necrosis	post-chemotherapy,	when	assessed	via	histological	analysis,	were	associated	with	relapse	free	survival	at	5-year	follow-up2.	Furthermore,	when	tumour	size	remains	stable	following	treatment	(without,	or	with	minor,	reduction	in	volume),	it	may	appear	that	treatment	was	ineffective.	However,	this	approach	has	been	suggested	to	be	unreliable,	as	the	volume	of	necrosis	may	have	increased	despite	small	overall	tumour	volume	changes3.	Thus,	quantifying	the	degree	of	necrosis	in	Wilms’	tumour	tissue	is	an	important	clinical	indicator.	
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In	the	body,	MRI	can	identify	necrotic	tissue	via	administration	of	gadolinium-based	contrast	agents	and	T1-weighted	imaging	(T1w).	The	contrast	agent	extravasates	into	viable	tissue	via	the	local	capillary	network,	and	as	such	in	poorly-perfused	necrotic	tissue,	absent	or	decreased	enhancement	may	represent	necrosis.	This	method	has	previously	been	used	in	Wilms’	tumour3–5	to	identify	necrotic	regions.	Furthermore,	it	has	been	shown	that	identifying	these	regions	using	T1w	imaging	and	gadolinium	can	assist	with	determining	the	effects	of	chemotherapy6.	However,	gadolinium	requires	venous	access,	raises	examination	costs,	and	can	cause	sides	effects	such	as	nausea	and	irritation	at	the	injection	site.	Additionally,	gadolinium	is	contra-indicated	in	those	with	renal	failure7,	and	while	many	Wilms’	patients	will	not	have	complete	renal	failure,	their	renal	function	is	likely	to	be	compromised.	In	addition,	recent	reports	have	described	gadolinium	retention	in	neural	and	body	tissue	regardless	of	renal	function,	however	currently	there	are	no	known	sequelae	related	to	this8.	While	gadolinium	is	still	frequently	administered	and	has	many	additional	uses,	an	alternative	approach	to	identify	and	quantify	necrosis	would	be	beneficial.		The	apparent	diffusion	coefficient	(ADC),	derived	from	diffusion	weighted	imaging	(DWI),	has	been	shown	to	be	related	to	cell	density;	low	ADC	values	correlate	with	high	cell	counts	in	a	range	of	paediatric	body	tumours9.	ADC	values	have	been	shown	to	increase	following	chemotherapy	in	abdominal	tumours3	and	specifically	in	Wilms’	tumour4.	Thus,	areas	of	necrosis	in	Wilms’	tumour	could	potentially	be	identified	as	regions	with	low	cellular	density;	potentially	resulting	in	higher	ADC	values.	However,	lower	ADC	values	do	not	necessarily	indicate	viable	tissue;	necrosis	by	coagulation	results	in	low	ADC	values	which	mimics	high	cellular	density	tissue10.	However,	hyper-intense	regions	on	pre-gadolinium	T1w	images	can	indicate	areas	of	coagulated	blood,	thus	a	combination	of	ADC	and	pre-gadolinium	T1w	may	enable	necrosis	in	Wilms’	tumour	to	be	identified	and	quantified,	without	the	need	for	exogenous	contrast	agents.		Furthermore,	non-Gaussian	diffusion	models	of	diffusion,	such	as	IVIM11,	stretched	exponential12	and	kurtosis13,	provide	additional	diffusion	parameters	(see	Chapter	3	for	details	on	each	of	these	models).	It	has	been	shown	that	these	models	provide	better	fits	(according	to	AIC)	to	DWI	data	compared	to	a	mono-exponential	model,	when	assessed	in	Wilms’	tumour	patients,	both	pre-	and	post-chemotherapy	(Chapter	7).		Given	that	these	models	may	provide	a	more	accurate	description	of	the	diffusion	MR	signal,	and	provide	additional	information	about	tissue-microstructure	compared	to	the	standard	mono-exponential	model14,	it	was	hypothesised	that	they	may	also	be	able	to	identify	necrotic	tissue	in	Wilms’	tumour.	IVIM	could	be	particularly	beneficial	in	assessing	
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necrosis,	as	it	accounts	for	the	influence	of	blood	flow	on	the	DWI	signal15,	which	should	be	absent	in	necrotic	tissue.			
8.2:	Aims	and	Hypotheses		 It	would	be	beneficial	to	non-invasively	identify	necrosis	in	Wilms’	tumour;	diffusion	parameters	and	T1w	imaging	may	provide	the	means	to	achieve	this.	In	this	study	it	was	hypothesised	that	combining	non-contrast-enhanced	T1w	imaging	and	DWI	the	degree	of	necrosis	in	Wilms’	tumour	could	be	estimated,	as	opposed	to	the	more	traditional	method	of	using	gadolinium.	Different	diffusion	parameters	were	used	in	combination	with	T1w	to	determine	a	relationship	with	enhancement,	these	models	were	tested	by	using	multiple	linear	regressions	and	the	preferred	model	was	selected	based	on	the	highest	adjusted	R2	value.			 It	was	expected	that	an	inverse	relationship	would	be	seen	in	majority	of	the	parameters	with	an	increase	in	ADC	(mono-exponential),	D	and	D*(IVIM),	DDC	and	a	(stretched	exponential),	Dk	and	K	(kurtosis)	being	significantly	(p	<	0.05)	related	to	a	decrease	in	mean	fractional	enhancement,	the	parameter	f	x	D*	was	also	investigated	and	the	same	relationship	was	expected.	Furthermore,	a	positive	relationship	was	anticipated	with	f,	with	an	increase	in	mean	f	being	significantly	(p	<	0.05)	related	to	an	increase	in	mean	fractional	enhancement.			 It	was	expected	that	the	models	with	the	IVIM	parameters	would	provide	the	highest	adjusted	R2	values.	The	selected	model	from	the	regression	analysis	will	be	compared	to	the	gadolinium	method	and	will	have	little	bias.	A	small	bias	will	be	defined	as	below	10%	based	on	Bland-Altman	analysis.		 Additionally,	this	study	aimed	to	establish	a	minimum	threshold	of	enhancement,	based	on	typical	values	found	in	necrotic	tumour	tissue,	as	defined	by	manual	delineation	of	necrotic	tumour	regions	on	post-gadolinium	T1w	images	by	two	radiologists.	Tissue	which	showed	enhancement	below	this	threshold	(using	either	measured	or	predicted	enhancement	data)	would	be	classified	as	necrotic,	therefore	allowing	quantification	of	the	volume	of	necrotic	tissue	in	future	Wilms’	tumour	studies.			
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8.3:	Methods	
	
8.3.1:	Study	Population	Institutional	ethical	approval	was	granted	and	waived	the	need	for	consent	for	this	single	centre	review	of	clinically	acquired	MRI	scans.	A	5-year	retrospective	review	(March	2012-2017)	of	the	radiology	imaging	system	was	performed	for	all	MRI	abdominal	studies	in	children	with	proven	histological	diagnosis	of	Wilms’	tumour	at	Great	Ormond	Street	Hospital	(London,	UK).	Inclusion	criteria	were	children	who	had	completed	a	full	6-week	course	of	chemotherapy,	with	MRI	sequences	that	included	both	DWI	with	multiple	b	value	DWI	data	(with	a	maximum	b	value	of	1,000	s/mm2),	and	T1w	sequences	(pre-	and	post-gadolinium	contrast).	Cases	where	the	post-chemotherapy	size	of	the	tumour	did	not	cover	more	than	2	axial	slices	on	diffusion	imaging	were	excluded.			
8.3.2:	MRI	and	Contrast	Agents	The	details	of	the	DWI	protocol	can	be	found	in	Chapter	7.3.2.	Patients	also	received	fat-supressed	axial	T1-weighted	imaging	(T1w)	after	DWI	which	was	acquired	both	before	and	after	intravenous	administration	of	gadolinium-based	contrast,	using	identical	protocols	for	the	pre-	and	post-gadolinium	acquisitions:	voxel	size:	0.49	x	0.49	x	9.5mm,	matrix	size:	512	x	384	x	20,	number	of	slices:	20.	One	of	two	T1w	sequences	were	performed,	this	was	either	a	fast	2D	spin	echo	sequence:	TR/TE:	450ms	–	550ms/8ms	–	18ms,	with	a	selective	water-exciting	RF	pulse,	or	a	fast	low-angle	shot	2D	gradient	echo	sequence:	TR/TE:	1500ms/7ms,	flip	angle:	15°,	with	a	selective	water-exciting	RF	pulse.	The	former	sequence	was	acquired	during	free	breathing	in	children	who	were	anaesthetised,	and	the	latter	sequence	used	prospective	diaphragmatic	gating	in	those	patients	who	were	awake	or	moderately	sedated.		Patients	were	administered	gadolinium	contrast	and	received	the	following:			Dotarem	0.5mmol/ml	(Manufactured	by	Guerbet),	dosage:	0.2mls	per	kg	body-weight.	The	post-contrast	T1w	sequence	was	started	2	to	4	minutes	after	injection	of	the	contrast	agent.	Hyoscine	butylbromide	(Buscopan)	20mg/ml	(manufactured	by	Sanofi)	was	also	administered	prior	to	all	sequences	to	prevent	peristalsis,	dosage:	0.02ml	per	kg	body-weight,	however,	maximum	dosage	was	based	on	patient	age:	1month	–	4	years	=	0.25ml	maximum,	4	years	–	12	years	=	0.5ml	maximum.	
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8.3.4:	Processing	of	MRI	Data	&	ROIs	Data	processing	and	analysis	was	performed	using	in-house	routines	written	in	Matlab	R2015b	(MathWorks	Inc.,	Natick,	MA,	USA).	All	registrations	were	performed	using	NiftyReg16	packages	using	affine	transformations,	and	Regions	of	Interest	(ROIs)	were	generated	using	Mango	Software	(Research	Imaging	Institute,	UTHSCSA).	Tumour	ROIs	were	independently	drawn	by	two	radiologists	specialising	in	paediatric	radiology	(S.S:	4	years	paediatric	radiology;	M.V:	2	years	paediatric	radiology).	ROIs	were	drawn	around	the	perimeters	of	each	Wilms’	tumour	on	b=0	(non-diffusion-weighted)	images	on	each	axial	slice,	using	all	clinically	acquired	images	for	guidance.	The	overlapping	areas	(between	the	two	radiologists)	were	defined	as	the	final	Wilms’	tumour	ROIs.	ROIs	which	displayed	substantial	visual	mismatch	between	the	two	radiologists	were	reviewed	until	consensus	was	achieved.	To	compare	similarity	of	size	between	the	independently	defined	ROIs	the	Intraclass	Correlation	Coefficient	(ICC)	was	calculated.	Data	from	each	patient	was	processed	using	four	different	models	of	diffusion:	mono-exponential,	IVIM,	stretched	exponential,	and	kurtosis.	The	details	of	these	fitting	methods	can	be	seen	in	Chapter	6.3.3.		The	resulting	parameter	maps	were	then	smoothed	with	a	2mm	Gaussian	kernel	using	FSLmaths17.		Fractional	enhancement	maps	were	generated	from	T1w	scans.	All	T1w	scans	(pre-	and	post-gadolinium)	were	smoothed	with	a	2mm	Gaussian	kernel	prior	to	registrations	to	counteract	registration	errors.	Post-gadolinium	T1w	images	(post-Gd	T1w)	were	then	registered	to	pre-gadolinium	T1w	images	(pre-Gd	T1w)	using	an	affine	registration16.	Voxel-wise	fractional	enhancement	maps	were	calculated	using	Equation	8.1	where	the	terms	are	measured	in	signal	intensities.			
Fractional	Enhancement	=	("#$%&'(	*+,	&"-.&'(	*+	/)"-.&'(	*+	/ 				[8.1]			For	example,	a	fractional	enhancement	of	0.50	indicates	a	50%	increase	in	signal	intensity	on	the	T1w	image	following	gadolinium	administration.	Fractional	enhancement	maps	were	co-registered	to	DWI	space.	Additionally,	pre-Gd	T1w	images	were	normalised	to	mean	pre-Gd	T1w	signal	intensity	in	a	reference	tissue	in	each	patient,	to	produce	semi-quantitative,	normalised	pre-Gd	T1w	images	(T1wnorm).	This	was	achieved	by	dividing	each	pre-Gd	T1w	image	by	the	mean	signal	intensity	of	an	ROI	placed	in	normal	appearing	
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erector	spinae	muscles	for	each	patient.	These	T1wnorm	images	were	also	registered	to	the	DWI	scans.		
8.3.5:	Analysis	and	Statistics	Wilms’	tumour	ROIs	were	placed	on	co-registered	fractional	enhancement,	diffusion,	and	T1wnorm	maps.	Mean	values	were	calculated	for	each	parameter	in	every	Wilms’	tumour.	The	diffusion	parameters	included	ADC,	the	fitted	IVIM	parameters	(D,	D*	and	f),	the	fitted	stretched	exponential	parameters	(DDC	and	α),	and	the	fitted	kurtosis	parameters	(Dk	and	K).	Additionally,	the	parameter	f	x	D*	(from	IVIM)	was	also	investigated.	Multiple	linear	regression	was	used	to	calculate	the	relationship	between	mean	fractional	enhancement	(dependent	variable)	and	a	combination	of	the	mean	of	a	single	diffusion	parameter	and	mean	T1wnorm	(predictor	variables).	Statistically	significant	regression	coefficients	were	defined	as	having	a	p-value	<0.05.	Models	were	then	compared	based	on	adjusted	R2	values.		Using	the	selected	regression	model,	voxel-wise	predicted	enhancement	maps	were	generated	for	each	Wilms’	tumour.	Using	a	Bland-Altman	plot,	whole	tumour	values	of	predicted	and	measured	fractional	enhancement	were	compared,	to	determine	the	similarity	(confidence	intervals)	and	level	of	bias	(mean	difference)	between	the	two	techniques.	Good	agreement	between	techniques	was	defined	as	have	a	level	of	bias	£10%.		An	upper	threshold	for	enhancement	in	necrotic	tissue	was	also	generated,	which	would	allow	tumours	to	be	separated	into	viable	and	necrotic	components.	Regions	within	each	tumour	which	confidently	represented	necrosis	were	independently	delineated	by	the	two	radiologists	on	the	b0	images,	using	all	clinically	acquired	MR	sequences	for	guidance.	The	overlapping	areas	between	the	radiologists	were	defined	as	the	final	necrotic	ROIs.	These	were	used	as	the	‘gold-standard’	to	represent	the	necrotic	part	of	each	tumour.	The	remainder	of	the	Wilms’	tumour	was	defined	as	the	viable	ROI.	Both	viable	and	necrotic	ROIs	were	registered	onto	corresponding	measured	fractional	enhancement	maps.	The	fractional	enhancement	value	of	every	necrotic	and	viable	voxel	was	pooled	across	the	cohort.	Receiver	Operator	Characteristic	(ROC)	analysis	was	used	to	define	a	fractional	enhancement	threshold	which	best	separated	viable	and	necrotic	tissue	based	on	AUC	(Area	Under	Curve)	values.	Tissue	within	a	Wilms’	tumour	with	enhancement	below	this	threshold	would	be	classified	as	necrotic,	and	tissue	with	enhancement	above	this	threshold	would	be	classified	as	having	some	degree	of	viability.	
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8.4:	Results	
	
8.4.1:	Study	Population		A	total	of	37	Wilms’	tumours	from	34	patients	were	included	as	the	final	cohort.	The	median	age	of	patients	at	the	time	of	their	MRI	scans	was	2.6	years	(Mean:	3.3	years,	
SD:	2.6,	Minimum:	0.4	years,	Maximum:	11.0	years).	Patient	inclusion	and	exclusion	metrics	are	shown	in	Figure	8.1.	Eight	Wilms’	tumour	DWI	acquisitions	were	acquired	using	the	7	b	values	range	and	29	Wilms’	tumour	DWI	acquisitions	were	acquired	using	the	8	b	values	range.		 	
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8.4.2:	Post-Processing		After	initial	delineation	of	the	Wilms’	tumour	ROIs,	visual	inspection	showed	that	8/37	(21.6%)	had	a	substantial	mismatch	between	the	radiologists;	these	were	re-defined	after	consensus.	The	remaining	29	Wilms’	tumours	had	a	high	level	of	agreement	between	radiologists	with	an	average	overlapping	area	of	88%	(SD:	0.67).	After	adjustment	of	the	8	mismatched	ROIs,	there	was	high	similarity	in	the	size	of	the	37	Wilms’	tumours	as	defined	by	the	two	readers,	with	an	ICC	of	0.98,	(ICC	prior	to	adjustment:	0.96).	There	was	
Figure	8.1.	Flowchart	highlighting	inclusions	and	exclusions	of	Wilms’	tumour	data.	DWI	=	Diffusion	Weighted	Imaging.	T1w	=	T1	weighted	imaging.	np	=	number	of	patients,	nt	=	number	of	tumours.	
59	patients	with	a	confirmed	diagnosis	of	Wilms’	tumour 
Exclusion: Did	not	have	both	DWI	and	T1w	with	and	without	gadolinium	(np	=	25) 
34	Wilms’	tumour	patients	with	necessary	MRI,	of	which	bilateral	tumours	(np=	5) 
Exclusion: Tumour	did	not	cover	at	least	2	axial	imaging	slices	on	DWI	(nt	=	2) 
34	Wilms’	tumour	patients	 37	Wilms’	tumours	 
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also	high	similarity	in	the	size	of	the	necrotic	ROIs	defined	by	the	two	readers,	with	an	ICC	of	0.83.			
8.4.3:	Analysis	All	multiple	linear	regression	models	used	to	predict	fractional	enhancement	were	statistically	significant	(p	<	0.05),	as	shown	in	Table	8.1.	The	combination	of	D	from	IVIM	and	T1wnorm	gave	the	most	significant	regression	model	F(2,	34)	=	13.78,	p	<	0.001,	adjusted	R2	=	0.42.	However,	this	represented	only	a	very	marginal	improvement	compared	to	ADC	(F(2,	34)	=	13.2,	p	<	0.001,	adjusted	R2	=	0.40).	While	the	other	7	models	all	reached	significance	(p	<	0.05),	the	higher	p	values	and	comparatively	low	adjusted	R2	values	indicated	that	they	did	not	predict	fractional	enhancement	levels	as	well.	Due	to	the	similarity	in	performance	between	the	regression	models	based	on	D	(IVIM)	and	ADC	(mono-exponential),	and	the	fact	that	ADC	data	are	more	widely	acquired	clinically	(as	fewer	b-values	are	required),	we	chose	to	focus	on	the	ADC-based	model	for	further	analysis.			 	
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	Figure	8.2	demonstrates	the	relationship	between	both	ADC	and	T1wnorm	with	fractional	enhancement.	Both	ADC	(p	<	0.001)	and	T1wnorm	(p	=	0.001)	added	significantly	to	the	prediction,	with	both	increased	ADC	and	increased	T1wnorm	being	associated	with	reduced	fractional	enhancement.	The	standard	error	of	the	estimate	was	0.24.					
Table	8.1.		The	p-values,	adjusted	R2	and	correlation	coefficients	(β)	of	the	nine	multiple	regression	models	used	to	predict	Fractional	Enhancement,	based	on	a	combination	of	T1wnorm	and	one	of	the	diffusion	parameters.	ADC,	D,	D*,	f	x	D*,	DDC,	Dk	were	all	measured	in	standard	units	of	mm/s2.		f,	α,	K,	and	T1wnorm	are	unitless	Diffusion	Parameter	 β0	(Intercept)	 β1	(Diffusion)	 β2	(T1wnorm)	 Model	p	Value	 Model	Adjusted	R2	ADC		(mono-exponential)	 1.85	 -408.4	 -0.4	 5.7	x	10-5	 0.40	
D	(IVIM)	 1.83	 -419.64	 -0.4	 4.2	x	10-5	 0.42	
D*	(IVIM)	 1.18	 -1.09	 -0.3	 0.017	 0.17	
f	(IVIM)	 1.01	 1.07	 -0.34	 0.025	 0.15	
f	x	D*	(IVIM)	 1.2	 -5.53	 -0.33	 0.023	 0.15	
DDC	
	(stretched	exponential)	 1.11	 -1958.39	 -0.27	 0.003	 0.25	α		(stretched	exponential)	 3.04	 -2.28	 -0.32	 0.001	 0.29	
Dk	(kurtosis)	 1.91	 -324.16	 -0.41	 0.001	 0.31	
K	(kurtosis)	 1.17	 3.32	x	10-7	 -0.35	 0.032	 0.14	
Note.	ADC	=	apparent	diffusion	coefficient.	IVIM	=	intravoxel	incoherent	motion.	D	=	thermally-driven,	‘slow’	diffusion,	D*	=	flow-driven,	‘fast’	diffusion,	f	=	volume	fraction	associated	with	‘fast’	diffusion,	DDC	=	distributed	diffusion	coefficient,	α	=	stretching	parameter,	Dk	=	diffusion	kurtosis	coefficient,	K	=	kurtosis	
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	Using	the	ADC-	T1wnorm	model,	predicted	enhancement	was	calculated	according	to	the	regression	model	given	by	Equation	8.2	below,	which	was	derived	using	the	‘fitlm’	algorithm	in	Matlab:		 Predicted	Enhancement	=	1.85 − (408.4 ∗ 9:;) − (0.4 ∗ <=>?#-@)				[8.2]	where	ADC	is	measured	in	mm/s2.		 Comparisons	between	fractional	enhancement	and	predicted	enhancement	maps	in	three	representative	patients	are	illustrated	in	Figure	8.3.	Both	highlight	similar	regions	of	enhancing	and	non-enhancing	tissue.							
Figure	8.2.	(A)	Linear	regression	of	mean	ADC	(apparent	diffusion	coefficient)	versus	mean	fractional	enhancement	in	37	Wilms’	Tumours,	adjusted	R2	=	0.19	(B)	Linear	regression	of	mean	T1wnorm	(normalised	semi-quantitative	T1weighted	imaging)	versus	mean	fractional	enhancement	in	37	Wilms’	Tumours,	adjusted	R2	=	0.16.	For	the	multiple	linear	regression	model	(with	both	ADC	and	T1wnorm	as	predictors),	the	adjusted	R2	was	0.40	(p	<	0.001).				
153 
 
							
	The	level	of	agreement	between	fractional	enhancement	and	predicted	enhancement	is	illustrated	in	the	Bland-Altman	plot	in	Figure	8.4.	There	was	a	small	bias	(9.3%)	in	predicted	values	overestimating	the	level	of	enhancement	across	a	wide	range	of	enhancement	levels	(Mean	difference	(measured	FE	–	predicted	FE)	=	-0.093,	95%	CI	=	[-0.52,	0.34]).									
Figure	8.3.	Examples	of	single	axial	slices	from	three	representative	Wilms’	tumours.	(A1,	B1,	C1)	Fractional	enhancement	maps	of	the	Wilms’	tumours	(outlined	in	red),	measured	using	gadolinium.	(A2,	B2,	C2)	The	same	slices	of	the	same	Wilms’	tumours	from	predicted	enhancement	maps,	predicted	using	Equation	8.2	(without	gadolinium).	Increased	signal	represents	greater	enhancement,	and	hence	more	viable	tissue.	Tumour	details:	A	–	subtype:	mixed,	age	at	scan:	11	years,	B	–	subtype:	blastemal,	age	at	scan:	1.8	years,	C	–	subtype:	mixed,	age	at	scan:	1.08	years.  
Figure	8.4.	A	Bland-Altman	plot	showing	the	level	of	agreement	in	mean	enhancement	values	in	37	Wilms’	tumours,	as	calculated	using	fractional	enhancement	(FE)	and	predicted	enhancement	(PE)	from	the	ADC-T1wnorm	model	(Equation	8.2).	
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ROC	analysis	provided	an	optimal	threshold	to	distinguish	between	viable	and	necrotic	tissue,	based	on	fractional	enhancement	(Figure	8.5a).	The	upper	threshold	was	0.33	(i.e.	voxels	showing	less	than	33%	signal	enhancement	on	T1w	imaging,	after	administration	of	gadolinium,	were	classified	as	necrotic).	This	threshold	provided	a	sensitivity	of	85%	and	specificity	of	90%	for	identifying	the	‘gold-standard’	necrotic	tissue	(i.e.	all	voxels	contained	within	the	necrotic	ROIs	defined	by	the	two	radiologist),	with	an	AUC	of	0.93.		Figure	8.5b	displays	a	box	and	whisker	plot	of	the	fractional	enhancement	values	in	all	voxels	within	the	manually	defined	necrotic	and	viable	ROIs	across	the	entire	cohort.	An	independent	sample	t-test	revealed	a	significant	difference	between	fractional	enhancement	values	in	the	viable	(Mean:	0.73	SD:	0.33)	and	necrotic	(Mean:	0.14	SD:	0.2)	voxels;	t(195364)	=	-446.96,	p	<	0.001.	The	optimum	threshold	(0.33)	which	separates	necrotic	and	viable	tumour	tissue	is	also	highlighted	in	Figure	8.5b.					 	
Figure	8.5.	(A):	Receiver	operator	characteristic	curve	to	determine	a	threshold	which	best	separates	necrotic	and	viable	Wilms’	tumour	tissue.	The	optimum	upper	threshold	(0.33),	whereby	voxels	displaying	enhancement	above	this	value	are	classified	as	viable,	is	highlighted	in	red.	For	this	threshold	the	area	under	the	curve	was	0.93,	sensitivity	was	85%,	and	the	specificity	was	90%.	(B):	Box	and	whisker	plot	displaying	fractional	enhancement	of	every	voxel	from	the	37	Wilms’	tumours	which	were	either	classified	as	necrotic	or	viable.	The	dotted	line	reflects	the	optimum	threshold	(0.33	fractional	enhancement)	for	this	separation	based	on	ROC	analysis	which	is	shown	in	5A.		
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8.5:	Discussion	
	This	study	investigated	whether	necrosis	could	be	identified	without	using	gadolinium	contrast-enhanced	T1w	images	in	Wilms’	tumour.	Good	agreement	(defined	as	
£10%)	was	found	between	mean	tumour	enhancement	values	calculated	using	non-gadolinium-based	metrics	(ADC	and	T1wnorm),	and	the	level	of	enhancement	measured	using	gadolinium	in	the	same	tumours.	Additionally,	a	threshold	of	maximum	enhancement	in	necrotic	tissue	was	determined,	which	separated	viable	and	necrotic	tissue	in	good	agreement	with	manually	delineated	necrotic	tumour	regions,	as	defined	by	two	specialist	paediatric	radiologists.	As	such,	this	threshold	could	be	used	to	quantify	the	total	fraction	of	necrotic	tissue	in	Wilms’	tumours	in	future	studies,	using	either	measured	or	predicted	enhancement	values.		Necrosis	within	Wilms’	tumours	can	indicate	chemotherapy	response,	with	high	volumes	of	necrosis	representative	of	‘good	response’18.	Quantifying	the	percentage	of	necrosis	in	Wilms’	tumour	has	previously	been	challenging	as	histological	methods	usually	only	sample	a	sub-section	of	tissue.	Thus,	measuring	the	level	of	necrosis	of	the	entire	tumour	volume	using	imaging-based	assessment,	particularly	without	exogenous	contrast,	is	greatly	beneficial.	In	addition,	although	‘contrast	enhancement’	is	currently	used	in	a	qualitative	manner	to	identify	viable/necrotic	tumour	tissue,	this	is	rarely	done	in	a	quantitative	manner,	and	as	such	the	intra-tumour	volume	fraction	of	necrotic	tissue	is	rarely	reported	radiologically.	By	deriving	a	threshold	value	for	the	minimum	level	of	enhancement	necessary	for	tissue	to	be	classified	as	viable	(which	could	be	measured	using	either	gadolinium	or	the	non-gadolinium-based	model	presented	here),	we	hope	that	the	degree	of	necrosis	in	a	tumour	can	be	quantified	in	future	studies.	Additionally,	in	instances	of	bilateral	Wilms’	tumour	whole	tumour	resection	is	not	possible	and	thus	total	necrosis	fractions	cannot	be	quantified	using	histological	analysis.	Furthermore,	DWI	and	T1w	imaging	are	routinely	acquired	in	Wilms’	tumour	patients,	so	no	additional	scan	time	is	needed,	aiding	the	transference	to	clinical	practice.	A	further	benefit	of	identifying	this	necrotic	tissue	is	that	it	can	assist	with	identifying	subtypes.	Previous	work	has	shown	that	some	Wilms’	tumour	subtypes	could	be	separated	into	lower	and	higher-risk	groups	using	ADC4.	This	work	highlighted	that	using	lower	quartile	ADC	values	provided	better	separation	compared	to	mean	ADC	values,	thus,	removing	higher	diffusion	values	(which	are	likely	to	represent	necrotic	
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tissue)	improved	subtype	identification.	Therefore,	providing	another	use	for	the	proposed	method	–	this	is	discussed	in	more	detail	in	Chapter	9.	The	current	gadolinium-based	method	of	identifying	non-enhancing	tissue	has	some	possible	limitations	due	to	potential	adverse	reactions	in	patients	(including	nausea,	headaches	and	irritation),	and	the	as-yet	unknown	impact	of	the	accumulation	of	contrast	agent	in	patients	undergoing	repeated	follow-up	imaging8.	Additionally,	gadolinium	may	not	always	be	appropriate	in	Wilms’	tumour,	for	example	if	the	patient	has	renal	failure;	which	will	be	dependent	on	co-morbid	disorders,	tumour	staging,	treatment	timeline	and	whether	the	tumour	is	bilateral19,20;	additionally,	chemotherapy	drugs	can	lead	to	nephrotoxicity21.	For	these	reasons,	alternative	approaches	for	predicting	enhancement	and	identifying	and	quantifying	necrotic	tissue	without	gadolinium,	are	potentially	beneficial.		ADC	is	a	well-defined	diffusion	parameter;	however,	multiple	b	value	DWI	data	allows	non-Gaussian	diffusion	models	to	be	applied,	which	provide	additional	fitted	parameters.	This	study	compared	ADC	and	non-Gaussian	diffusion	parameters	in	predicting	fractional	enhancement.	Out	of	all	the	models	considered	here,	IVIM	had	the	highest	adjusted	R2	value.	Previous	work	has	shown	that	D	and	f	have	higher	accuracy	in	distinguishing	between	enhancing	and	non-enhancing	kidney	lesions	compared	to	ADC22.	Furthermore,	bi-exponential	models	have	been	suggested	rather	than	mono-exponential	for	more	reliable	diffusion	estimates	of	healthy	kidney	tissue23.	Interestingly,	regression	models	which	incorporated	the	f	and	f	x	D*	parameters	did	not	reach	high	significance	for	predicting	enhancement.	f	is	assumed	to	represent	the	contribution	to	the	DWI	signal	due	to	blood	flowing	in	the	randomly	orientated	capillary	network11,	and	f	x	D*	represents	a	surrogate	measure	of	blood	flow24.	Due	to	the	lack	of	blood	flow	in	necrotic	tissue	it	would	be	expected	that	these	parameters	would	be	better	predictors	of	fractional	enhancement,	however	our	results	suggest	this	is	not	the	case.	This	may	be	because	it	is	beyond	the	sensitivity	of	the	IVIM	model	to	identify	the	small	level	of	perfusion	in	viable	Wilms’	tumours	compared	to	non-enhancing	tissue.		
D	produced	the	strongest	regression	model,	however,	the	difference	between	the	predictive	power	of	D	and	ADC	was	minimal.	Due	to	the	similarity	in	the	performance	of	these	two	predictors,	and	the	fact	that	ADC	values	are	routinely	acquired	in	clinical	practice	(whereas	D	requires	longer,	multiple	b	value	acquisitions),	ADC	represents	the	preferred	option	for	predicting	fractional	enhancement	when	combined	with	T1wnorm.	This	combination	is	needed	as	ADC	alone	cannot	account	for	necrosis	via	coagulation,	and	as	
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can	be	seen	(Figure	8.2)	the	regression	is	much	stronger	when	T1wnorm	is	added	as	a	predictor.		This	study	had	several	limitations.	Firstly	slightly	different	b	values	were	used	for	a	small	number	of	our	patients	(8/37	were	acquired	with	7	b	values	and	29/37	were	acquired	with	8	b	values),	however	previous	work	has	shown	high	reproducibility	between	ADC	values	acquired	on	different	scanners	with	varying	b	values25.	Furthermore,	comparisons	of	ADC	when	acquired	with	either	7	or	8	b	values	(using	the	exact	same	MRI	protocols	as	in	the	present	study)	in	healthy	renal	tissue	showed	a	small	coefficient	of	variation	(6.27%),	and	almost	no	bias	when	assessed	via	Bland-Altman	analysis	(<1%)	(Chapter	6).	Therefore,	the	b	value	alterations	would	be	unlikely	to	influence	our	analysis.		Secondly,	when	comparing	the	measured	and	predicted	mean	enhancement	values,	the	predicted	values	were	slightly	overestimated.	However,	this	bias	was	small	(9%)	and	may	be	due	to	registration	errors	between	T1w	and	ADC	maps.		Thirdly,	our	sample	size	was	fairly	small,	and	a	more	robust	model	may	be	possible	with	a	larger	cohort.	Furthermore,	we	did	not	assess	tumour	necrosis	independently	using	histological	methods.	However,	it	is	important	to	note	that	for	histological	analysis	of	Wilms’	tumour,	only	a	sub-section	of	the	tumour	is	sampled,	and	this	may	not	accurately	reflect	the	total	necrosis	volume.	As	such,	we	preferred	in	this	study	to	use	visual	assessment	of	the	entire	tumour	volume,	using	all	clinically	available	MRI	scans,	to	ensure	the	entire	tumour	volume	was	assessed.	For	this	method	we	must	rely	on	the	ROIs	defined	by	the	two	radiologists,	thus	if	they	were	incorrect	then	the	tumour	and	necrosis	selection	would	be	wrong.	This	in	turn	would	impact	the	mean	values	of	the	diffusion	parameters	and	T1wnorm	and	therefore	generate	incorrect	regression	models	and	the	threshold.	However,	as	the	radiologists	had	many	years	of	experience	in	this	paediatric	population,	and	both	selected	similar	regions	when	they	created	the	ROIs	independently	we	can	place	confidence	in	the	selected	regions.		An	additional	limitation	may	arise	from	the	possible	reliance	of	our	model	on	the	specifics	of	the	T1w	protocol	used	in	this	study.	Alterations	in	the	delay	time	between	gadolinium	administration	and	T1w	imaging	may	lead	to	different	levels	of	enhancement	on	contrast-enhanced	T1w	scans.	However,	as	our	model	uses	the	fractional	difference	between	the	pre-	and	post-contrast	T1w	signal,	provided	the	T1w	protocol	remains	consistent	between	these	two	acquisitions,	the	influence	of	variations	in	the	specifics	of	the	T1w	acquisition	between	different	institutions	should	mostly	cancel	out.	
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Finally,	gadolinium	is	frequently	administered	for	indications	broader	than	necrosis	assessment,	for	example,	vascular	anatomy,	and	detecting	lesions	in	a	variety	of	organs.	We	acknowledge	that	the	proposed	method	cannot	entirely	replace	gadolinium.	Despite	this,	our	method	would	be	a	suitable	alternative	for	those	with	severe	renal	impairment	and	limit	the	cumulative	gadolinium	exposure	for	patients	who	have	repeated	follow-up	MRI	scans.	Gadolinium-free	MRI	examinations	are	currently	being	investigated	for	paediatric	oncology26	and	the	proposed	model	could	facilitate	this,	given	that	it	uses	data	acquired	as	part	of	the	clinical	standard.		
	
8.6:	Conclusions	and	Summary	Volume	of	necrotic	tissue	in	Wilms’	tumour	is	informative	of	treatment	response.	Currently	visualisation	of	necrotic	regions	relies	on	gadolinium-contrast	enhanced	imaging.		This	study	sought	to	determine	whether	an	alternative	method	of	combining	DWI	and	T1w	could	identify	and	quantify	necrosis,	as	there	are	associated	risks	and	complications	with	gadolinium.		All	diffusion	parameters	were	significantly	related	to	enhancement,	and	the	IVIM	parameter,	D,	did	produce	the	strongest	regression	model	(determined	by	adjusted	R2)	as	predicted	by	the	hypotheses.	However,	D*,	f,	and	f	x	D*	models	did	not	produce	as	strong	regressions	as	anticipated.		Although	the	D-T1wnorm	model	produced	the	highest	adjusted	R2,	it	was	not	much	greater	than	ADC,	and	given	the	wider	clinical	use	of	ADC,	the	ADC-T1wnorm	was	chosen.	This	model	generated	maps	which	were	visually	similar	to	the	gadolinium	method	and	also	had	good	agreement	with	the	gadolinium	data	(£10%).		A	threshold	of	maximum	enhancement	in	necrotic	regions	was	generated	based	on	the	chosen	model	(enhancement	<	0.33	=	necrotic),	allowing	the	percentage	of	necrotic	tissue	to	be	quantified	in	future	Wilms’	tumour	studies	using	imaging-based	methods	without	the	need	for	an	exogenous	contrast	agent.		
Main	Finding:	ADC	and	T1w	imaging	can	provide	an	alternative	approach	to	identify	and	quantify	necrosis	in	Wilms’	tumour	without	the	need	for	contrast	agents.	
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Chapter	9:	Identification	of	Wilms’	Tumour	Subtypes	using	Non-
Gaussian	Models	of	Diffusion	
		 This	chapter	describes	an	original	research	study	which	aimed	to	identify	Wilms’	tumour	subtypes	(blastemal,	epithelial,	mixed,	stromal,	regressive)	using	diffusion	parameters.	Parameters	from	four	models	of	diffusion	were	compared	to	determine	whether	they	could	separate	Wilms’	tumour	subtypes	based	on	one-way	ANOVAs.	Whole	tumour	values	were	compared	to	viable	tumour	regions	to	determine	whether	limiting	analysis	to	viable	tumour	tissue	increases	the	amount	of	subtype	separations.	It	was	found	that	all	parameters	other	than	f	could	separate	some	subtypes,	and	that	limiting	analysis	to	viable	tumour	tissue	improved	these	identifications.	D*	and	K	provided	the	most	separations	and	were	able	to	distinguish	blastemal	from	epithelial	subtypes,	which	has	previously	not	been	possible.		
9.1:	Background	The	SIOP-20011	approach	categorises	Wilms’	tumours	into	distinct	histological	subtypes	based	on	the	predominant	viable	cell	type	which	remains	following	chemotherapy.	The	main	subtypes	are	completely	necrotic	(low	risk),	stromal,	epithelial,	mixed	(intermediate	risk)	and	blastemal	(high	risk).	There	are	differences	in	outcome	and	treatment	between	risk	groups,	with	the	higher	risk	subtype	having	the	poorest	outcome	and	benefitting	from	more	intense	treatment.	Further	details	describing	how	these	subtypes	are	identified,	treated	and	their	outcomes	are	given	in	Chapter	1.5.			Currently	subtypes	can	only	be	identified	via	histological	analysis	post-surgery,	and	thus	it	would	be	beneficial	to	be	able	to	identify	these	subtypes	in	a	non-invasive	manor,	at	an	earlier	stage,	in	order	to	guide	the	severity	of	pre-operative	treatment	or	surgical	resection.	Given	that	ADC	is	related	to	cell	density2,	and	subtypes	will	have	distinct	cellular	compositions,	this	parameter	may	help	in	identifying	subtypes.	However,	using	the	mean	or	median	ADC	value	of	the	entire	tumour	may	not	provide	accurate	measurements.	Areas	of	necrotic	tissue	could	corrupt	average,	whole-tumour	values;	as	necrotic	tissue	would	be	likely	to	have	higher	ADC	values	than	viable	tumour	tissue2,3.	Furthermore,	it	has	been	shown	that	in	post-chemotherapy	Wilms’	tumour	tissue,	median	ADC	values	differed	depending	on	whether	or	not	necrotic	tissue	was	excluded4.		
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Previous	work	has	shown	that	when	avoiding	areas	of	high	ADC	(thought	to	be	necrotic	tissue),	some	subtypes	could	be	distinguished	from	one	another3.	Post-chemotherapy	ADC	maps	were	used	for	analysis	as	this	was	the	closest	time	point	to	histology,	and	it	was	found	that	the	higher	risk	blastemal	subtype	had	significantly	lower	ADC	values	compared	to	the	intermediate	subtypes;	stromal,	regressive	and	mixed.	However,	no	differences	in	ADC	were	found	between	epithelial	and	blastemal	subtypes,	and	unfortunately	these	subtypes	confer	a	different	diagnosis.	In	addition,	another	study	showed	that	within	individual	Wilms’	tumours	the	proportion	of	stromal	tissue	was	correlated	with	ADC4.	Further	details	and	more	in-depth	discussion	of	both	experiments	are	given	in	Chapter	4.2.4.		Non-Gaussian	models	of	diffusion	have	not	been	explored	in	subtype	separation	in	Wilms’	tumour.	It	was	shown,	however,	that	post-chemotherapy	Wilms’	tumours	were	better	described	by	non-Gaussian	diffusion	models	compared	to	the	mono-exponential	model	according	to	AIC	(Chapter	7).	Out	of	62	post-chemotherapy	Wilms’	tumours	all	but	one	favoured	non-Gaussian	models	(stretched	exponential5,	IVIM6	and	kurtosis7).	As	Wilms’	tumour	tissue	was	better	described	by	these	models	and	additional	diffusion	parameters	are	provided	by	these	models,	perhaps	they	may	also	assist	with	subtype	separation.			
9.2:	Aims	and	Hypotheses	This	experiment	builds	on	previous	work	by	utilising	the	threshold	generated	in	Chapter	8,	which	identified	necrotic	tissue	in	Wilms’	tumours	using	ADC	and	T1w.	After	excluding	necrotic	tissue,	four	models	of	diffusion	(mono-exponential,	IVIM,	stretched	exponential	and	kurtosis)	were	used	to	determine	whether	any	of	the	diffusion	parameters	could	distinguish	between	Wilms’	tumour	subtypes.	It	was	expected	that	significant	differences	(p	<	0.05)	would	be	seen	between	the	subtypes	based	on	the	diffusion	values.	Given	that	the	non-Gaussian	models	provided	better	fits	to	the	diffusion	data	it	was	expected	that	these	parameters	may	provide	more	distinctions	between	subtypes	compared	to	ADC.			Based	on	past	research,	it	was	also	expected	that	the	blastemal	and	epithelial	subtypes	will	have	lower	ADC	values	compared	to	the	other	subtypes	and	that	stromal	will	have	the	highest	values.	
164 
 
	As	an	additional	aim,	whole	tumour	values	(including	necrotic	tissue)	were	compared	to	the	viable	ROIs	to	establish	whether	excluding	necrotic	regions	improved	the	subtype	separations.	It	was	hypothesised	that	more	distinctions	would	be	found	by	limiting	the	ROIs	to	viable	tumour	tissue.			
9.3:	Methods		
9.3.1:	Study	Population		Patients	were	identified	based	on	methods	described	in	Chapter	7.3.1.	Inclusion	criteria	were	children	who	had	completed	a	full	6-week	course	of	chemotherapy,	with	MRI	sequences	that	included	both	DWI	and	T1w	(without	contrast)	sequences.	Cases	where	the	post-chemotherapy	size	of	the	tumour	did	not	cover	more	than	2	axial	slices	on	diffusion	imaging	were	excluded.	Tumours	were	also	excluded	if	they	did	not	have	a	histologically	confirmed	subtype	according	to	SIOP-2001	protocol1.		
9.3.2:	MRI	Diffusion	and	T1w	imaging	(without	gadolinium-contrast)	were	acquired	according	to	the	methods	described	in	Chapter	8.3.2.	DWI	data	was	acquired	on	the	1.5T	Siemens	Avanto	scanner	and	both	the	7	and	8	b	value	ranges	were	included.	All	patients	underwent	DWI	followed	by	T1w	imaging.			
9.3.3:	Processing	of	MRI	Data	&	ROIs	Data	from	each	patient	was	processed	using	four	different	models	of	diffusion:	mono-exponential,	IVIM6,	stretched	exponential5,	and	kurtosis7.	The	details	of	these	fitting	methods	can	be	seen	in	Chapter	6.3.3.	Whole	tumour	volume	ROIs	were	generated	according	to	the	methods	described	in	Chapter	8.3.4.					
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9.3.4:	Analysis	A	flowchart	detailing	the	processing	and	analysis	of	the	data	is	shown	in	Figure	9.1.													
	To	determine	whether	Wilms’	tumour	subtypes	could	be	distinguished	from	one	another	based	on	diffusion	measurements,	and	to	test	the	clinical	utility	of	applying	the	predicted	enhancement	model	described	in	Chapter	8,	voxel-wise	predicted	enhancement	maps	were	generated	according	to	equation	8.2	(Chapter	8).	Whole	tumour	ROIs	were	placed	on	the	predicted	enhancement	maps	and	voxels	which	had	enhancement	values	under	0.33	were	identified;	these	voxels	represented	areas	of	necrosis	(see	Chapter	8).	New	viable	tumour	ROIs	were	then	generated	which	excluded	these	regions,	so	that	analysis	would	only	focus	on	the	viable	portions	of	the	tumours.			Viable	ROIs	were	then	placed	on	the	diffusion	parameter	maps:	ADC	(mono-exponential)	D,	D*,	f	(IVIM),	DDC,	α	(stretched	exponential),	Dk,	K	(kurtosis),	additionally	
D*	x	f	parameter	maps	were	also	explored.	For	each	tumour	and	parameter	(except	f)	the	25th	percentile	was	calculated	within	the	ROIs.	This	was	shown	previously	to	best	stratify	Wilms’	tumour	subtypes	based	on	the	values	in	the	most	cellular	‘subpopulation’	of	Wilms’	
Figure	9.1.	Flowchart	detailing	the	steps	involved	to	analyse	the	Wilms’	tumour	subtypes	
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tumour	tissue3	and	should	further	reduce	the	chance	of	including	the	unwanted	necrotic	tissue,	which	would	be	likely	to	have	higher	diffusion	values	due	to	lower	cell	counts2.	For	the	f	parameter	the	75th	percentile	was	calculated	for	each	tumour	instead	of	the	25th,	as	it	has	been	suggested	that	lower	values	of	f	are	related	to	necrosis8.		Statistical	analyses	were	performed	using	IBM	SPSS	(Version	24).	The	calculated	parameter	values	were	then	compared	between	subtypes	using	a	one-way	ANOVA.	For	this	statistical	test	certain	assumptions	must	be	met;	each	subtype	must	not	have	any	significant	outliers	(defined	as	3	x	the	interquartile	range),	the	dependent	variable	(25th	or	75th	percentile)	should	be	approximately	normally	distributed	for	each	category	of	the	independent	variable	(subtype),	and	the	data	must	not	violate	the	homogeneity	of	variances.	To	test	for	normality	of	data	a	Shapiro-Wilk	test	was	performed.	As	one-way	ANOVAs	are	considered	robust	against	the	normality	assumption,	the	data	only	needed	to	be	approximately	normally	distributed,	for	this	reason	p	>	0.01	was	selected	as	the	criterion	for	data	to	be	considered	normally	distributed.	Levene's	test	for	homogeneity	of	variances	was	used,	where	p	≥	0.05	would	indicate	no	violation.	If	the	data	passed	all	of	the	assumptions	then	a	one-way	ANOVA	was	performed,	where	a	significant	result	was	defined	as	p	<	0.05.	Post-hoc	Tukey	tests	were	used	to	determine	which	subtypes	differed	from	each	other,	where	p	<	0.05	indicated	a	significant	difference.	If	the	data	violated	the	homogeneity	of	variances,	then	a	Welch	test	was	used	followed	by	a	Games-Howell	post	hoc	test	(again	with	p	<	0.05	indicting	a	significant	result).		In	addition,	whole	tumour	volume	ROIs	were	also	used	to	determine	whether	viable	ROIs	provided	any	improvement	in	subtype	identification,	using	the	same	methodology	as	described	above	(excluding	the	removal	of	necrotic	regions	from	the	ROI).			
	
9.4:	Results	
	
9.4.1:	Study	Population			 A	total	of	48	Wilms’	tumours	were	included	in	the	final	cohort;	exclusions	and	inclusions	can	be	seen	in	Figure	9.2.	The	mean	age	of	patients	at	the	time	of	their	MRI	scans	were	3.47	years	(SD:	2.91,	median:	2.66	years,	minimum:	0.44	years,	maximum:	12.17	years).	The	subtypes	of	the	tumours	were	as	follows:	blastemal:	7,	epithelial:	7,	stromal:	11,	mixed:	15,	regressive:7,	completely	necrotic:	1.	As	there	was	only	one	tumour	classed	as	completely	necrotic	it	was	excluded	from	all	analyses.	
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Figure	9.2.	Flowchart	of	study	population	showing	exclusion	criteria.	DWI	=	diffusion	weighted	imaging.	T1w	=	T1	weighted	imaging.	np	=	number	of	patients,	nt	=	number	of	tumours.		
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9.4.2:	Wilms’	Tumour	Subtypes	–	Descriptive	Statistics		 Using	the	threshold	of	0.33	enhancement,	the	percent	of	viable	tumour	tissue	per	tumour	was	calculated.	The	average	percent	of	viable	tumour	tissue	was	94%	(SD:	11.6,	minimum:	49.4%,	maximum:	100%).	The	mean,	and	25th	percentile	(75th	percentile	for	f),	were	averaged	over	each	subtype	group	per	parameter	for	the	viable	and	whole	tumour	ROIs.	Tables	9.1	and	9.2	detail	these	results.	The	mean	values	of	DDC	were	very	high,	which	was	likely	due	to	the	fitting	method	used	to	generate	this	parameter,	this	is	discussed	in	more	detail	in	Chapter	6.5.		
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Table	9.1.	Descriptive	statistics	averaged	over	each	subtype	for	each	parameter.	Values	were	obtained	from	viable	ROIs.	The	25th	percentile	is	displayed	for	every	parameter	other	than	f	where	the	75th	percentile	is	given.	ADC,	D,	D*,	f	x	D*,	DDC	and	Dk	are	all	measured	in	standard	units	of	mm/s2.		f,	α,	and	K	are	unitless		 Blastemal	
(n	=	7)	
Epithelial	
(n	=	7)	
Stromal	
(n	=	11)	
Mixed	
(n	=	15)	
Regressive	
(n	=	7)	
	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	ADC	(mono-exponential)	 1.24	x	10
-3	(2.06	x	10-4)	 0.92	x	10-3	 1.02	x	10-3	(2.11	x	10-4)	 0.80	x	10-3	 1.70	x	10-3	(2.47	x	10-4)	 1.50	x	10-3	 1.39	x	10-3	(2.83	x	10-4)	 1.10	x	10-3	 1.41	x	10-3	(3.5	x	10-4)	 1.10	x	10-3	
D	(IVIM)	 1.14	x	10-3	(2.12	x	10-4)	 0.83	x	10-3	 0.92	x	10-3	(1.93	x	10-4)	 0.73	x	10-3	 1.60	x	10-3	(2.32	x	10-4)	 1.39	x	10-3	 1.30	x	10-3	(2.74	x	10-4)	 1.01	x	10-3	 1.33	x	10-3	(3.43	x	10-4)	 1.02	x	10-3	
D*	(IVIM)	 90.3	x	10-3	(11.0	x	10-2)	 4.09	x	10-3	 69.2	x	10-3	(7.72	x	10-2)	 6.71	x	10-3	 66.6	x	10-3	(14.5	x	10-2)	 3.34	x	10-3	 43.3	x	10-3	(6.52	x	10-2)	 3.97	x	10-3	 88.2	x	10-3	(5.16	x	10-2)	 2.75	x	10-3	
f	(IVIM)	 0.18	(0.04)	 0.11	 0.15	(0.03)	 0.09	 0.18	(0.06)	 0.10	 0.15	(0.04)	 0.09	 0.71	(0.02)	 0.75	
f	x	D*	(IVIM)	 1.4	x	10-2	(1.92	x	10-2)	 6	x	10-4	 1.07	x	10-2	(1.18	x	10-2)	 7.5	x	10-4	 1.29	x	10-2	(3.47	x	10-2)	 4.7	x	10-4	 0.71	x	10-2	(1.92	x10-2)	 4.6	x	10-4	 1.35	x	10-2	(0.92	x	10-2)	 4	x	10-4	
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DDC	(stretched	exponential)	 0.56	(1.47)	 0.93	x	10-3	 8.79	(23.2)	 0.79	x	10-3	 1.27	x	10
-2	(382.72)	 1.62	x	10-3	 0.14	(0.49)	 1.14	x	10-3	 5.18	x	10+6	(1.37	x	10+7)	 1.14	x	10-3	α	(stretched	exponential)	 0.81	(3.71	x	10-2)	 0.74	 0.76	(4.08	x	10-2)	 0.70	 0.87	(4.28	x	10-2)	 0.83	 0.85	(3.86	x	10-2)	 0.79	 0.87	(5.41	x	10-2)	 0.81	
Dk	(kurtosis)	 1.85	x	10-3	(2.99	x	10-4)	 1.32	x	10-3	 1.89	x	10-3	(4.47	x	10-4)	 1.21	x	10-3	 2.33	x	10-3	(4.28	x	10-4)	 1.87	x	10-3	 1.99	x	10-3	(3.53	x	10-4)	 1.45	x	10-3	 2.01	x	10-3	(4.53	x	10-4)	 1.37	x	10-3	
K	(kurtosis)	 1.2	(0.39)	 0.39	 1.36	(0.32)	 1.09	 0.58	(0.14)	 0.34	 0.89	(0.34)	 0.55	 0.74	(0.29)	 0.30	
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Table	9.2.	Descriptive	statistics	averaged	over	each	subtype	for	each	parameter.	Values	were	obtained	from	whole	tumour	ROIs.	The	25th	percentile	is	displayed	for	every	parameter	other	than	f	where	the	75th	percentile	is	given.		ADC,	D,	D*,	f	x	D*,	DDC	and	Dk	are	all	measured	in	standard	units	of	mm/s2.		f,	α,	and	K	are	unitless		 Blastemal	
(n	=	7)	
Epithelial	
(n	=	7)	
Stromal	
(n	=	11)	
Mixed	
(n	=	15)	
Regressive	
(n	=	7)	
	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	 Mean	(Std)	 25th	/	75th	Percentile	ADC	(mono-exponential)	 1.34	x	10
-3	(4.09	x	10-4)	 1.01	x	10-3	 1.02	x	10-3	(2.12	x	10-4)	 0.80	x	10-3	 1.74	x	10-3	(2.4	x	10-4)	 1.50	x	10-3	 1.42	x	10-3	(3.11	x	10-4)	 1.11	x	10-3	 1.50	x	10-3	(4.18	x	10-4)	 1.15	x	10-3	
D	(IVIM)	 1.24	x	10-3	(4.32	x	10-4)	 0.91	x	10-3	 0.92	x	10-3	(1.93	x	10-4)	 0.73	x	10-3	 1.65	x	10-3	(2.27	x	10-4)	 1.40	x	10-3	 1.33	x	10-3	(2.98	x	10-4)	 1.03	x	10-3	 1.42	x	10-3	(4.21	x	10-4)	 1.08	x	10-3	
D*	(IVIM)	 90.8	x	10-3	(10.9	x	10-2)	 3.74	x	10-3	 69.2	x	10-3	(7.72	x	10-2)	 6.71	x	10-3	 101	x	10-3	(14.3	x	10-2)	 3.26	x	10-3	 58.3	x	10-3	(6.69	x	10-2)	 3.89	x	10-3	 88.9	x	10-3	(4.90	x	10-2)	 2.56	x	10-3	
f	(IVIM)	 0.18	(0.04)	 0.10	 0.15	(0.03)	 0.10	 0.18	(0.06)	 0.10	 0.16	(0.04)	 0.09	 0.18	(0.03)	 0.07	
f	x	D*	(IVIM)	 1.41	x	10-2	(1.9	x	10-2)	 5.67	x	10-4	 1.07	x	10-2	(1.18	x	10-2)	 7.47	x	10-4	 2.18	x	10-2	(3.42	x	10-2)	 4.63	x	10-4	 1.15	x	10-2	(1.92	x	10-2)	 4.55	x	10-4	 1.32	x	10-2	(0.87	x	10-2)	 3.71	x	10-4	
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DDC	(stretched	exponential)	 67.1
	(1.77)	 1.06	x	10-3	 8.79	(23.2)	 0.79	x	10-3	 1.15	x	10+2	(3.79	x	10+2)	 1.63	x	10-3	 12.9	(0.49)	 1.16	x	10-3	 4.68	x	10+6	(1.24	x	10+7)	 1.21	x	10-3	α	(stretched	exponential)	 0.83	(4.88	x	10-2)	 0.75	 0.76	(1.08	x	10-2)	 0.70	 0.88	(4.37	x	10-2)	 0.83	 0.85	(3.94	x	10-2)	 0.79	 0.87	(5.62	x	10-2)	 0.82	
Dk	(kurtosis)	 1.91	x	10-3	(3.79	x	10-4)	 1.45	x	10-3	 1.89	x	10-3	(4.47	x	10-4)	 1.21	x	10-3	 2.36	x	10-3	(4.15	x	10-4)	 1.89	x	10-3	 2.03	x	10-3	(3.76	x	10-4)	 1.48	x	10-3	 2.08	x	10-3	(4.82	x	10-4)	 1.44	x	10-3	
K	(kurtosis)	 1.12	(0.45)	 0.61	 1.36	(0.32)	 1.09	 0.47	(0.13)	 0.32	 0.91	(0.34)	 0.52	 0.69	(0.30)	 0.24	
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9.4.3:	Wilms’	Tumour	Subtypes	–	One-way	ANOVA	Results		 Five	Wilms’	tumour	subtypes	(blastemal,	epithelial,	stromal,	mixed	and	regressive)	were	compared	based	on	9	diffusion	parameters:	ADC	(mono-exponential),	D	(IVIM),	D*	(IVIM),	f	(IVIM),	f	x	D*	(IVIM),	DDC	(stretched	exponential),	α	(stretched	exponential),	Dk	(kurtosis),	and	K	(kurtosis).	For	every	viable	and	whole	tumour	ROI	the	25th	percentile	of	each	parameter	was	calculated	(apart	from	f	where	the	75th	percentile	was	calculated).	Mean	and	medians	were	also	investigated	however	the	25th	percentile	provided	more	significant	results.				
9.4.3.1:	One-way	ANOVA	Results	-	Mono-exponential			 For	the	viable	ROIs	ADC	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.05).	Significant	differences	between	groups	was	found	by	a	one-way	ANOVA:	F(4,	42)	=	9.42,	p	=	1.6	x	10-5.	Post-hoc	Tukey	tests	revealed	that	there	were	significant	differences	between	the	blastemal	and	stromal	(p	=	4.05	x10-4),	epithelial	and	stromal	(p	=	1.8	x	10-5),	mixed	and	stromal	(p	=	0.003)	and	regressive	and	stromal	subtypes	(p	=	0.024),	with	the	stromal	being	significantly	higher	than	the	other	subtype	groups.			 For	the	whole	tumour	ROIs,	ADC	had	no	significant	outliers,	the	data	was	normally	distributed,	but	it	did	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.032).	For	this	reason	a	Welch	ANOVA	was	used	which	showed	significant	differences	between	groups:	F(4,	42)	=	7.24,	p	=	1.58	x	10-4.	Post-hoc	Games-Howell	tests	revealed	that	there	were	similar	significant	differences	to	the	viable	ROI	with	the	stromal	group	being	significantly	higher	than	the	blastemal	(p	=	0.02),	epithelial	(p	=	4.0	x	10-6),	and	mixed	(p	=	0.002).	The	difference	between	regressive	and	stromal,	however,	was	not	found	to	be	significant	(p	>	0.05),	unlike	with	the	viable	ROIs.	However,	epithelial	ADC	values	were	significantly	smaller	than	the	mixed	which	was	not	seen	in	the	viable	ROIs	(p	=	0.021).	Figure	9.3	shows	the	ADC	ANOVA	results.							
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9.4.3.2:	One-way	ANOVA	Results	-	IVIM			 For	the	viable	ROIs,	D	had	no	significant	outliers,	the	data	was	normally	distributed,	and	but	it	did	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.042).	Significant	differences	between	groups	was	found	by	a	Welch	ANOVA:	F(4,	42)	=	10.36,	p	=	6.0	x	10-6.	Post-hoc	Games-Howell	tests	revealed	that	there	were	significant	differences	between	the	blastemal	and	stromal	(p	=	0.001),	epithelial	and	stromal	(p	=	2.0	x	10-6),	mixed	and	stromal	(p	=	0.001)	with	stromal	being	significantly	higher	than	the	other	subtype	groups.	Additionally,	there	was	a	significant	difference	between	epithelial	and	mixed	subtypes	(p	=	0.016),	with	mixed	being	significantly	higher	than	epithelial	subtypes.		For	the	whole	tumour	ROIs,	D	also	had	no	significant	outliers,	the	data	was	normally	distributed,	and	violated	the	assumption	of	homogeneity	of	variance	(p	=	0.014).	Significant	differences	between	groups	was	found	by	a	Welch	ANOVA:	F(4,	42)	=	7.89,	p	=	7.8	x	10-5.	Post-hoc	Games-Howell	tests	revealed	the	same	significant	differences	as	D	from	the	viable	ROIs;	with	stromal	being	significantly	higher	than	blastemal	(p	=	0.014),	epithelial	(p	=	2.0	x	10-6),	mixed	(p	=	0.001).	The	significantly	higher	D	values	were	also	seen	in	mixed	compared	to	epithelial	subtypes	(p	=	0.013).	Figure	9.4	shows	the	D	ANOVA	results.		 				
Figure	9.3.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	ADC	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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For	the	viable	ROIs,	D*	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.738).	A	one-way	ANOVA	showed	significant	differences	between	groups:	F(4,	42)	=	6.9,	p	=	2.32	x	10-4.	Post-hoc	Tukey	tests	revealed	that	epithelial	subtypes	had	significantly	higher	D*	values	than	blastemal	(p	=	0.024),	stromal	(p	=	0.001),	mixed	(p	=	0.004)	and	regressive	(p	=	2.16	x	10-4)	subtypes.			 For	the	whole	tumour	ROIs,	D*	results	were	the	same	as	with	the	viable	ROIs.	There	were	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.836).	One	way	ANOVA:	F(4,	42)	=	7.65,	p	=	1.01	x	10-4.	Epithelial	were	shown,	again,	to	have	significantly	higher	D*	values	than	blastemal	(p	=	0.007),	stromal	(p	=	3.2	x	10-4),	mixed	(p	=	0.002)	and	regressive	(p	=	8.6	x	10-5)	subtypes.	Figure	9.5	shows	the	D*	ANOVA	results.								
Figure	9.4.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	D	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
176 
 
						
	 For	f,	both	the	viable	and	whole	tumour	ROIs	revealed	one	significant	outlier	(an	epithelial	tumour).	After	removing	this	tumour	from	the	cohort,	both	the	viable	and	whole	tumour	ROIs	had	normally	distributed	data	and	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.16:	viable,	p	=	0.11:	whole	tumour).	One-way	ANOVAs	showed	no	significant	differences	between	groups	for	the	viable	ROIs	(p	=	0.14)	or	whole	tumour	ROIs	(p	=0.15).	Figure	9.6	shows	the	f	ANOVA	results.								
		 The	f	x	D*	parameter	was	also	investigated,	and	the	viable	ROIs	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	
Figure	9.5.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	D*	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
Figure	9.6.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	f	75th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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homogeneity	of	variance	(p	=	0.202).	A	one-way	ANOVA	revealed	significant	differences	between	groups:	F(4,	42)	=	3.79,	p	=	0.01.	Post-hoc	Tukey	tests	showed	epithelial	values	to	be	significantly	higher	than	stromal	(p	=	0.04),	mixed	(p	=	0.021)	and	regressive	(p	=	0.016).		The	same	results	were	shown	for	the	whole	tumour	ROI,	with	f	x	D*	having	no	significant	outliers,	normally	distributed	data,	and	not	violating	the	assumption	of	homogeneity	of	variance	(p	=	0.20).	A	one-way	ANOVA	revealed	significant	differences	between	groups:	F(4,	42)	=	4.12,	p	=	0.007.	Post-hoc	Tukey	tests,	again,	showed	epithelial	values	to	be	significantly	higher	than	stromal	(p	=	0.032),	mixed	(p	=	0.016)	and	regressive	(p	=	0.007).	Figure	9.7	shows	the	f	x	D*	ANOVA	results.						
	
	
	
9.4.3.3:	One-way	ANOVA	Results	–	Stretched	Exponential		For	the	viable	ROIs,	DDC	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.116).	A	one-way	ANOVA	showed	significant	differences	between	groups:	F(4,	42)	=	9.13,	p	=	2.1	x	10-5.	Post-hoc	Tukey	tests	revealed	that	stromal	subtypes	had	significantly	higher	DDC	values	compared	to	blastemal	(p	=	4.6	x10-4),	epithelial	(p	=	2.6	x	10-5),	mixed	(p	=	0.004)	and	regressive	subtypes	(p	=	0.027).		
Figure	9.7.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	f	x	D*	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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	 For	the	whole	tumour	ROIs,	DDC	also	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.076).	A	one-way	ANOVA	showed	significant	differences	between	groups:	F(4,	42)	=	6.7,	p	=	2.89	x	10-4.	The	same	differences	were	found	as	with	the	viable	ROIs	with	stromal	values	being	significantly	higher	than	blastemal	(p	=	0.014),	epithelial	(p	=	1.4	x	10-4),	mixed	(p	=	0.015).	However,	there	was	not	a	significant	difference	between	stromal	and	regressive	(p	>	0.05)	which	was	seen	with	the	viable	ROIs.	Figure	9.8	shows	the	DDC	ANOVA	results.								
For	the	viable	ROIs,	α	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.901).	A	one-way	ANOVA	showed	significant	differences	between	groups:	F(4,	42)	=	6.33,	p	=	4.41	x	10-4.	Post-hoc	Tukey	tests	revealed	that	epithelial	subtypes	had	significantly	smaller	α	values	compared	to	stromal	(p	=	0.001),	mixed	(p	=	0.02)	and	regressive	subtypes	(p	=	0.014).	Additionally,	stromal	values	were	significantly	greater	than	blastemal	(p	=	0.022).		For	the	whole	tumour	ROIs	α	also	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.807).	A	one-way	ANOVA	also	showed	significant	differences	between	groups:	F(4,	42)	=	6.05,	p	=	2.89	x	10-4.	Post-hoc	Tukey	tests	showed	that	epithelial	subtypes	had	significantly	smaller	α	than	stromal	(p	=	0.001),	mixed	(p	=	0.017)	and	regressive	subtypes	(p	=	0.008),	which	was	also	seen	in	the	viable	ROIs.		However,	no	significant	differences	were	found	between	stromal	and	blastemal	subtypes	(p	>	0.05),	unlike	the	viable	ROIs.	Figure	9.9	shows	the	α	ANOVA	results.	
Figure	9.8.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	DDC	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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9.4.3.4:	One-way	ANOVA	Results	–	Kurtosis		 For	Dk,,	both	the	viable	and	whole	tumour	ROIs	revealed	one	significant	outlier	each:	two	different	blastemal	tumours	(viable	–	25th	percentile:	7.1	x	10-4,	whole	tumour	–	
25th	percentile:	2.31	x	10-3).	Once	these	tumours	were	removed	from	the	cohort,	both	the	viable	and	whole	tumour	ROIs	had	normally	distributed	data	and	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.051:	viable,	p	=	0.131:	whole	tumour).	For	the	viable	ROI	a	one-way	ANOVA	revealed	significant	differences	between	groups	F	(4,	41)	=	5.25,	p	=	0.002.	Post-hoc	Tukey	tests	showed	that	stromal	subtypes	had	higher	Dk,	values	than	epithelial	(p	=	0.002),	mixed	(p	=	0.020),	and	regressive	(p	=	0.025)	subtypes.	The	whole	tumour	ROIs	also	revealed	significant	group	differences	F	(4,	41)	=	4.71,	p	=	0.003.	However,	post-hoc	Tukey	results	showed	a	different	pattern;	there	were	no	significant	differences	between	stromal	and	epithelial,	regressive	or	mixed	subtype	(p	>	0.05).	However,	there	were	significant	differences	between	blastemal	and	regressive	(p	=	0.024),	with	blastemal	having	higher	values,	and	epithelial	and	regressive	(p	=	0.004),	with	regressive	having	higher	values.	Figure	9.10	shows	the	Dk	ANOVA	results.					
Figure	9.9.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	α	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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	 For	the	viable	ROIs,	K	had	no	significant	outliers,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.657).	A	one-way	ANOVA	revealed	significant	differences	between	groups	F	(4,	42)	=	12.07,	p	=	1.0	x	10-6.	Post-hoc	Tukey	tests	showed	that	epithelial	values	were	significantly	higher	than	blastemal	(p	=	0.036),	stromal	(p	=	3.0	x	10-6),	regressive	(p	=	6.0	x	10-6),	and	mixed	(p	=	2.93	x	10-4).	In	addition,	blastemal	values	were	also	shown	to	be	higher	than	regressive,	and	this	difference	just	reached	significance	(p	=	0.047).	Blastemal	values	were	also	higher	than	stromal	values,	but	this	just	failed	to	reach	significance	(p	=	0.053).	For	the	whole	tumour	ROIs,	K	had	one	significant	outlier:	a	mixed	tumour	(25th	
percentile:	1.23).	After	removing	this	tumour	from	analysis,	the	data	was	normally	distributed,	and	it	did	not	violate	the	assumption	of	homogeneity	of	variance	(p	=	0.196).	A	one-way	ANOVA	revealed	significant	differences	between	groups	F	(4,	41)	=	13.21,	p	=	5.32	x	10-7.	Post-hoc	Tukey	tests	showed	similar	results	to	the	viable	ROIs;	epithelial	values	were	significantly	higher	than	blastemal	(p	=	0.009),	stromal	(p	=	1.0	x	10-6),	regressive	(p	=	2.0	x	10-6),	and	mixed	(p	=	3.4	x	10-5).	The	difference	between	blastemal	and	regressive	was,	however,	not	significant	(p	>	0.05),	unlike	with	the	viable	ROIs.	Figure	9.11	shows	the	K	ANOVA	results.				
Figure	9.10.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	Dk	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001		
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9.5:	Discussion		 This	study	sought	to	determine	whether	various	diffusion	parameters	could	distinguish	Wilms’	tumour	subtypes	from	one	another.	Nine	post-chemotherapy	diffusion	parameters	were	investigated:	ADC	(mono-exponential),	D	(IVIM),	D*	(IVIM),	f	(IVIM),	f	x	
D*	(IVIM),	DDC	(stretched	exponential),	α	(stretched	exponential),	Dk	(kurtosis),	and	K	(kurtosis).	Necrotic	portions	of	the	tumour	were	excluded	according	to	results	from	Chapter	8.	Additionally,	whole	tumour	volume	ROIs	were	also	investigated	to	determine	whether	viable	ROIs	improved	subtype	identification.	It	was	found	that	there	were	significant	differences	between	subtypes	when	compared	using	the	25th	percentile	of	each	of	the	parameters	for	both	whole	volume	ROIs	and	viable	ROIs,	except	for	f	which	did	not	reveal	a	significant	result.	Overall,	slightly	more	differences	were	seen	when	using	viable	ROIs	compared	to	whole	tumour	volume	ROIs;	for	DDC	a	regressive-stromal	difference	was	seen,	for	α	a	blastemal-stromal	difference	was	seen,	and	for	K	a	blastemal-regressive	difference	was	revealed,	whereas	these	were	not	present	when	using	whole	tumour	volume	ROIs.	As	necrosis	identification	is	also	a	very	important	aspect	of	Wilms’	tumour	treatment	response	and	outcome,	it	is	suggested	that	one	should	use	the	enhancement	threshold	derived	in	Chapter	8	(>	0.33	=	viable)	when	making	subtype	separations.		Previous	work	showed	ADC	values	of	the	blastemal	subtype	(n	=	5)	to	be	significantly	smaller	than	the	ADC	values	of	mixed	(n	=	11),	stromal	(n	=	6)	and	regressive	
Figure	9.11.	One-way	ANOVA	results	for	Wilms’	tumour	subtype	separation	using	K	25th	percentile	as	the	dependent	variable.	A:	Data	acquired	with	viable	ROIs.	B:	Data	acquired	with	whole	tumour	ROIs.	Post-hoc	significant	differences	are	shown	by	bars,	*	=	p	<	0.05,	**	=	p	≤	0.001			
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(n	=	5)	subtypes,	and	also	epithelial	(n	=	4)	ADC	values	to	be	smaller	than	stromal	values3.	In	the	present	study,	while	blastemal	ADC	values	were	lower	than	mixed	and	regressive	this	difference	was	not	significant,	however,	both	blastemal	and	epithelial	ADC	values	were	significantly	smaller	than	stromal.	The	reason	for	these	differences	may	be	due	to	the	increased	number	of	each	subtype	in	the	present	study,	and	therefore	a	greater	spread	of	ADC	values	leading	to	less	significant	differences	between	the	blastemal	and	other	subtypes.	However,	as	the	blastemal	ADC	values	were	still	low	in	the	present	study,	it	supports	previous	ideas	that	blastemal	tissue	which	remains	after	treatment	is	chemotherapy-resistant,	with	a	high	cellularity9.	There	were	more	significant	differences	seen	between	stromal	and	other	subtypes	compared	to	the	previous	study3,	with	all	other	subtypes	having	significantly	smaller	ADC	values	when	viable	ROIs	were	used.	It	has	been	suggested	that	chemotherapy	might	induce	maturation	of	Wilms’	tumour	tissue	resulting	in	stromal	subtypes9,	therefore	higher	ADC	values	may	reflect	the	decrease	in	cellularity	from	this	maturation	process.	Additionally,	previous	research	has	shown	that	median	post-chemotherapy	ADC	values	correlated	with	the	proportion	of	stromal	tissue	and	that	these	ADC	values	were	significantly	higher	than	other	subtypes4,	further	details	on	this	investigation	can	be	found	in	Chapter	4.2.4.		For	the	IVIM	model,	no	significant	differences	between	subtypes	were	found	when	using	the	f	parameter	based	on	the	75th	percentile.	This	metric	was	chosen	as	lower	values	of	f	are	linked	to	necrosis	and	this	study	aimed	to	exclude	necrotic	regions	as	to	not	obscure	values.	It	has	been	previously	shown	that	f	was	significantly	lower	in	necrotic	liver	tumours	compared	to	the	viable	tumour	components	as	defined	via	gadolinium	enhancement	and	histological	assessment8.	Despite	excluding	necrotic	tissue	in	the	present	study	using	a	threshold	and	also	taking	higher	values	to	further	avoid	necrotic	regions,	no	subtype	differences	were	seen.	
D*	revealed	many	significant	differences;	with	the	epithelial	subtype	having	higher	values	than	all	other	subtypes.	This	is	a	very	interesting	result	as	previously	epithelial	values	have	appeared	very	similar	to	blastemal,	with	both	showing	higher	cellularity	and	lower	ADC	values3.	Previous	work	using	IVIM	in	the	kidney	has	shown	D*	to	be	of	less	value	compared	to	D	and	f.	For	example,	no	differences	were	seen	when	comparing	diabetic	kidney	tissue	to	controls	in	D*	unlike	D	and	f10,	and	also	D	and	f	have	been	shown	to	be	related	to	estimated	glomerular	filtration	rate	(eGFR)	unlike	D*11.	However,	there	are	a	few	studies	which	have	shown	D*	to	provide	useful	information	with	it	being	able	to	detect	significant	differences	between	normal	kidney	function	and	mild	impairment,	and	between	normal	and	severe	impairment	in	the	renal	cortex,	whereas	D	and	f	could	not	
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make	these	distinctions12.	D*	is	thought	to	be	related	to	perfusion	in	the	randomly	orientated	capillaries,	however	other	factors	may	influence	this	parameter	such	as	tubular	flow	or	glandular	secretion13.	Epithelial	tumours	are	made	up	of	tubular	structures14,	therefore	the	higher	D*	values	seen	in	the	epithelial	subtypes	may	reflect	the	flow	through	these	tubules,	however	this	is	just	speculation.	Previously,	D*	has	been	shown	to	have	low	reproducibility15–20	(Chapter	6),	and	high	variability,	particularly	in	hypo-perfused	tissue21.	Therefore,	although	D*	could	be	very	useful	at	separating	epithelial	and	blastemal	subtypes,	this	distinction	may	not	appear	if	different	acquisitions	are	used,	thus,	limiting	the	clinical	transference	of	this	finding.	This	result	therefore	suggests	that	non-Gaussian	models	may	provide	additional	clinical	information	compared	to	ADC,	but	optimisation	of	the	models	to	ensure	low	variability	is	needed	before	making	definitive	conclusions.				Out	of	the	four	models,	the	stretched	exponential	model	was	previously	shown	to	provide	the	best	fit	to	the	Wilms’	tumour	data	(Chapter	7),	therefore	it	could	have	been	expected	to	provide	more	subtype	distinctions	compared	to	ADC.	However,	DDC	revealed	the	same	results	as	ADC	for	subtype	separations.	On	the	other	hand,	α	revealed	slightly	different	results;	with	less	stromal	differences	(only	epithelial-stromal	and	blastemal-stromal	were	seen).	However,	more	epithelial	differences	were	observed,	unlike	ADC,	with	epithelial	having	significantly	smaller	α	values	compared	to	stromal,	mixed	and	regressive.	Therefore,	although	the	model	may	provide	a	better	fit	to	the	data	(Chapter	7)	and	α	has	been	shown	to	be	reproducible17,18,22	(Chapter	6),	one	needs	to	determine	which	subtype	differences	are	the	most	important;	as	ADC	can	provide	many	differences	from	the	stromal	subtype	and	α	from	the	epithelial	subtype.	In	terms	of	treatment	and	outcome,	in	most	cases,	only	blastemal	would	differ	from	the	other	subtypes1.	Therefore,	it	may	not	be	necessary	to	acquire	multiple	b	values	to	obtain	α.				 For	the	kurtosis	model,	different	outliers	were	identified	in	DK	depending	on	which	ROIs	were	used.	In	addition,	different	subtype	distinctions	were	also	revealed	depending	on	ROIs.	Whole	volume	ROIs	could	distinguish	blastemal	and	epithelial	from	regressive,	and	viable	ROIs	could	separate	stromal	from	epithelial,	mixed	and	regressive.	The	viable	ROIs	provided	a	similar	pattern	to	the	other	diffusion	parameters	(DDC,	D,	ADC)	and	are	more	likely	to	reflect	the	differences	in	the	viable	tumour	components	compared	to	whole	tumour	ROIs.	Furthermore,	more	subtype	separations	were	identified	using	the	viable	ROIs	with	K	compared	to	the	whole	tumour	ROIs.	K	provided	many	subtype	separations	and	could	distinguish	epithelial	from	blastemal	which	as	previously	mentioned	has	not	been	shown	before3.	K	provided	the	same	results	to	D*,	with	the	addition	of	blastemal	also	showing	higher	values	than	regressive.	It	has	been	suggested	that	a	higher	value	of	K	may	
184 
 
imply	a	more	complex	tissue	environment23.	It	could	be	that	the	epithelial	subtypes	have	a	more	complex	environment	as	they	are	highly	cellular	at	the	surface	of	the	tubular	structures	and	then	are	less	cellularly	dense	in	the	centre	of	these	structures,	whereas	the	blastemal	subtypes	are	more	uniform;	consisting	of	densely	packed	cells14.	K	may	also	reflect	the	interaction	of	water	molecules	with	intracellular	compounds	and	cell	memebranes7,24,	however,	it	is	unclear	what	exactly	K	describes	in	a	biophysical	sense.	Despite	the	potentially	useful	subtype	separations	(with	blastemal	distinctions),	K	has	been	shown	have	high	variability17	and	low	reproducibility	(Chapter	6).	This	may	be	due	to	the	fitting	methods	where	without	upper	bounds	K	produces	very	high	values,	and	when	boundaries	are	applied	K	simply	hits	this	limit	(this	is	discussed	further	in	Chapter	6.5).	Therefore,	as	with	D*,	it	is	important	to	be	aware	of	the	variability	of	K,	however	this	parameter	did	show	promising	results.			 There	are	several	limitations	to	this	study,	firstly	it	relies	on	the	threshold	generated	in	Chapter	8	to	accurately	identify	necrotic	tissue.	Additionally,	Wilms’	tumours	are	very	heterogeneous,	and	it	might	be	considered	crude	to	label	a	tumour	as	a	certain	subtype	when	various	regions	of	different	cellular	compositions	exist	within	it.	Future	analysis	should	consider	reviewing	each	MRI	slice	and	matching	it	to	individual	histological	slices	to	gain	a	better	understanding	of	how	diffusion	parameters	describe	the	tissue.	Previous	work	has	shown	this	is	feasible	and	that	the	25th	percentile	of	ADC	was	correlated	with	the	percent	of	blastemal	tissue25.	However,	for	the	present	study	this	was	not	possible	and	so	the	SIOP-2001	categorisation	system	was	used.				 The	25th	percentile	was	used	as	the	dependent	variable	to	avoid	areas	with	high	diffusion	values.	Previous	work	has	found	this	to	be	a	useful	metric	in	subtype	distinctions3,4,25,	however	it	is	possible	that	other	metrics	may	also	provide	useful	subtype	separation.		 Finally,	diffusion	measurements	were	generated	from	7	and	8	b	value	ranges.	These	were	combined	to	ensure	a	larger	cohort.	As	shown	in	a	previous	chapter	(Chapter	6)	the	coefficients	of	variation	(CV)	of	DDC	(CV:	116.4%),	K	(CV:	31.82%),	and	D*	(CV:27.87%)	were	very	high	when	these	b	value	ranges	were	compared	in	healthy	adult	renal	tissue.	Therefore,	one	needs	to	be	cautious	when	interpreting	the	results	as	the	same	differences	may	not	be	found	when	different	b	values	are	used.		
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9.6:	Conclusions	and	Summary			 Wilms’	tumour	subtypes	are	identified	via	histological	analysis	after	surgery,	therefore	this	study	investigated	whether	diffusion	parameters	could	non-invasively	distinguish	Wilms’	tumour	subtypes	prior	to	surgery,	as	this	may	impact	on	treatment	decisions.			Nine	diffusion	parameters	were	investigated,	and	it	was	expected	that	all	of	these	would	provide	a	significant	one-way	ANOVA	result.	However,	the	f	parameter	did	not	reach	significance	unlike	the	other	eight	parameters	which	found	significant	differences	when	using	the	25th	percentile.	As	hypothesised,	ADC	values	were	significantly	higher	in	stromal	tissue	compared	to	other	subtypes	(p	<	0.05).	ADC	values	of	blastemal	and	epithelial	subtypes	were	also	lower	than	the	other	subtypes	as	predicted,	but	this	relationship	did	not	reach	significance.		Most	distinctions	were	seen	when	using	non-Gaussian	models	as	hypothesised.	D*	(IVIM)	and	K	(kurtosis)	provided	the	most	separations	and	managed	to	distinguish	between	blastemal	and	epithelial	subtypes,	which	previously	has	not	been	possible.	However,	both	of	these	parameters	have	low	reproducibility	and	therefore	these	results	may	not	be	replicated	in	future	studies.	Therefore,	this	result	should	be	interpreted	as	a	suggestion	that	non-Gaussian	models	may	be	clinically	useful	in	subtype	identification,	but	more	work	is	needed	to	optimise	the	reproducibility	of	certain	parameters.			As	predicted,	excluding	necrotic	regions	prior	to	separating	subtypes	improved	identification	in	some	parameters.	As	necrosis	identification	is	important	in	assessing	treatment	and	predicting	patient	outcomes,	it	is	suggested	that	this	tissue	is	identified	and	removed	for	subtype	identification.			
Main	finding:	For	subtype	identification	in	Wilms’	tumour,	analysis	should	be	limited	to	the	viable	portions	of	the	tumour.	There	is	potential	for	non-Gaussian	models	(IVIM	and	kurtosis)	to	be	able	to	identify	subtypes,	and	distinguish	between	blastemal	and	epithelial	subtypes,	however	greater	investigation	is	needed	to	optimise	and	validate	these	parameters	in	terms	of	reproducibility.			
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Chapter	10:	Thesis	Conclusions	and	Summary			The	primary	aim	of	this	thesis	was	to	investigate	the	use	of	diffusion	weighted	imaging	in	Wilms’	tumours.	Currently	in	the	UK,	in	most	cases,	Wilms’	tumour	is	treated	with	pre-operative	chemotherapy	and	then	surgery	to	remove	the	tumour,	or	the	entire	kidney1.	Most	patients	will	have	MRI	scans	prior	to	chemotherapy	and	post-treatment,	prior	to	surgery.	DWI	is	often	obtained	as	part	of	the	standard	protocol	for	Wilms’	tumour,	and	research	has	investigated	the	use	of	ADC	in	terms	of	separation	from	benign	tumours2,3,	separation	from	neuroblastoma4,	chemotherapy	changes5–7	and	subtype	identification7–9.	This	thesis	aimed	to	build	on	previous	research	by	using	non-Gaussian	models	of	diffusion:	IVIM10,	stretched	exponential11	and	kurtosis12.	Although	multiple	b	values	are	required	for	these	models,	this	thesis	explored	whether	the	models	would	better	describe	the	diffusion	signal	and	provide	additional	information	regarding	tissue	status,	thus	justifying	the	longer	scan	time.		This	thesis	consisted	of	four	experimental	chapters	(chapters	6	–	9)	which	investigated	the	reproducibility	of	diffusion	parameters	in	healthy	adult	kidney	tissue,	the	fitting	of	the	diffusion	models	in	Wilms’	tumour,	the	ability	to	identify	necrotic	tissue	without	using	gadolinium,	and	subtype	identification.			
10.1:	Chapter	Summaries	
	
10.1.1:	Summaries:	Chapter	6	Summary	The	first	study	investigated	the	reproducibility	of	eight	diffusion	parameters	from	four	models	of	diffusion	in	five	pairs	of	healthy	adult	kidneys.	Coefficients	of	variation	and	Bland-Altman	analyses	investigated	the	variability	in	parameters	across	magnetic	field	strengths	(1.5T	vs.	3T)	and	b	values.	Low	variability	was	defined	as	coefficients	of	variation	and	levels	of	bias	(as	assessed	by	the	mean	difference	from	Bland-Altman	analysis):	£15%.	
Aims	and	Hypotheses:		- In	healthy	adult	kidneys	there	will	be	a	difference	in	reproducibility	between	the	derived	parameters	from	each	model.		
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- For	both	experiments	(field	strength	and	b	values)	it	is	expected	that	the	greatest	variability	will	be	seen	in	D*	and	f	(IVIM)	and	K	(kurtosis).	- The	other	parameters	ADC	(mono-exponential),	D	(IVIM),	DDC	and	α	(stretched	exponential)	and	Dk	(kurtosis)	will	have	lower	variability.	
Conclusions		- Differences	in	reproducibility	were	found	between	the	parameters.	- The	greatest	variability	was	found	in	D*	and	K	as	expected,	however	f	was	found	to	be	reproducible.	DDC,	was	also	found	to	be	highly	variable.		- ADC,	D,	Dk,	and	α	were	all	found	to	have	low	variability	
Main	Finding:	Most	parameters	(ADC,	D,	Dk,	and	α)	are	reproducible	across	field	strengths	and	when	different	b	values	are	acquired.	More	caution	needs	to	be	taken	when	interpreting	D*,	K	and	DDC	as	these	parameters	have	high	levels	of	variability.			
10.1.2:	Summaries:	Chapter	7	Summary		 The	second	study	tested	the	how	well	each	of	the	four	diffusion	models	described	the	raw	diffusion	data	in	Wilms’	tumours,	and	the	contralateral	unaffected	normal	kidney.	Goodness	of	fit	was	based	on	the	Akaike	information	criterion.		
Aims	and	Hypotheses:		- In	contralateral	renal	tissue	IVIM	will	provide	a	superior	fit	to	the	raw	diffusion	data	compared	to	the	mono-exponential	model.		- As	there	is	a	lack	of	research	into	stretched	exponential	and	kurtosis	models	in	normal	renal	tissue	and	a	lack	of	research	into	all	three	non-Gaussian	models	in	Wilms’	tumour,	specific	directional	hypotheses	cannot	be	made	on	these	models.	This	study	thus	aims	to	identify	which	of	the	models	provide	the	best	fit	to	this	data.		- It	is	expected	that	the	different	Wilms’	tumour	subtypes	will	favour	different	models	as	they	have	different	cellular	environments.		
Conclusions:	- In	the	contralateral	renal	tissue,	the	IVIM	model	provided	the	best	fit	to	the	diffusion	data	- The	stretched	exponential	model	provided	the	best	fit	to	the	Wilms’	tumour	data		
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- While	majority	of	tumours	favoured	the	stretched	exponential	model,	there	was	high	heterogeneity	within	the	tumours,	and	kurtosis	and	IVIM	models	also	provided	good	fits	to	the	data	- There	were	no	differences	in	model	preferences	based	on	subtype		
Main	Finding:	Non-Gaussian	models	provide	superior	fits	to	diffusion	data	in	Wilms’	tumour	and	contralateral	normal	kidney	tissue	compared	to	a	mono-exponential	model.	Out	of	112	tumours	only	1	favoured	the	mono-exponential	model,	and	out	of	77	contralateral	kidneys	none	favoured	the	mono-exponential	model.			
10.1.3:	Summaries:	Chapter	8	Summary	The	third	study	attempted	to	identify	necrotic	tissue	within	post-chemotherapy	Wilms’	tumours	using	DWI	and	T1w	imaging.	The	volume	of	necrosis	in	a	Wilms’	tumour	is	informative	of	treatment	response	and	survival	rates13,	and	currently	can	be	visualised	as	non-enhancing	tissue	using	T1w	after	injecting	a	gadolinium-based	contrast	agent.	However,	there	are	many	associated	risks	with	gadolinium	and	it	may	not	always	be	a	viable	option	for	all	patients14.		
Aims	and	Hypotheses:	- There	will	be	a	relationship	between	mean	diffusion	values	and	mean	fractional	enhancement	(based	on	gadolinium	contrast)	in	Wilms’	tumours.	An	inverse	relationship	will	be	seen	in	the	majority	of	parameters	with	an	increase	in	ADC	(mono-exponential),	D	and	D*(IVIM),	DDC	and	α	(stretched	exponential),	Dk	and	K	(kurtosis)	being	significantly	(p	<	0.05)	related	to	a	decrease	in	mean	fractional	enhancement,	the	parameter	f	x	D*	(IVIM)	will	also	be	investigated	and	the	same	relationship	will	be	seen.		- A	positive	relationship	will	be	seen	with	f,	with	an	increase	in	mean	f	being	significantly	(p	<	0.05)	related	to	an	increase	in	mean	fractional	enhancement.		- The	IVIM	parameters	are	expected	to	provide	the	highest	adjusted	R2	values.	- The	selected	model	from	the	regression	analysis	will	be	compared	to	the	gadolinium	method	and	will	have	little	bias.	A	small	bias	will	be	defined	as	below	10%	based	on	Bland-Altman	analysis.	
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- A	threshold	will	be	determined	which	can	separate	necrotic	and	viable	Wilms’	tumour	tissue	based	on	diffusion	and	T1weighted	imaging	
Conclusions:	- Multiple	linear	regressions	revealed	that	combining	a	single	diffusion	parameter	and	T1w	(without	contrast)	was	significantly	related	to	fractional	enhancement	in	Wilms’	tumours.		- There	was	a	significant	inverse	relationship	between	mean	ADC	(mono-exponential),	D,	D*,	and	f	x	D	(IVIM),	DDC	and	α	(stretched	exponential),	Dk	and	K	(kurtosis)	and	mean	fractional	enhancement.	There	was	also	a	significant	positive	relationship	between	mean	f	and	mean	fractional	enhancement		- The	D-T1wnorm	model	(D	from	IVIM)	provided	the	highest	adjusted	R2	value.	However,	this	was	not	much	greater	than	ADC,	and	as	ADC	is	more	widely	available	the	ADC-T1wnorm	model	was	selected.		- The	ADC-T1wnorm	model	provided	visually	similar	maps	to	the	gadolinium	method	and	a	small	bias	was	found	between	the	two	methods	(9%)	- A	threshold	off	33%	was	generated,	thus	meaning	that	tissue	with	signal	enhancement	of	less	than	33%	(using	conventional,	post-gadolinium	T1w	data,	or	using	the	ADC-T1wnorm	model)	could	identify	necrotic	tissue	with	high	specificity	(90%)	and	sensitivity	(85%)	
Main	Finding:	ADC	and	T1w	imaging	can	provide	an	alternative	approach	to	identify	and	quantify	necrosis	in	Wilms’	tumour	without	the	need	for	contrast	agents	
	
10.1.4:	Summaries:	Chapter	9	Summary	The	final	study	aimed	to	identify	Wilms’	tumour	subtypes	using	DWI.	Currently	subtypes	can	only	be	identified	via	histological	analysis	post-surgery,	therefore	this	study	attempted	to	non-invasively	identify	the	subtypes	using	DWI.	Necrotic	tissue	was	removed	using	the	threshold	developed	in	the	third	study	(Chapter	8)	to	avoid	obscuring	the	distribution	of	diffusion	measurements	within	the	tumour	volume.	One-way	ANOVAs	compared	five	subtypes:	epithelial,	stromal,	mixed,	and	regressive	(all	intermediate	risk)	and	blastemal	(high	risk),	using	the	25th	percentile	of	diffusion	parameters	from	the	four	diffusion	models	(and	the	75th	percentile	for	the	f	parameter	from	IVIM).			
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Aims	and	Hypotheses:	- There	will	be	significant	differences	between	the	subtypes	based	on	diffusion	values.		- The	non-Gaussian	models	will	provide	more	subtype	separations	compared	to	the	mono-exponential	model	- The	blastemal	and	epithelial	subtypes	will	have	lower	ADC	values	compared	to	the	other	subtypes.	- The	stromal	subtype	will	have	the	highest	ADC	values	compared	to	the	other	subtypes.		- Limiting	the	analysis	to	just	the	viable	tumour	tissue	will	provide	more	significant	differences	between	the	subtypes	compared	to	using	the	whole	tumour	values.	
Conclusions:	- Out	of	nine	parameters	investigated	all	but	one	(f)	revealed	significant	ANOVAs	between	subtypes.	- D*	and	K	from	the	non-Gaussian	models	(IVIM	and	kurtosis)	provided	the	best	subtype	stratification,	and	could	separate	epithelial	and	blastemal	subtypes,	which	has	not	been	shown	previously7.		- The	blastemal	and	epithelial	subtypes	had	lower	ADC	values	although	this	did	not	reach	significance	when	compared	to	all	other	subtypes.	- The	stromal	subtype	had	significantly	higher	ADC	values	compared	to	the	other	subtypes.	- Limiting	the	analysis	to	the	viable	portions	of	the	tumour	provided	more	subtype	distinctions	compared	to	whole	tumour	analysis.	
Main	finding:	For	subtype	identification	in	Wilms’	tumour,	analysis	should	be	limited	to	the	viable	portions	of	the	tumour.	There	is	potential	for	non-Gaussian	models	(IVIM	and	kurtosis)	to	be	able	to	identify	subtypes,	and	distinguish	between	blastemal	and	epithelial	subtypes,	however	greater	investigation	is	needed	to	optimise	and	validate	these	parameters	in	terms	of	reproducibility.		
	
10.1.5:	Overall	Summary	Overall	this	thesis	has	explored	the	feasibility	and	utility	of	acquiring	more	advanced	measures	of	diffusion	(beyond	ADC)	in	Wilms’	tumour.	It	has	shown	that	using	
194 
 
non-Gaussian	models	can	provide	better	descriptions	of	diffusion	data	than	a	mono-exponential	model,	and	that	some	of	these	parameters	could	be	useful	in	clinical	investigations	such	as	identifying	Wilms’	tumour	subtypes.	It	has	also	demonstrated	that	necrotic	tissue	can	be	identified	using	standard	ADC	and	T1w	imaging	with	comparable	results	to	gadolinium	contrast-enhanced	imaging.			
10.2:	Limitations	Limitations	of	each	experiment	are	given	in	the	discussion	sections	of	each	experimental	chapter.	Here,	the	overall	limitations	relating	to	the	thesis	as	a	whole	are	discussed.	The	main	limitation	with	this	thesis,	and	clinical	investigations	in	general,	is	the	lack	of	control	over	the	data.	As	the	Wilms’	DWI	data	was	retrospectively	collected	and	acquired	using	the	standard	clinical	protocols	at	this	institution,	the	MRI	sequence	parameters	could	not	be	adapted.	This	meant	there	was	variation	in	b	values	used,	and	these	were	not	optimised	for	the	non-Gaussian	models	used	throughout	this	thesis,	further	details	on	this	are	discussed	in	section	10.5.	Another	limitation	with	using	a	clinical	population	is	that	it	is	very	difficult	to	acquire	a	perfect	sample.	One	cannot	control	the	size	and	subtype	of	the	tumours,	or	whether	there	is	equal	pre-	and	post-chemotherapy	data,	or	whether	all	patients	have	histological	analysis,	or	all	the	necessary	MRI	sequences.	This	can	create	challenges,	for	example	when	comparing	subtypes	with	small	uneven	populations	in	each	group.	A	limitation	which	has	been	frequently	refereed	to	throughout	this	thesis	is	the	lack	of	a	gold	standard,	and/or	histological	reference.	As	mentioned	previously,	currently	only	a	subsection	of	the	tumour	is	histologically	sampled	and	a	crude	estimate	of	necrosis	and	main	cellular	subtype	is	given.	As	Wilms’	tumours	are	very	heterogenous	this	poses	many	challenges.	Ideally	the	tumour	would	be	entirely	sampled,	and	each	slice	would	be	analysed,	thus	providing	information	about	distinct	populations	of	cellular	environments	throughout	the	tumour.	Following	this	process,	MRI	slices	could	be	matched	to	histology.	This	would	improve	MRI	analysis	as	one	would	then	be	more	confident	in	defining	a	DWI	threshold	for	subtypes	or	necrosis	identification.			
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10.3:	Improvements	to	Experiments	Conducted	From	reviewing	this	thesis	there	are	areas	which	could	have	been	improved	upon.	Firstly,	in	Chapter	6	more	volunteers	could	have	been	recruited.	This	would	have	increased	the	generalisability	of	the	findings,	however	due	to	time	constraints	this	was	not	feasible.	Furthermore,	for	field	strength	comparisons	sequences	could	have	been	adapted	so	that	they	were	perfectly	matched,	with	the	only	altered	variable	being	the	field	strength.	This	would	have	enabled	more	definitive	conclusions	to	have	been	drawn	regarding	reproducibility	relating	to	field	strength.	The	initial	aim	was	to	focus	on	the	clinical	sequences	used	at	this	institution	as	Wilms’	data	was	to	be	retrospectively	collected	and	therefore	analysis	would	have	to	rely	on	the	sequences	which	are	commonly	acquired	here.	Therefore,	the	sequences	were	not	adapted.		A	larger	cohort	of	Wilms’	patients	would	have	improved	the	investigations	in	this	thesis.	A	larger	variety	of	patients	with	varying	levels	of	treatment	response	would	have	assisted	with	necrosis	identification,	and	greater	numbers	of	epithelial	and	blastemal	subtypes	would	have	improved	the	subtype	identification.	Furthermore,	it	would	have	been	beneficial	to	have	all	the	MRI	scans	for	every	patient,	and	a	detailed	histology	and	notes	regarding	their	diagnosis,	and	treatment.	This	would	have	helped	build	up	a	clearer	picture	of	each	patient,	however	due	to	data	access	this	was	not	possible.			
10.4:	Implications	for	Future	Research	and	Patient	Care	This	thesis	has	shown	the	potential	of	using	ADC	and	non-Gaussian	models	of	diffusion	in	Wilms’	tumour.		It	has	demonstrated	that	non-Gaussian	models	describe	the	raw	diffusion	signal	better	than	a	mono-exponential	model,	according	to	AIC	values.	This	finding	will	help	with	interpretation	of	past	and	future	research	which	relies	on	ADC,	as	alternative	models	may	provide	a	more	accurate	representation	of	the	underlying	signal.	A	number	of	the	parameters	from	these	non-Gaussian	models	were	also	shown	to	have	low	variability	in	normal	renal	tissue	and	given	that	they	fit	the	data	well,	this	may	help	with	increasing	the	use	of	these	models.	Different	centres	will	be	able	to	combine	their	data	and	be	confident	that	the	parameters	will	be	not	vary	based	on	sequence	alterations.	Additionally,	certain	parameters;	D*,	K,	and	DDC,	were	not	found	to	be	reproducible	and	thus	this	will	also	assist	with	interpreting	research	and	deciding	whether	results	could	be	replicated.			
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Identifying	subtypes	in	vivo	would	greatly	improve	patient	care.	Different	subtypes	will	have	different	treatment	paths,	and	thus	early	identification	of	these	subtypes	would	improve	personalisation	of	treatment.	It	would	assist	with	decisions	in	increasing	treatment	in	those	with	high	risk	subtypes	and	also	avoiding	unnecessary	treatment	in	those	with	lower	risk	subtypes.	Given	the	side	effects	and	later	effects	of	chemotherapy,	defining	a	treatment	path	early	would	be	greatly	beneficial	for	this	paediatric	population.		This	thesis	demonstrated	that	ADC	and	parameters	from	non-Gaussian	diffusion	models	have	the	potential	to	non-invasively	identify	subtypes.	In	line	with	previous	research7–9	this	thesis	has	shown	that	the	stromal	subtype	has	a	lower	cellularity,	represented	by	a	high	ADC,	and	that	blastemal	and	epithelial	subtypes	have	a	higher	cellular	density	indicated	by	a	lower	ADC.	Previously,	however	blastemal	and	epithelial	subtypes	have	not	been	able	to	be	distinguished	using	ADC	due	to	their	similar	cellular	densities7.	Epithelial	subtypes	are	classed	as	intermediate	risk	and	blastemal	as	high	risk;	thus,	they	would	confer	a	different	treatment	path.	Non-Gaussian	models	produce	a	range	of	parameters	that	may	assist	with	this	separation.	This	thesis	suggested	that	by	using	the	25th	percentile	of	D*	and	K	there	is	a	significant	different	between	these	two	subtypes.	However,	given	the	variability	of	these	parameters	and	the	low	number	of	tumours	in	each	subtype	this	result	needs	to	be	further	explored,	which	is	discussed	in	section	10.5.	However,	this	result	does	indicate	the	potential	of	these	non-Gaussian	models	and	how	they	may	have	clinical	significance	and	thus	paves	the	way	for	future	research	in	this	area.		A	main	clinical	implication	from	this	thesis	was	the	ability	to	identify	necrotic	tissue	without	the	need	of	a	contrast	agent.	As	discussed	throughout	this	thesis	there	are	associated	challenges	and	risks	with	using	contrast	agents	and	thus	an	alternative	approach	would	be	beneficial.	The	proposed	method	uses	current	clinical	sequences,	thus	easing	clinical	transference.	Furthermore,	it	provided	a	threshold	which	would	allow	quantification	of	the	volume	of	necrotic	tissue,	and	this	could	be	identified	using	either	post-gadolinium	T1w	data	or	predicted	enhancement	maps	(using	ADC	and	pre-non-contrast	enhanced	T1w	imaging).	The	volume	of	necrosis	is	related	to	treatment	response15	and	patient	outcome13	and	thus	this	threshold	could	be	very	clinically	useful.	Additionally,	the	utility	of	non-Gaussian	models	for	detecting	necrotic	tissue	was	also	investigated.	However,	they	did	not	greatly	improve	this	estimation,	therefore	although	they	may	be	superior	at	describing	the	Wilms’	tumour	diffusion	data,	they	are	not	necessary	for	this	particular	clinical	investigation.	This	may	help	with	using	this	method	in	future	research	as	ADC	is	a	very	common	parameter	and	does	not	require	multiple	b	values.	
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10.5:	Future	Work	Based	on	the	findings	of	this	thesis	future	work	should	focus	on	the	optimisation	of	non-Gaussian	models,	in	the	hope	of	decreasing	variability	and	increasing	reproducibility.	This	could	be	done	by	exploring	different	b	values	for	different	models.	As	this	thesis	suggested	that	D*	and	K	have	the	potential	to	be	clinically	useful	in	subtype	identification,	then	future	work	should	focus	on	optimising	the	b	values	for	IVIM	and	kurtosis.	For	the	IVIM	model	a	greater	range	of	lower	b	values	should	be	used	to	capture	the	faster	diffusion	and	perfusion	effects,	for	example,	including	10	b	values	below	200mm2/s	may	help	capture	these	effects.	Conversely	for	the	kurtosis	model	higher	b	values	may	be	needed,	for	example	increasing	the	maximum	b	value	from	1,000mm2/s	to	2,000mm2/s.		This	work	could	be	evaluated	using	phantoms	by	only	altering	the	b	values	and	keeping	the	other	parameters	consistent.	By	repeating	these	experiments	and	selecting	different	b	value	ranges,	optimisation	may	be	possible.	Following	this	reproducibility	studies	could	then	be	performed	in	healthy	renal	tissue.	Firstly,	repeating	the	scans	in	a	single	session	with	no	sequence	alterations	and	then	moving	on	to	studies	where	field	strength	is	altered	to	see	if	this	would	affect	the	fitted	parameters.		Once	the	reproducibility	of	D*	and	K	are	determined	then	Wilms’	tumour	subtype	identification	can	be	further	explored	with	a	larger	cohort	of	patients.	Ideally,	histological	slices	would	be	matched	to	MR	slices	and	on	each	slice	regions	of	different	cell	types	would	be	identified.	Then	D*	and	K	values	could	be	compared	between	the	subpopulations	of	distinct	cellular	environments,	and	ANOVAs	and	post-hoc	testing	could	confirm	significant	differences.							 	
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